| Excerpt | Reference |
|---|
| "It is of note that patients with squamous cell carcinoma of the head and neck were those who responded best to this treatment, although the treatment is worthy of consideration for advanced squamous carcinoma in other areas." | ( Fletcher, WS; Grage, TB; McConnell, DB; Merhoff, GC; Moseley, HS; Sasaki, T; Wiess, AJ; Wilson, WL, 1976) |
| "During treatment of keratinizing squamous cell carcinomas with bleomycin tumor cells are devitalized by keratinization, while simple necrosis plays a minor role." | ( Bommer, G; Burkhardt, A; Gebbers, JO; Höltje, WJ, 1976) |
| "Thirty-four patients with recurrent squamous cell carcinoma of the head and neck were randomized to receive the five-drug chemotherapy regimen BACON (bleomycin, adriamycin, CCNU, vincristine [Oncovin], and mechlorethamine [nitrogen mustard]; 14 patients) or the same regimen plus bacillus Calmette-Gu erin (BCG) by scarification (20 patients)." | ( Gutterman, JU; Hersh, EM; Livingston, RB; Richman, SP; Suen, JY, 1976) |
| "Since April 1974, 60 patients with squamous cell carcinoma of the head and neck region, of poor prognosis and generally in advanced stages, were treated with the combination of a cytotoxic regimen--VBM (Vincristine, Bleomycin and Methotrexate) and radical radiotherapy." | ( Clifford, P; Dalley, VM; Edwards, W; Hollis, BA; O'Connor, AD; Smith, DJ, 1977) |
| "Forty-seven patients with squamous cell carcinoma of the esophagus were treated with a combination of cis-dichlorodiammineplatinum (II) (cis-DDP) and bleomycin by infusion." | ( Bains, M; Cvitkovic, E; Golbey, RB; Hopfan, S; Howard, J; Kelsen, DP; Shils, M, 1978) |
| "Thirty-four patients with advanced squamous cell carcinoma of the head and neck have been treated with sequential combination chemotherapy consisting of Cytoxan, methotrexate, oncovin, bleomycin and adriamycin, followed by Leucovorin (COMBAL)." | ( Kinnealey, A; Lester, EP; Matz, GJ, 1979) |
| "In 204 patients with squamous cell carcinoma of the oral tongue treated with radiation therapy, the most significant prognostic factors appeared to be the presence of neck lymph node metastasis on presentation and the status of the disease three months after treatment." | ( Chan, EK; Fu, KK; Phillips, TL; Ray, JW, 1976) |
| "Combination chemotherapy in advanced squamous carcinoma of the head and neck resulted in objective remission in 5 of 8 patients, with a median duration of 9 months." | ( Andréasson, L; Hellekant, C; Mattsson, W, 1977) |
| "Patients with squamous cell carcinoma of the head and neck, squamous cell carcinoma of the cervix, and lung carcinoma were treated with radiation therapy (RT) prior to being randomly assigned either to a group receiving no further treatment or to a group treated with combined adjuvant immunotherapy (bacillus Calmette-Guérin and levamisole)." | ( McLaren, JR; Olkowski, ZL; Skeen, MJ, 1978) |
| "Forty-three patients with squamous cell carcinoma of the head and neck were evaluated immunologically at various times before and after treatment." | ( Borowiecki, B; Croft, CB; Emeson, EE; Kukwa, A; Papenhausen, PR; Silver, C, 1979) |
| "Advanced squamous carcinoma of the head and neck remains refractory to the best combinations of surgery and radiotherapy." | ( Kirkwood, JM; Miller, D; Pitman, SW; Weichselbaum, R, 1979) |
| "The proper treatment of squamous cell carcinoma of the hand is surgical only." | ( Konz, B; Wilhelm, K, 1977) |
| "Forty four patients with squamous cell carcinoma of the head and neck from a variety of primary sites were treated with high dose methotrexate with folinic acid rescue from 1975 to 1977." | ( Bell, R; Fleming, WB; Grey, PA; Millar, HS; Sullivan, JR, 1979) |
| "Multiple lesions of Bowen's disease and squamous cell carcinoma on the penis and pubic areas developed in a 32-year-old patient with psoriasis who was undergoing treatment with psoralen and long-wave ultraviolet radiation (PUVA)." | ( Tam, DW; Urbach, F; Van Scott, EJ, 1979) |
| "A series of 9 patients with extensive squamous cell carcinomas of the conjunctiva, affecting also the cornea in 5 of them, were treated with local applications of urea." | ( Danopoulos, ED; Danopoulou, IE; Liarikos, SB; Merkuris, KM, 1979) |
| "Eight patients with squamous cell carcinoma in situ of the vagina were treated with monthly 5 day courses of 20% 5-fluorouracil cream applied to the vagina." | ( Barlow, JJ; Gamarra, M; Piver, MS; Sandecki, A; Tsukada, Y, 1979) |
| "Three dogs developed squamous cell carcinomas invading deep into the submucosal area as early as 13 to 30 weeks after the first carcinogen treatment." | ( Hanzawa, S; Katsuki, H; Kobayashi, N; Okamoto, T; Okita, M; Yarita, T, 1978) |
| "Fifty-five patients with squamous cell carcinoma of the head and neck and esophagus were evaluated prior to irradiation and thymosin fraction 5 therapy." | ( Ammann, AJ; Wara, DW; Wara, WM, 1978) |
| "Ninety-six patients with advanced squamous cell carcinoma of the head and neck were randomized to treatment with intravenous methotrexate followed by radical irradiation or radiotherapy alone." | ( Bobrow, S; Fischer, JJ; Knowlton, AH; Percarpio, B, 1975) |
| "Of the treated animals 29% died with squamous cell carcinomas of the forestomach after an average inductiom time of 167 days." | ( Eisenbrand, G; Preussmann, R; Schmähl, D, 1976) |
| "Eight squamous cell carcinomas developed in the tracheas treated with BP alone and 10 similar neoplasms arose in the CC-BP treated group, but 3 of those induced by CC-BP had metastasized by 9 months." | ( Lane, BP; Mass, MJ, 1977) |
| "A fourth patient with previously treated epidermoid carcinoma of the anus presented with biopsy-proven pulmonary metastasis and was placed on the chemotherapeutic regimen alone." | ( Newman, HK; Quan, SH, 1976) |
| "A total of 18 squamous cell carcinomas of the skin were reported in 2975 PUVA-treated patients until 1987." | ( Berne, B; Larkö, O; Lindelöf, B; Sigurgeirsson, B; Tegner, E, 1992) |
| "Twenty-eight patients with recurrent squamous carcinoma of the cervix not amenable to cure by further surgery or radiation therapy were entered into a Phase II trial utilizing i." | ( Blessing, JA; Look, KY; Malfetano, JH; Muss, HB; Partridge, EE, 1992) |
| "Sixty-seven patients with squamous cell carcinoma of the oral cavity were treated by implantation of radio-active iridium wire between 1977 and 1986." | ( Henk, JM, 1992) |
| "A third malignant neoplasm (dermal squamous cell carcinoma) was seen in a 64-year-old woman with rheumatoid arthritis after 13 months treatment with 7." | ( Eisenlohr, H; Lydtin, H; Prechtel, K; Trenkwalder, P, 1992) |
| "The authors report a case of pulmonary squamous cell carcinoma which occurred after chemotherapy of non-Hodgkin's lymphoma (NHL)." | ( Annoh, S; Arai, N; Kaneko, H; Shirai, T; Tsukahara, T; Umeda, M, 1992) |
| "A total of 8 patients with advanced squamous cell carcinoma of the penis (Jackson stages III and IV) received chemotherapy with 100 mg." | ( Fossa, SD; Ous, S; Shammas, FV, 1992) |
| "Ten patients with squamous cell carcinoma of the cervix metastatic to periaortic lymph nodes were treated with external-beam radiation therapy and synchronous infusion of intravenous 5-fluorouracil (5-FU) chemotherapy at doses of 350 mg/m2/day." | ( Drescher, CW; Hopkins, MP; Perez-Tamayo, C; Reid, GC; Roberts, JA; Schoeppel, SL; Terada, K, 1992) |
| "Fifty untreated cases of squamous cell carcinoma arising from the middle one-third of the esophagus, with no apparent extraesophageal spread on a computed tomography (CT) scan and with a Karnofsky performance status of over 70, were treated by external beam irradiation to a dose of 3500 cGy/15 fractions/3 weeks." | ( Ayyagari, S; Bhatia, SP; Kochhar, R; Negi, PS; Patel, F; Sethi, T; Sharma, SC; Singh, DP; Singh, MT; Sur, RK, 1992) |
| "The cell kinetics of 82 squamous cell carcinomas of the head and neck were studied by in vivo administration of the thymidine analogue, bromodeoxyuridine (BrdUrd)." | ( Bowie, G; Cooke, LD; Cooke, TG; Forster, G; Stanton, PD; Stell, PM, 1992) |
| "Since January 1989, eight patients with squamous cell carcinoma esophageal cancer were treated with two cycles of cytosine arabinoside (50 mg/m2) by continuous infusion for 4 days and by cisplatin (100 mg/m2) on the 5th day." | ( Batist, G; Boos, G; Mulder, D; Shennib, H; Thirlwell, M; Trudeau, M, 1992) |
| "Between 1979 and 1988, 33 patients with squamous cell carcinoma of the anal canal were treated with chemoradiation." | ( Fleshman, JW; Fry, RD; Halverson, JD; Kodner, IJ; Lopez, MJ; Monafo, WW; Myerson, RJ; Shapiro, SJ, 1991) |
| "Twelve patients with unresectable squamous cell carcinoma of the esophagus were treated with a combination chemotherapy regimen consisting of cis-diamminedichloroplatinum (CDDP), bleomycin (BLM) or peplomycin (PEP), and 5-fluorouracil (5-FU)." | ( Inoue, Y; Masamune, O; Nakamura, J; Nasu, H, 1990) |
| "Metastatic squamous cell carcinoma of the skin is associated with a poor prognosis even after surgical treatment or irradiation." | ( Garbe, C; Metelmann, HR; Müller, KP; Orfanos, CE; Zouboulis, CC, 1990) |
| "Three squamous carcinoma cell lines HBPC-1, HBPC-2, and HBPC-3 were established from hamster buccal pouch tumors induced by topical 7,12-dimethylbenz(a)anthracene (DMBA) treatment alone, topical DMBA treatment in conjunction with type 1 herpes simplex virus (HSV-1) inoculation, and topical DMBA application in combination with type 2 HSV (HSV-2) inoculation, respectively." | ( Cherrick, HM; Kim, K; Min, BM; Park, NH, 1991) |
| "Thirty-six patients with advanced squamous cell carcinoma of the head and neck (SCCHN) were treated with a regimen including cisplatinum (CP) 30 mg/m2 i." | ( Caliceti, U; Dall'Olio, D; Guaraldi, M; Laudadio, P; Martoni, A; Occhiuzzi, L; Pannuti, F; Tononi, A, 1991) |
| "A case of invasive pure squamous cell carcinoma of the urinary bladder effectively responsive to combination chemotherapy in a 79-year-old female is reported." | ( Fukuyama, T; Itoyama, M; Okamoto, E; Okamoto, K; Okuno, H, 1991) |
| "GSHt contents in squamous cell carcinomas (SCC) were twice the values measured in papillomas and 5- to 8-fold greater than the values measured in non-treated skins, and the non-tumorous tissue adjacent to SCC." | ( Cappel, RE; Gilbert, HF; Kodari, E; Reiners, JJ, 1991) |
| "A case of squamous cell carcinoma developing in a perianal condyloma acuminatum in a 38-year-old man treated for over 5 years with podophyllin is presented." | ( Barzilai, A; Bishara, B; Eitan, A, 1991) |
| "The surgical treatment of epidermoid carcinoma of the lip too rarely resorts to pluri-disciplinary confrontation, although all the possible techniques, i." | ( Barrellier, P; Clouet, JA; Kaluzinski, E; Louis, Y; Meunier-Guttin-Cluzel, A, 1991) |
| "Eleven cats with feline squamous cell carcinoma were treated with intratumoral Etanidazole and radiation therapy." | ( Brown, DQ; Curran, WJ; Evans, SM; Hanks, G; Helfand, S; LaCreta, F; VanWinkle, T, 1991) |
| "Thirty-one patients with inoperable squamous cell carcinoma of the lung were treated with a combination of cis-platin (CDDP, 100 mg/m2 day 1), ifosfamide (IFX, 2 g/m2 day 1, 2, 3; with mesna) and vindesine (VDS, 3 mg/m2 day 1)." | ( Asakawa, M; Fujita, A; Honda, R; Inoue, Y; Nakajima, S; Sasaki, H; Sekine, K; Suzuki, A, 1991) |
| "Advanced squamous cell carcinoma of the head and neck (SCCHN) is both a local-regional and a systemic disease that is ineffectively managed by conventional surgery and radiotherapy." | ( Clark, JR; Dreyfuss, AI, 1991) |
| "PME/ATP remained constant in two squamous cell carcinomas that responded to therapy and decreased in one squamous cell carcinoma that decreased in size by 40% but was classified as a nonresponder." | ( Boska, MD; Hubesch, B; Karczmar, GS; Matson, GB; Meyerhoff, DJ; Poole, J; Valone, F; Weiner, MW, 1991) |
| "Twenty-two patients with squamous cell carcinoma of the oral cavity were treated intra-arterially with epirubicin and cisplatin." | ( Haase, S; Hemmer, J; Kreidler, J; Thein, T, 1991) |
| "C-fos mice showed squamous cell carcinoma in both skin and gingiva at 8 weeks after the treatment." | ( Sakai, N, 1990) |
| "All patients had biopsy-proved squamous cell carcinoma of the head and neck, and they had either failed the traditional treatment modalities or refused conventional therapies." | ( Appelbaum, EL; Grossweiner, LI; Harris, DM; Kurtzman, DM; Lobraico, RV; Mafee, MF; Prycz, RA; Wenig, BL, 1990) |
| "Treatment of A431 squamous carcinoma cells (SqCC) with epidermal growth factor (EGF) has previously been shown to result in an induction of the synthesis and extracellular accumulation of uPA and the plasminogen-dependent proteolysis of extracellular matrix (ECM)." | ( Bajetta, S; Carbone, R; Niedbala, MJ; Sartorelli, AC, 1990) |
| "We report two cases of squamous cell carcinoma of the esophagus following endoscopic injection sclerotherapy for esophageal varices." | ( Harihara, Y; Idezuki, Y; Kokudo, N; Sanjo, K; Tada, Y; Umekita, N, 1990) |
| "Eighteen patients with advanced squamous cell carcinoma of the esophagus without prior chemotherapy were treated with carboplatin." | ( Achterrath, W; Beyer, JH; Edler, L; Fritze, D; Mross, KB; Preusser, P; Queisser, W; Rieche, K, 1990) |
| "Patients with squamous cell carcinoma of the head and neck are treated with cisplatin and fluorouracil according to a schedule based on the findings of clinical studies." | ( Rydell, R; Wennerberg, J, 1990) |
| "Two patients who had squamous cell carcinoma with extensive limbal and corneal involvement were treated with surgery and cryotherapy." | ( Char, DH; Copeland, RA, 1990) |
| "Eight patients with untreated squamous cell carcinoma of the esophagus accompanying distant metastases who were treated by one to five cycles of chemotherapy consisting of Cisplatin and 120 hour infusion of 5-Fluorouracil were reported." | ( Sueyama, H, 1990) |
| "Twelve patients with squamous cell carcinoma of the head and neck were treated with 3-day continuous infusions of etoposide (90 mg/m2/day) and doxorubicin (15 mg/m2/day)." | ( Gradishar, WJ; Kies, MS; Vokes, EE, 1990) |
| "Multicellular spheroids of MDA886LN squamous carcinoma cells treated with CDDP showed intense staining on the growing periphery compared with weak but homogeneous staining within the spheroid." | ( Khokhar, AR; Murray, L; Newman, RA; Nishikawa, K; Rosenblum, MG, 1990) |
| "A murine lung squamous carcinoma model for chemoimmunotherapy using mAb 174H." | ( Diener, E; Ding, L; Longenecker, BM; MacLean, GD; Noujaim, AA; Samuel, J, 1990) |
| "Thirty-seven patients with oral squamous cell carcinoma, many with advanced disease, were treated initially with a protocol using simultaneous intravenous 5-fluorouracil (5-FU) cis-platinum, and radiation." | ( Adelstein, DJ; Earle, AS; Indresano, AT; Sharan, VM; Vlastou, C, 1990) |
| "Thirty-five patients with nonmetastatic squamous cell carcinoma of the esophagus were treated with chemotherapy (5-fluorouracil, cisplatin) and concomitant split-course radiation therapy." | ( Carcassonne, Y; Fuentes, P; Gauthier, AP; Giovannini, M; Giudicelli, R; Padaut-Cesana, J; Seitz, JF, 1990) |
| "Epidermal growth factor (EGF) treatment of A-431 epidermoid carcinoma cells elicited a redistribution of phospholipase C-gamma 1 (PLC-gamma 1) from a predominantly cytosolic localization to membrane fractions." | ( Carpenter, G; Rhee, SG; Todderud, G; Wahl, MI, 1990) |
| "Twenty women with recurrent squamous cell carcinoma of the cervix were treated with bleomycin followed by adriamycin and mitomycin-C." | ( Blackledge, G; Chan, KK; Lawton, FG; Luesley, DM; Meanwell, CA; Mould, JJ; Perren, TJ, 1985) |
| "Fifteen patients with advanced squamous cell carcinoma of the anal canal were treated with a combination of bleomycin, vincristine, and high-dose methotrexate (BOM) with leucovorin rescue." | ( Herrera, L; Mittelman, A; Petrelli, N; Wilking, N, 1985) |
| "Advanced stage squamous cell carcinomas of the head and neck have a particularly poor prognosis despite surgical and irradiation treatment." | ( Bruntsch, U; Gallmeier, WM; Hiller, T; Theissing, J; Wandt, H; Wolff, L, 1985) |
| "Adults with advanced, measurable, squamous cell carcinoma of the esophagus were treated with a combination of cisplatin, bleomycin, and vindesine." | ( Bartolucci, AA; Dinwoodie, WR; Lyman, GH; Martelo, OJ; Sarma, PR; Velez-Garcia, E, 1986) |
| "A series of 344 patients with squamous cell carcinoma (oropharynx, larynx, hypopharynx, or buccal cavity) were treated between November 1982 and January 1985 by chemotherapy." | ( Bassot, V; Brasnu, D; Donnadieu, S; Fabre, A; Jacquillat, C; Lacau-St-Guily, J; Laccourreye, H; Menard, M, 1986) |
| "Forty patients with advanced squamous cell carcinoma of the esophagus were treated with a combination of cisplatin, 5-FU (by continuous 5-day infusion), and allopurinol; 37 are evaluable for response." | ( Cartei, G; De Besi, P; Fiorentino, M; Fosser, V; Paccagnella, A; Peracchia, A; Salvagno, L; Sileni, VC; Tremolada, C, 1986) |
| "Twenty-three patients with squamous cell carcinoma were treated with a combination chemotherapy consisting of cisplatin, vincristine, and peplomycin." | ( Araki, Y; Seita, M; Tamura, K, 1986) |
| "Fifty-six patients with squamous cell carcinoma of the head and neck were treated with the combination of vincristine, bleomycin, and methotrexate (VBM) on an every 2-week schedule." | ( Bottomley, RM; Fletcher, W; Gad-el-Mawla, N; Heilbrun, LK; Smith, RE, 1986) |
| "A maxillary squamous cell carcinoma line and an eccrine carcinoma cell line failed to express HLA-DR with gamma interferon treatment; however, the growth of cells was inhibited by gamma interferon treatment." | ( Eto, H; Kameyama, K; Kanzaki, T; Nishiyama, S; Takezaki, S; Tone, T, 1987) |
| "Ten patients with advanced squamous cell carcinoma of the uterine cervix received induction chemotherapy with cis-platinum, mitomycin-C, vincristine, and bleomycin (BOMP) over a 5 week period, followed by radiotherapy with concomitant weekly cisplatinum." | ( Bloomer, WD; Cohen, C; Dalton, JF; Dottino, P; Goodman, HM; Kredentser, D; Lipsztein, R, 1987) |
| "Between 1975 and 1984, 33 patients with squamous cell carcinoma of the nasopharynx received adjuvant chemotherapy before and/or after definitive radiotherapy at UT M." | ( Dimery, IW; Fields, R; Goepfert, H; Harrison, ML; Oswald, MJ; Peters, LJ, 1988) |
| "In case 1, a 73-year-old female with squamous cell carcinoma was successfully treated with irradiation of 4,000 rad and peplomycin of 60 mg intravenously given." | ( Kanai, S; Kondo, A; Miyake, K; Okamura, K; Otani, T; Sahashi, M; Saitoh, M; Sakakibara, T; Shimozi, T; Takashi, M, 1988) |
| "Twenty-four patients with squamous cell carcinoma of the cervix of whom 17 had relapsed following radiotherapy were studied." | ( Newlands, ES; Rustin, GJ, 1988) |
| "Twenty-three patients with gynecologic squamous cell carcinomas (20 cervical, 2 vulvar, 1 ovarian) were treated with bleomycin, vincristine, mitomycin-C, and cis-platinum." | ( Chambers, JT; Chambers, SK; Del Prete, SA; Flynn, SD; Schwartz, PE, 1989) |
| "43 patients with advanced squamous cell carcinoma of the oral cavity and oropharynx were treated preoperatively by a combined chemotherapy with bleomycin and cisplatinum." | ( Bettinger, R; Klima, A; Meyer-Breiting, E, 1988) |
| "The authors report a case of squamous cell carcinoma of the hand unusual because of its very rapid extension: A 64 year old man was referred to us for treatment of a keratoacanthoma located in the thumb web (histological diagnosis on two occasions)." | ( Garnier, D; Pageaut, G; Tropet, Y; Vichard, P, 1989) |
| "The histopathology of 54 squamous carcinomas of the head and neck was evaluated by qualitative grading and morphometry in order to identify those features which predicted a good response to cisplatinum chemotherapy." | ( Atkinson, MW; Cooke, LD; Cooke, TG; Helliwell, TR; Stell, PM, 1989) |
| "Thirty patients with advanced squamous carcinoma of the uterine cervix recurrent after radiotherapy or surgery and refractory to first-line chemotherapeutic agents were treated with ifosfamide in a dose of 1." | ( Adcock, L; Blessing, JA; DeEulis, T; Sutton, GP; Webster, KD, 1989) |
| "Twenty-one patients with squamous carcinoma of the genital tract were treated with bleomycin, Oncovin, mitomycin-C, and cisplatin (BOMP)." | ( Belinson, JL; McClure, M; Richards, AL; Stewart, JA, 1985) |
| "30 patients with locally advanced squamous cell carcinoma of the head and neck were given chemotherapy with methotrexate, bleomycin and cis-Platinum prior to planned definitive surgery and/or radiation therapy." | ( Adelstein, DJ; Carter, SG; Damm, C; Earle, AS; Haria, CD; Hines, JD; Shah, AC; Sharan, VM; Streeter, RR; Vlastou, C, 1985) |
| "Seventy patients with squamous cell carcinoma or cloacogenic carcinoma of the anus treated from 1979-1987 were reviewed." | ( Ajani, JA; Delclos, L; Hughes, LL; Martin, RG; Rich, TA, 1989) |
| "Sixty patients with advanced squamous cell carcinoma of the cervix (SCC) who had received no prior chemotherapy were entered onto a study of mitolactol (dibromodulcitol [DBD])." | ( Barrett, RJ; Blessing, JA; McGehee, R; Stehman, FB, 1989) |
| "Pre-treatment of the murine squamous carcinoma cell line CH72 with benzoyl peroxide added to the tissue culture medium increased the invasive capacity of these cells 5-8 times." | ( Bonfil, RD; Conti, CJ; Klein-Szanto, AJ; Momiki, S, 1989) |
| "We report two cases of metastasizing squamous cell carcinoma after treatment for psoriasis with methotrexate." | ( Albrektsen, SB; Jensen, DB; Krag, C, 1989) |
| "Sixty one aged patients with advanced squamous cell carcinoma of the upper aerodigestive tract were given a chemotherapy Cis DDP-5 FU before any local treatment." | ( Camuzard, JF; Demard, F; Falewee, MN; Santini, J; Schneider, M; Thyss, A; Vallicioni, J, 1989) |
| "After wide excision of the squamous cell carcinoma, the large defect of the ulnar side of the left hand was treated successfully by a distally based ulnar artery island forearm flap." | ( Endo, T; Sakai, S; Shojima, M; Soeda, S, 1989) |
| "Significant growth inhibition of squamous cell carcinoma was observed in implantable cell growth chambers retrieved 3 days after quercetin treatment." | ( Campbell, JH; Castillo, MH; Doerr, R; Hassett, JM; Kandaswami, C; Middleton, E; Perkins, E, 1989) |
| "Normal tissues and squamous cell carcinoma xenografts were examined in nude mice after administration of HPD." | ( Cobleigh, MA; Harris, DM; Hill, JH; Rok, B, 1986) |
| "Fifty-seven patients with advanced squamous carcinoma of the larynx and hypopharynx were entered on a pilot study of initial therapy using split course radiation therapy combined with simultaneous chemotherapy using mitomycin-C and 5-fluorouracil." | ( Beale, FA; Cummings, BJ; Elhakim, T; Harwood, AR; Keane, TJ; Payne, DG; Rawlinson, E, 1986) |
| "Of the 77 patients who had squamous cell carcinoma, 62 received definitive treatment for disease confined to the esophagus and regional nodes." | ( Carlson, RW; Goffinet, DR; Hancock, SL; Mark, JB, 1987) |
| "We report a case of invasive squamous cell carcinoma of the urinary bladder, which was perforated intraperitoneally after intra-arterial chemotherapy." | ( Sakurai, T; Sugao, H; Takatera, H; Takiuchi, H; Yokokawa, K, 1987) |
| "On the other hand, the incidences of squamous cell carcinoma increased in cases of mice, especially in mice treated with EHBN." | ( Fukushima, S, 1988) |
| "20 patients with primarily inoperable squamous cell carcinoma of the head and neck were treated with 2 cycles of chemotherapy prior to surgical treatment." | ( Löhr, G; Musil, J; Nagel, GA; Rauschning, W; Schröder, M; Schuff-Werner, P, 1987) |
| "Thirteen advanced, untreated squamous carcinomas of the mouth were injected and then irradiated to tolerance." | ( Barry, L; Blekkenhorst, G; Cridland, S; Rombouts, T; Sealy, R, 1988) |
| "Only squamous cell carcinomas developed in these mice, but at a significantly higher rate than in MCA-treated mice not exposed prenatally to DES." | ( Walker, BE, 1988) |
| "This report emphasizes that squamous cell carcinoma of the esophagus should be considered in the differential diagnosis of postsclerotherapy dysphagia." | ( Bochna, GS; Harned, RK; Harty, RF; Markin, RS, 1988) |
| "Thirty patients with recurrent squamous cell carcinoma of the head and neck were treated with an outpatient schedule: cisplatin (100 mg/m2) day 1 and an 8-hour infusion of 5-fluorouracil (1000 mg/m2) on days 1-4 every 28 days." | ( Airoldi, M; Brando, V; Gabriele, P; Giordano, C; Pedani, F, 1988) |
| "In patients with Stage I-II squamous cell carcinoma of the lung without regional lymph node metastases the used regimen of combined therapy had no significant effect." | ( Amiraliev, MA; Barchuk, AS; Glagolev, AN; Grigoryeva, SP; Kovalev, VN; Malay, EF; Trakhtenberg, AKh; Vidyak, IV; Zakharchenkov, AV; Zhiglov, MA, 1988) |
| "Sixty-six patients with squamous cell carcinoma of the esophagus were treated with combined surgery and radiotherapy, mostly in a sandwich fashion." | ( Hambraeus, GM; Lamm, IL; Landberg, T; Mercke, CE; Ranstam, J; Samuelsson, L; Willeń, R, 1988) |
| "The incidences of squamous cell carcinoma of the forestomach in MNNG-treated animals were significantly elevated by the diets containing CC (P less than 0." | ( Fukushima, S; Hirose, M; Ito, N; Kurata, Y; Tatematsu, M; Tsuda, H, 1988) |
| "A marked inhibition of squamous cell carcinomas and basal cell carcinomas was observed following a combined administration of MCA and vitamin A (retinol) compared to the finding for animals treated with MCA alone (P less than ." | ( Lupulescu, A, 1986) |
| "Forty-two patients with advanced squamous carcinoma of the head and neck were randomized to receive either high-dose methotrexate with leucovorin calcium rescue (23 patients) or no chemotherapy (19 patients) prior to definitive conventional treatment." | ( Caldarelli, DD; Corey, JP; Holinger, LD; Hutchinson, JC; Kooser, JA; Showel, JL; Taylor, SG, 1986) |
| "We treated 20 patients with squamous cell carcinoma of the esophagus with the following regimen: cisplatin = 100 mg/m2 i." | ( Farfaglia, R; Lancini, GP; Marini, G; Marpicati, P; Montini, E; Pezzola, D; Simoncini, E; Tonini, G; Zaniboni, A, 1987) |
| "Two patients with squamous cell carcinoma of the head and neck are reported in whom the syndrome of inappropriate antidiuretic hormone (SIADH) secretion occurred transiently during the rapid cytolytic phase of tumor destruction after chemotherapy with cis-platinum diamminedichloride and bleomycin." | ( Ervin, TJ; Hayes, DF; Lechan, RM; Miller, D; Posner, MR; Weichselbaum, RR, 1986) |
| "However, the squamous cell carcinoma group exhibited significantly lower mean G0 values after treatment with UV light (82% that of normal donors), (Ac)2ONFln (70%), MeSO2OMe (70%), and MeNOUr (69%)." | ( Burkhardt, MR; Edler, L; Jung, EG; Thielmann, HW, 1987) |
| "In 22 patients with advanced squamous cell carcinoma of the head and neck we evaluated the efficacy and toxicity of 200 mg/m2 cisplatin administered in 3% NaCl with vigorous hydration." | ( Baker, SR; Forastiere, AA; Kudla-Hatch, V; Takasugi, BJ; Wolf, GT, 1987) |
| "A human squamous carcinoma cell line (P3) was first exposed to a nontoxic dose of Rhodamine-123 (1 microgram/ml for 1 hour), then subjected to treatment with a single mode argon laser at 514." | ( Castro, DJ; Fetterman, HR; Saxton, RE; Ward, PH, 1987) |
| "In 27 patients with squamous cell carcinomas of the head and neck region hyaluronidase was added to cytostatic chemotherapy, in part of them from the beginning and in part after development of chemoresistance." | ( Baumgartner, G; Neumann, H, 1987) |
| "A human head and neck squamous cell carcinoma line (SCC25) derived from a patient with no prior history of radiotherapy or chemotherapy was made resistant to cis-diamminedichloroplatinum(II) (CDDP) by continuous escalation of weekly 30-min pulses of the CDDP from 0 to 0." | ( Cucchi, CA; Flatow, JL; Frei, E; Rosowsky, A; Teicher, BA; Trites, DH; Wright, JE, 1987) |
| "The pathogenesis of squamous carcinoma of the uterine cervix was studied by means of morphologic and cytochemical techniques in mice treated with 3,4-benzopyrene." | ( Auer, GU; Näslund, I; Rubio, CA, 1987) |
| "18 patients with advanced squamous cell carcinoma of the head and neck region were treated via chemotherapy and radio therapy." | ( Klima, A; Szepesi, S, 1987) |
| "A 87-year-old female patient with a squamous cell carcinoma of the conjunctiva was treated with local strontium-90 irradiation (with a so-called 'Dermaplatte')." | ( Daxecker, F; Göttinger, W; Langmayr, J; Philipp, W, 1987) |
| "Thirty-two patients with squamous cell carcinomas of the head and neck and three patients with parotid gland carcinomas were treated with methotrexate 40 mg/m2 followed 1 h later by 5-fluorouracil 600 mg/m2." | ( Cripps, C; Gerin-Lajoie, J; Laframboise, G; Maroun, JA; Stewart, DJ; Young, V, 1986) |
| "Fifty patients with advanced squamous cell carcinoma and adenocarcinoma of the lung having good prognostic features (performance status less than or equal to 2; weight loss less than or equal to 10%; age less than or equal to 70 years; absence of brain metastases; and no prior treatment) were treated on an outpatient basis with etoposide (120 mg/m2 on Days 1, 3, and 5) and cisplatin (60 mg/m2 on Days 1 and 2) every 21-28 days." | ( Ardizzoni, A; Baracco, F; Canobbio, L; De Palma, M; Faravelli, B; Nosenzo, M; Pronzato, P; Rubagotti, A; Serrano, J; Serrano, S, 1986) |
| "The development of metastatic squamous cell carcinoma in two of the other seven patients with multiple cutaneous neoplasms suggests that this potential hazard must be considered in the evaluation and treatment of patients with mycosis fungoides." | ( Abel, EA; Hoppe, RT; Sendagorta, E, 1986) |
| "Twenty-seven patients with squamous cell carcinoma of the head and neck were treated with i." | ( Gerin-Lajoie, J; Laframboise, G; Maroun, JA; Stewart, DJ, 1986) |
| "Sixty-two patients with squamous cell carcinoma of the head and neck were administered a mean total dose of 75." | ( Fukukita, K; Harada, T; Ito, Y; Kubo, M; Sakakura, Y; Yamagiwa, M, 1986) |
| "Thirty-one patients with unresectable squamous cell carcinoma of the head and neck, 28 with local or distant recurrences following primary surgery and/or radiation and three with distant metastases at diagnosis, were treated with cisplatin and methylglyoxal bis-guanylhydrazone (MGBG)." | ( Forastiere, AA; Perry, DJ; Takasugi, BJ; Wheeler, RH, 1986) |
| "Thirty-six patients with stage IV squamous cell carcinoma of the head and neck were treated with cisplatin (15 mg/m2), administered synchronously with high-dose radiation therapy." | ( Snyderman, NL; Suen, JY; Wetmore, SJ, 1986) |
| "Invasion or metastasis of the squamous cell carcinomas to other organs was observed in 2 male mice treated at 100 mg/kg and in 3 male mice and one female mouse treated at 200 mg/kg." | ( Boorman, GA; Cardy, RH; Chan, PC; Haseman, JK; Huff, J; Manus, AG, 1986) |
| "A woman with unresectable squamous cell carcinoma of the thymus was treated with combination chemotherapy consisting of cyclophosphamide, adriamycin, cisplatin, and prednisone." | ( Barkley, HT; Chiuten, DF; Chong, C; McKenna, RJ; Umsawasdi, T; Weedn, VW, 1986) |
| "Thirty patients with squamous cell carcinoma of the head and neck were treated with a combination of mitomycin (10 mg/m2, Day 1), vindesine (3 mg/m2, Days 1 and 8), and cisplatin (60 mg/m2, Day 1), repeated every 28 days." | ( Barrelet, L; Bernasconi, S; Leyvraz, S; Savary, M, 1987) |
| "Eleven patients with untreated advanced squamous cell carcinoma of the cervix (FIGO Stage IIIB and IVA, or positive paraaortic nodes) were treated with cisplatin 50 mg/m2 every 3 weeks for six courses prior to irradiation therapy (RT)." | ( Ferree, C; Homesley, HD; Jobson, VW; Muss, HB; Welander, C, 1987) |
| "One hundred and eight patients with squamous cell carcinoma of the upper aerodigestive tract (UADT) (T3, T4, NO-N3; 17% stage II, 54% stage III, 27% stage IV) were given three courses of chemotherapy before any local treatment." | ( Caldani, C; Chauvel, P; Demard, F; Santini, J; Schneider, M; Thyss, A; Vallicioni, J, 1986) |
| "As far as squamous cell carcinoma is concerned, the post-therapeutic courses of our combination therapy have been satisfactory." | ( Hanazawa, S; Konno, A; Okamoto, Y; Togawa, K, 1985) |
| "Sixteen patients with advanced squamous cell carcinoma of the head and neck were entered into a phase II trial of Aclacinomycin-A (ACM), 100 mg/M2 administered by brief infusion every three weeks." | ( Eckenrode, JL; Forastiere, AA; Wheeler, RH, 1985) |
| "Ninety-five patients with squamous cell carcinoma of the head and neck were entered into a randomized study testing a two-week course of induction chemotherapy with methotrexate and leucovorin given prior to regional therapy." | ( Applebaum, E; Caldarelli, DD; Holinger, LD; Hutchinson, JC; Murthy, AK; Norusis, M; Showel, JL; Taylor, SG, 1985) |
| "Seventy-five cases of primary squamous cell carcinoma of the vagina treated at the University of Pennsylvania are reviewed with long-term follow-up presented." | ( Mikuta, JJ; Rubin, SC; Young, J, 1985) |
| "Two patients with extensive squamous cell carcinoma of the lower extremities, candidate for demolitive surgery, were treated by hyperthermic antiblastic perfusion in extracorporeal circulation." | ( Andreola, S; Attili, A; Belli, F; Cascinelli, N; Marolda, R; Nava, M; Prada, A; Santinami, M; Vaglini, M, 1985) |
| "Thirty-three patients with inoperable squamous cell carcinoma of the head and neck were treated with cisplatin, 15 mg/sq m, administered synchronously with high-dose radiation therapy." | ( Leipzig, B; Putzeys, R; Snyderman, NL; Suen, JY; Wetmore, SJ, 1985) |
| "A patient presenting with aggressive squamous cell carcinoma successfully received cisplatin chemotherapy via hyperthermic, isolated limb perfusion (renal impairment ruled out systemic use)." | ( Bryant, LR; Roseman, JM; Tench, D, 1985) |
| "Two cases with squamous cell carcinoma of the cervix stage IIB with primary tumor mass about 2 X 2 X 2 cm were treated with primary chemotherapy of cis-platinum, 20 micrograms/m2 body surface intravenously daily for 5 consecutive days." | ( Kang, KJ; Kim, DS; Moon, H, 1985) |
| "Thirty patients with squamous cell carcinoma of the head and neck were treated with a combination of cisplatin (20 mg/m2) and 5-FU (400-200 mg/m2) by iv push on Days 1-5 every 21 days." | ( Grimaldi, A; Margarino, G; Merlano, M; Rosso, R; Tatarek, R, 1985) |
| "Seventy-six patients with squamous cell carcinoma of the esophagus (SCE) were treated with either cisplatin and mitomycin in combination or as single agents on ECOG protocol 2278." | ( Engstrom, PF; Lavin, PT; Stoll, DB, 1985) |
| "Twenty patients with squamous cell carcinoma of the head and neck (SCC H/N) were treated with Adriamycin (doxorubicin) at a dosage of 60 mg/m2 at 3-week intervals." | ( Applebaum, EL; Cobleigh, MA; Gallagher, PA; Hill, JH; Kukla, LJ; Lad, TE; McGuire, WP; Shevrin, DH, 1985) |
| "Twenty patients with stage III-IV squamous cell carcinoma of the head and neck were treated with the combination of a multidrug cytotoxic regimen CMF-B (cyclophosphamide, methotrexate, 5-fluorouracil, bleomycin) and radical radiotherapy." | ( Corvò, L; Merlano, M; Rosso, R; Tatarek, R, 1984) |
| "Forty-five patients with advanced squamous cell carcinoma of the head and neck, 23 of whom had received no prior therapy, were given the combination of vinblastine, 4 mg/m2 intravenously (IV) on Day 1; bleomycin, 15 mg/day intramuscularly on Days 1-7; and cis-diamminedichloroplatinum (II), 60 mg/m2 with mannitol diuresis on Day 8." | ( Blom, J; Brown, AW; Butler, WM; Garcia-Guerrero, G; Henderson, RL; Richardson, MF, 1980) |
| "Fifteen patients with advanced squamous cell carcinoma of the head and neck were treated with the six-drug Price-Hill regimen (vincristine, bleomycin, methotrexate, hydrocortisone, 5-fluorouracil, and leucovorin)." | ( Oster, MW; Raafat, J, 1980) |
| "13 patients with far advanced squamous cell carcinoma of the head and neck were treated with a low dose combination chemotherapy of Vincristine, Bleomycin and Methrotrexate during 7--8 weeks prior to surgery or radio-therapy." | ( Haass, HG; Ross, H; Ruffmann, R; Seifert, R, 1981) |
| "Thirty-two patients with squamous cell carcinoma of head and neck not amenable to surgery or radiotherapy were treated with a combination of methotrexate 0." | ( Alberto, P; Lehmann, W; Medenica, R, 1981) |
| "Twenty patients with inoperable squamous cell carcinoma of the lung (14 previously untreated and 6 previously treated) received a combination of bleomycin and cis-platinum for 6 consecutive days every 3 or 4 weeks." | ( Battesti, JP; Breau, JL; Grefft, A; Huang, D; Israël, L; Santiago Lima, FP; Valeyre, D, 1981) |
| "Fifty-one patients with stage III or IV squamous cell carcinoma of the head and neck who received induction chemotherapy with cisplatin and bleomycin sulfate with and without high-dose methotrexate were studied." | ( Coker, DD; Didolkar, MS; Elias, EG; Morris, D; Zentai, TA, 1982) |
| "We have treated 24 patients with squamous carcinoma of the head and neck and advanced regional (N2-3) disease." | ( Byfield, JE; Davidson, TM; Seagren, SL; Sharp, TR, 1982) |
| "23 patients with recurrent squamous cell carcinoma of head and neck (SCCHN) were treated with a combination of cisplatin 120 mg/m2 and adriamycin 60 mg/m2, both administered by I." | ( Jakse, R; Lehnert, M; Scherlacher, A, 1982) |
| "Twenty patients with advanced squamous cell carcinoma of the hypopharynx received two courses of chemotherapy with cisplatinum, vincristine and bleomycin before undergoing surgery." | ( Kahn, A; Lore, JM; Spaulding, MB; Sundquist, N, 1983) |
| "Nineteen patients with squamous cell carcinoma of the penis had surgical treatment or a combination of surgery and radiation." | ( Maiche, AG, 1983) |
| "Twenty-seven patients with squamous cell carcinoma of the head and neck were treated with bleomycin 7." | ( Biller, H; Brooks, S; Holland, JF; Ohnuma, T; Plasse, TF; Saponaro, E, 1984) |
| "Seventy patients with squamous cell carcinoma of the head and neck were treated with a 24-hour infusion of cisplatin, followed by vincristine and bleomycin." | ( Amrein, PC; Fingert, H; Weitzman, SA, 1983) |
| "for the treatment of an epidermoid carcinoma of the maxilla." | ( Mizutani, H; Nakajima, T; Ohashi, Y; Watanabe, I; Yokobayashi, T, 1984) |
| "28 patients with recurrent squamous cell carcinoma of the Head and Neck underwent consecutive chemotherapy." | ( Scherpe, A; Schröder, M; Stennert, E; von Heyden, HW, 1984) |
| "44 patients with advanced squamous cell carcinoma of the head and neck were randomized and treated preoperatively either with arm "A": cis-DDP (3 mg/kg iv day 1) and BLM (15-20 mg iv continuously day 2-6) or arm "B": MTX (30 mg/m2 iv day 1 + 6) and VDS (3 mg/m2 iv day 2 + 7)." | ( Beyer, JH; Hoffmann, H; Nagel, GA; Scherpe, A; Schneider, B; Schröder, M; Stennert, E; von Heyden, HW, 1984) |
| "In one, two small, smooth-surfaced, squamous cell carcinoma tumors in the right B2b of a 74-year-old man who had refused surgery disappeared three days after HpD-photoradiation, and the patient remained disease-free 16 months after the treatment." | ( Hayata, Y; Kato, H; Konaka, C; Ono, J; Takizawa, N, 1982) |
| "Sixty-seven patients with inoperable squamous cell carcinoma of the lung were randomized to receive split-course irradiation therapy, 40 Gy in 10 fractions over 5 weeks plus either placebo or misonidazole 1." | ( Hansen, HH; Kjaer, M; Panduro, J; Wolff-Jensen, J, 1983) |
| "Patients with squamous carcinoma of the upper alimentary and respiratory tract, excluding those with early disease for which the prognosis was good, who were deemed suitable for radical radiotherapy and fit to receive the drug were entered into the study." | ( , 1984) |
| "Treatment in both cases was RO-109359." | ( Guix, M; Torne Escasany, R; Umbert Millet, P; Villodres Ramos, E, 1983) |
| "30 patients with advanced squamous cell carcinoma of the head and neck received initial chemotherapy with Cisplatin (100 mg/m2 i." | ( Nagel, GA; Scherpe, A; Schröder, M; von Heyden, HW, 1984) |
| "Of 55 patients with esophageal squamous cell carcinoma, 30 with localized disease were treated with a combined modality for curative intent." | ( Asfaw, I; Franklin, R; Hoschner, J; Loh, J; Miller, P; Rosenberg, J; Steiger, Z; Vaishampayan, G, 1983) |
| "One of the squamous cell carcinoma group had palpable cervical metastasis at diagnosis, with metastatic neck disease developing in eight patients from three to 25 months after treatment." | ( Bailey, BJ; Griffiths, C; LeLiever, WC, 1984) |
| "Sixteen patients with recurrent squamous cell carcinoma of the cervix were treated with a combination of cyclophosphamide and cisplatin to determine a tolerable dose schedule, major adverse effects, and a general estimate of response rate and duration." | ( Bundy, B; Homesley, HD; Jobson, VW; Muss, HB; Thigpen, JT, 1984) |
| "Ten patients with advanced squamous carcinoma of the cervix have been treated with both radiotherapy and monthly cyclical chemotherapy." | ( Anderson, T; Blake, PR; Dowdell, JW; Lambert, HE; MacGregor, WG; O'Sullivan, JC, 1984) |
| "An 83-year-old woman with multiple squamous cell carcinomas and keratoacanthomas of the legs was treated with orally administered isotretinoin (13 cis-retinoic acid)." | ( Levine, N; Meyskens, FL; Miller, RC, 1984) |
| "The chemotherapy schedule used for treatment of epidermoid carcinoma of the buccal cavity is described, together with the technique proposed by Richard for introduction of the intra-arterial catheters." | ( Bonduelle, M; Jagailloux, JL; Marx, O; Solas, J, 1984) |
| "Thirty-six patients with squamous cell carcinoma of the head and neck were treated with sequential methotrexate-5-fluorouracil followed by leucovorin rescue." | ( Ewert, G; Kinnman, J; Lundqvist, PG; Ringborg, U; Strander, H, 1983) |
| "Sixty-five patients with squamous carcinoma of the esophagus (32 patients), carcinoma of the stomach (18 patients) and carcinoma of the biliary tract (15 patients) received from 6000 to 7000 equivalent rad (60-70 Gray-equivalents) of helium radiotherapy at 2." | ( Austin-Seymour, M; Cartigny, A; Castro, JR; Chen, GT; Collier, JM; Friedman, M; Phillips, TL; Pitluck, S; Saunders, WM; Woodruff, KH, 1983) |
| "We report two cases in which cutaneous squamous cell carcinomata developed in patients with psoriasis on razoxane therapy." | ( Horton, JJ; MacDonald, DM; Wells, RS, 1983) |
| "Seventeen patients with head and neck squamous cell carcinoma were treated with cis-diamminedichloroplatinum (II) CDDP 2." | ( Howell, A; Tranter, RM, 1983) |
| "The treatment of squamous cell carcinomas of the oropharynx still remains a problem because of the high rate of recurrence and the functional importance of the oropharynx in speech and swallowing." | ( Kastenbauer, ER; von Scheel, J, 1983) |
| "From 1955 to 1975, 116 patients with squamous cell carcinoma of the floor of the mouth were primarily treated by irradiation in the Department of Radiation Oncology, University of Maryland at Baltimore." | ( Amornmarn, R; Aygun, C; Prempree, T; Salazar, OM; Sewchand, W, 1984) |
| "Thirty-six cases of squamous cell carcinoma of the maxillary sinus were treated between 1974 and 1981, and followed up for more than 2 years." | ( Miyata, M; Morita, M, 1984) |
| "Thirty patients with recurrent squamous cell carcinoma of the head and neck were treated with methotrexate (250 mg/m2) followed 1 hour later by 5-FU (600 mg/m2)." | ( Jacobs, C, 1982) |
| "Thirteen patients with squamous cell carcinoma of the lung (T1-3, N1-2, M0) received cisplatin (20 mg/m2 per day) on 5 consecutive days with NaCl hyperhydratation (0,9% NaCl, 2400 ml/24 hours as continuous infusion) in the first and last week of radiotherapy (5 X 2 Gy/week, 56 Gy target volume dose)." | ( Arndt, D; Henning, A; Higi, M; Schmitt, G; Schreiber, D, 1982) |
| "Twenty-eight patients with squamous cell carcinoma of the anal canal were treated by preoperative radiation therapy and chemotherapy." | ( Considine, B; Kinzie, JJ; Leichman, L; Nigro, ND; Seydel, HG; Vaitkevicius, VK, 1983) |
| "Until recently most squamous cell carcinomas of the anal canal were treated by radical surgery." | ( Bailly, C; Chassard, JL; Gerard, JP; Mayer, M; Montbarbon, JF; Papillon, J, 1983) |
| "Sixteen patients with advanced squamous cell carcinoma of the head and neck were treated with a 48-hour I." | ( Bromer, RH; Byrne, RE; Fofonoff, SA; Hoffer, SM; Hong, WK; Licciardello, JT; Popkin, JD; Strong, MS; Vaughan, CW; Welch, JM, 1983) |
| "Ten patients with terminal squamous cell carcinoma of the head and neck were treated with indomethacin, and inhibitor of PG synthesis." | ( Hirsch, B; Johnson, JT; Rabin, BS; Thearle, PB, 1983) |
| "The number and size of squamous cell carcinomas were 3-fold greater compared to those in mice treated with MCA alone." | ( Lupulescu, A, 1983) |
| "Patients presenting with Stage III-IV squamous carcinoma of the head and neck often relapse following aggressive surgery and/or radiotherapy." | ( Ervin, TJ; Frei, E; Kirkwood, J; Miller, D; Pitman, SW; Weichselbaum, RR, 1981) |
| "Thirty-one patients with advanced stage squamous cell carcinoma of the cervix were treated with the four-drug combination fluorouracil, doxorubicin, cyclophosphamide, and vincristine." | ( Aroney, RS; Chan, WK; Fox, RM; Levi, JA; Tattersall, MH; Woods, RL, 1982) |
| "One hundred and sixty-six patients with squamous cell carcinoma of the tongue were treated with radiation." | ( Horiuchi, J; Okuyama, T; Shibuya, H; Takeda, M, 1982) |
| "25 patients with advanced head-neck-squamous cell carcinoma were treated with a combination of Vindesine and Cis-Platinum." | ( Ross, H; Ruffmann, R; Seifert, R; Sturm, E, 1982) |
| "A rapidly growing squamous cell carcinoma developed in an area of active pemphigus vulgaris on the cheek of a 45-year-old woman during treatment with prednisone and cyclophosphamide." | ( Cramer, SF; Mahomed, Y; Mandel, MA; Michel, B, 1980) |
| "Twenty-four patients with maxillary squamous cell carcinoma were treated with 50 micrograms of phytohemagglutinin (PHA), saturated into pieces of gelatin sponge, and applied to the maxillary sinus which was in advance surgically exposed via the peroral route." | ( Okuda, M; Sakaguchi, K; Takahashi, M; Tomiyama, S, 1980) |
| "Antigenetic determinant of squamous cell carcinoma reactive with KYSM-1 was revealed to be protein moiety after enzyme treatment, and molecular weight of the antigen was about 60,000 analysed by Western blotting." | ( Tomita, Y, 1994) |
| "Recurrent squamous cell carcinoma of the head and neck is poorly responsive to most chemotherapy regimens." | ( Baez, L; Benner, SE; Brooks, J; Dimery, IW; Earley, CL; Hong, WK; Huber, MH; Lippman, SM; Shirinian, M; Winn, RJ, 1995) |
| "Patients with recurrent squamous cell carcinoma of the head and neck were treated with carboplatin 400 mg/m2 followed by bleomycin 15 units intravenously as a continuous infusion for 4 days." | ( Baez, L; Benner, SE; Brooks, J; Dimery, IW; Earley, CL; Hong, WK; Huber, MH; Lippman, SM; Shirinian, M; Winn, RJ, 1995) |
| "Sixty-three patients with head and neck squamous cell carcinomas, other than nasopharyngeal cancer and Stage I (UICC) laryngeal cancers, were treated by external radiotherapy and four courses of carboplatin at a dose of 100 mg/m2 per week." | ( Arimoto, T; Hosokawa, Y; Inuyama, Y; Kamada, T; Kitahara, T; Nishioka, T; Ohmori, K; Shirato, H; Yahata, H; Yasuda, M, 1995) |
| "Primary squamous cell carcinoma (SCC) of the breast is a rare malignancy whose optimal treatment and prognosis are unknown." | ( Davis, HL; Dayer, AM; Dejager, D; Komorowski, RA; Redlich, PN, 1995) |
| "Cytokinetics of 27 untreated oral squamous cell carcinomas were evaluated by in vitro bromodeoxyuridine (BrdU) labelling." | ( Chakraborty, RN; Chatterjee, R; Mukhopadhyay, D, 1995) |
| "One hundred nine patients with T1-2N0 squamous cell carcinoma of the glottic larynx were treated with definitive radiotherapy at the Fox Chase Cancer Center between June 1980 and November 1990." | ( Coia, LR; Curran, WJ; Fein, DA; Hanlon, AL; Langer, CJ; Lee, WR; Ridge, JA, 1995) |
| "C3H/HeJ mice bearing squamous cell carcinoma (SCCVII) were treated with piroxicam (0." | ( Abbas, MM; D'Amico, F; Snyderman, CH; Wagner, R, 1995) |
| "53 patients with squamous cell carcinoma of the head and neck recurrent after initial treatment were entered into a phase II trial of the epirubicin, methotrexate and bleomycin (EMB) combination." | ( Bianco, A; Cavaniglia, G; Frattina, A; Lunghi, F; Migliorini, V; Paccagnella, A; Pappagallo, GL; Segati, R; Sileni, VC; Zorat, P, 1993) |
| "Treatment of oral squamous carcinoma cells (SCC-15) with delta 12-PGJ2, PGJ2, and vitamin E succinate, individually, caused significant concentration-dependent inhibition of cell proliferation to various degrees." | ( elAttar, TM; Lin, HS, 1995) |
| "Patients with locally advanced squamous cell carcinoma of the bulbomembranous urethra fare poorly whether they undergo surgery or primary radiotherapy." | ( Huang, DT; Lutz, ST, 1995) |
| "From 1972 to 1991, 237 patients with squamous cell carcinoma of the lower lip were treated by exclusive LDR brachytherapy (192Ir)." | ( Beauvois, S; Carolus, JM; Dartois, D; Hoffstetter, S; Luporsi, E; Peiffert, D; Pernot, M, 1994) |
| "Advanced squamous cell carcinoma of the upper lip is necessarily managed by primary surgery when radiotherapy facilities are not available." | ( Jacob, OJ, 1995) |
| "Chemotherapy for squamous cell carcinoma with unknown primary (SCUP) has not been prospectively studied." | ( Allred, C; Anand, V; Khansur, T; Little, D, 1995) |
| "A case of Stage IV endometrial squamous cell carcinoma occurring 8 years after a low anterior resection and whole pelvic radiation therapy for a Dukes D colon carcinoma is presented." | ( Kaminski, PF; Kreider, J; Olt, GJ; Podczaski, ES; Sorosky, JI; Zaino, R, 1995) |
| "Recurrent squamous cell carcinoma of the head and neck is poorly responsive to chemotherapy in most patients; therefore, the development of new approaches is essential." | ( Benner, SE; Dimery, IW; Esparaz, B; Frenning, D; Guillory-Perez, C; Hong, WK; Huber, MH; Lippman, SM; Shirinian, M, 1994) |
| "Human squamous carcinoma cells, both previously untreated, as well as survivors of fractionated radiation therapy, were tested in vitro for their sensitivity to gamma radiation and cisplatinum." | ( Hyden, EC; Redpath, JL; Sun, C, 1995) |
| "Four patients with cervical cancer (squamous cell carcinoma: two cases of stage Ib, one of stage IIa, adenocarcinoma: one of stage Ib), were treated preoperatively by intravaginal administration of CDDP (20 mg) suppositories with pessary 7 times every other day." | ( Fujii, T; Furui, J; Kioka, H; Murakami, J; Naito, H; Nakagawa, H; Sanada, M; Tanaka, T; Tanimoto, H; Tanioka, Y, 1995) |
| "We report a primary squamous cell carcinoma of the prostate that developed in a 57-year-old man, 3 years after treatment with leuprolide and flutamide for Stage D1 adenocarcinoma of the prostate." | ( Braslis, KG; Civantos, F; Davi, RC; Nelson, E; Soloway, MS, 1995) |
| "However, for the SCC-VII squamous cell carcinoma, following small numbers of fractions there appeared to be more repopulation during the aerobic treatment schedule." | ( Hill, RP; Speke, AK, 1995) |
| "Seven oesophageal squamous carcinomas, treated with pre-operative chemotherapy (mitomycin-C, ifosfamide and cisplatin-MIC), with a course finishing 21 days prior to resection, were examined by electronmicroscopy." | ( Antonakopoulos, GN; Darnton, SJ; Duffy, JP; Matthews, HR; Newman, J, 1994) |
| "Several squamous cell carcinoma cell lines do not show a detectable decrease in cdc2 or increase in transglutaminase type I mRNA levels after IFN-gamma treatment and appear to be altered in their control of squamous differentiation." | ( Jetten, AM; Saunders, NA, 1994) |
| "Seventy four cases of squamous cell carcinoma of the oral cavity were treated using interstitial Iridium-192." | ( Barrie, R; Carton, AT; Dawes, PK; Henderson, R; Macleod, RL; Piggot, TA; Podd, TJ; Roberts, JT; Stassen, LF, 1994) |
| "We describe a case of invasive squamous carcinoma of the vagina submitted to neoadjuvant therapy with carboplatinum." | ( Bellino, R; Ferraris, G; Lanza, A; Lauricella, A; Leo, L; Re, A; Tessarolo, M, 1994) |
| "We have treated 17 patients with squamous cell carcinoma of the upper esophagus by alternating chemoradiotherapy and by following the patients for 2 to 5 years, or until their death." | ( Chadha, M; Malamud, S; Vikram, B; Yu, L, 1994) |
| "Head and neck squamous cell carcinoma has a relatively good prognosis but treatment may be at the expense of function and quality of life." | ( Caslin, AW; Cooke, LD; Cooke, TG; Forster, G; Jones, AS; Roland, NJ, 1994) |
| "In 2 cases of squamous cell carcinoma of maxillary gingiva, carboplatin (CBDCA) was administered by continuous infusion for 5 days, and the clinical outcome and platinum concentrations in the peripheral blood, urine and tissue were investigated." | ( Asanami, S; Susami, E; Uchiyama, K, 1994) |
| "Mouse squamous cell carcinoma VII (SCCVII) tumors were treated with a single dose of 10 Gy or a single dose of the bioreductive hypoxic cell cytotoxin, tirapazamine (SR 4233, 0." | ( Brown, JM; Kim, IH, 1994) |
| "Six patients with squamous cell carcinomas of the head and neck were given accelerated radiotherapy, carbogen breathing and high dose nicotinamide in order to evaluate the feasibility of this treatment regimen." | ( Denekamp, J; Dennis, M; Franzén, L; Henriksson, R; Littbrand, B; Rojas, AM; Stratford, M; Zackrisson, B, 1994) |
| "Neo-adjuvant therapy with MIC in squamous carcinoma of the oesophagus has shown encouraging early results, with acceptable toxicity." | ( Allen, SM; Cullen, MH; Darnton, SJ; Duffy, JP; Matthews, HR; Walker, SJ, 1994) |
| "The outcomes of patients with squamous cell carcinoma of the anal canal treated by either sphincter-preserving procedures or radical surgery were evaluated, with the goals of identifying factors predicting treatment failure and quantifying results of salvage therapy in patients with recurrent disease." | ( Coplin, MA; Johnson, FE; Longo, WE; Vernava, AM; Virgo, KS; Wade, TP, 1994) |
| "Treatment of squamous cell carcinoma (SCCVII) bearing mice with the immunostimulant schizophyllan (SPG) raised the relative content of Mac-1 positive host cells infiltrating the tumor and increased photofrin retention in these tumors." | ( Korbelik, M; Krosl, G, 1994) |
| "Cytosol from EGF-treated A-431 human epidermoid carcinoma cells was used as a source of PTPase activity, and tyrosine-phosphorylated ErbB2, EGF receptor, phospholipase C-gamma 1, and the Ras GTPase-activating protein were used as substrates to monitor PTPase activity." | ( Arteaga, CL; Carpenter, G; Hernández-Sotomayor, SM; Soler, C, 1993) |
| "Of the 16 tumors, 14 were squamous cell carcinomas; 11 were previously untreated." | ( Dunphy, EP; Terris, DJ, 1994) |
| "Twenty evaluable patients with squamous cell carcinoma of the cervix, who had previously received a cisplatin-containing regimen, were treated with amonafide 300 mg/m2 over 1 hour for 5 consecutive days every 3 weeks." | ( Asbury, RF; Blessing, JA; Soper, JT, 1994) |
| "Twelve patients with recurrent squamous cell carcinoma of the cervix restricted to the pelvis were treated with intra-arterial infusion of carboplatin." | ( Bertrand, M; Dahrouge, S; Genest, P; Prefontaine, M; Verma, S, 1994) |
| "12 patients with metastatic squamous cell carcinoma of an unknown primary tumor localized to the neck were treated with induction chemotherapy and radiotherapy." | ( Jeremic, B; Marinkovic, J; Matovic, M; Zivic, DJ, 1993) |
| "Eleven patients with biopsy-confirmed squamous cell carcinoma of the head and neck were studied before, during, and after a 6-week course of radiation therapy with positron emission tomography (PET)-FDG imaging." | ( Anzai, Y; Chaiken, L; Choi, Y; Hawkins, RA; Hoh, CK; Juillard, G; Lufkin, R; Maddahi, J; Phelps, ME; Rege, SD, 1993) |
| "The standard chemotherapy of squamous cell carcinomas of the head and neck is cisplatin and 5-FU." | ( Hainz, A; Schlappack, O; Springer, B, 1994) |
| "Head and neck squamous carcinoma (HNSCC) is a chemotherapy-sensitive tumour, but this sensitivity is not reflected in an impact on survival." | ( Cappelaere, P; Cognetti, F; De Mulder, PH; Kirkpatrick, A; Lefebvre, JL; Schornagel, JH; Vermorken, JB; Verweij, J, 1994) |
| "Twenty-six patients with squamous cell carcinoma of the head and neck and documented progression after or during previous chemotherapy were entered into the study." | ( Cappelaere, P; Cognetti, F; De Mulder, PH; Kirkpatrick, A; Lefebvre, JL; Schornagel, JH; Vermorken, JB; Verweij, J, 1994) |
| "27th, 1990 for lung cancer (squamous cell carcinoma), and courses of adjuvant chemotherapy (CBDCA, IFX, etoposide) during the following admission period." | ( Ando, M; Araki, N; Ikuta, N; Matsumoto, K; Suzuki, R; Takagi, K; Taki, F, 1993) |
| "Specimens from 39 cases of squamous cell carcinoma of the penis were treated for the papilloma virus using the bovine papilloma virus antibody and the peroxidase-antiperoxidase technique." | ( Kini, U; Shariff, S; Thomas, JA, 1993) |
| "We recommend then to treat T1 and T2 squamous cell carcinomas of the faucial arch by external radiation therapy to tumor site and neck areas (45 Gy/25 fractions/5 weeks) followed by a 30 Gy Iridium implant and, for patients with clinically positive nodes, either a further 25-30 Gy electron beam irradiation to the nodes or neck node dissection." | ( Belkacemi, Y; Calitchi, E; Haddad, E; Le Pechoux, C; Martin, M; Mazeron, JJ; Peynegre, R; Piedbois, P; Simon, JM; Strunski, W, 1993) |
| "Twenty-nine patients with squamous cell carcinoma of the nasal vestibule who were treated with curative intent between 1960 and 1989 were analyzed." | ( Poulsen, M; Turner, S, 1993) |
| "Chemotherapeutic treatment of squamous cell carcinoma (SCC) of the head and neck has been largely ineffective because of tumor cell resistance." | ( Burgess, R; Dawson, D; Haller, J, 1993) |
| "Thirty patients treated for squamous cell carcinoma of the upper aerodigestive tract were reviewed for a cell kinetics study using bromodeoxyuridine (BrdU)." | ( Gluckman, JL; Hirano, T; Zitsch, RP, 1993) |
| "Twenty-six patients with advanced squamous carcinoma of the head and neck or local recurrence after surgery and/or radiotherapy received carboplatin 300 mg/m2 intravenously on day 1 and 5-fluorouracil 1 gm/m2 by continuous intravenous infusion for 4 days." | ( Canney, P; Junor, E; Yosef, H, 1993) |
| "The management of locoregional squamous cell carcinoma of the anus with a combined modality approach comprising chemotherapy and radiotherapy is well established." | ( Evans, TR; Glees, JP; Mansi, JL, 1993) |
| "All 12 patients with squamous carcinoma treated with preoperative mitomycin, ifosfamide, and cisplatin (MIC) showed noticeable histological changes when compared with the 13 control cases." | ( Allen, SM; Darnton, SJ; Edwards, CW; Matthews, HR, 1993) |
| "We report 2 additional cases of squamous cell carcinoma of the bladder that occurred in patients after cyclophosphamide treatment for Wegener's granulomatosis." | ( Boyd, SD; Skinner, DG; Skinner, EC; Stein, JP, 1993) |
| "Seventy patients with local squamous cell carcinoma of the esophagus were treated between 1981 and 1990 with preoperative chemotherapy, surgical resection, and possible postoperative radiation therapy and/or chemotherapy." | ( Bromberg, C; Carey, RW; Choi, NC; Grillo, HC; Hilgenberg, AD; Logan, DL; Mathisen, DJ; Wain, JC; Wilkins, EW, 1993) |
| "From 1972 to 1986, 108 patients with squamous cell carcinoma of the maxillary sinus were treated at the Department of Radiology, University of Tokyo Hospital." | ( Akanuma, A; Aoki, Y; Hasezawa, K; Karasawa, K; Muta, N; Nakagawa, K; Onogi, Y; Sakata, K; Sasaki, Y; Terahara, A, 1993) |
| "Fifteen patients with squamous cell carcinoma of the uterine cervix--7 in stage II, 6 in stage III and 2 in stage IV--were considered not to respond at the end of radiotherapy." | ( Raffetto, N; Salvatori, F; Trinci, C; Trinci, M, 1993) |
| "Forty-three patients with locoregional squamous cell carcinoma or adenocarcinoma of the esophagus or cardia were treated with fluorouracil (5-FU), cisplatin, and bolus vinblastine concurrent with radiation administered over 21 days." | ( Forastiere, AA; Orringer, MB; Perez-Tamayo, C; Urba, SG; Zahurak, M, 1993) |
| "Of the squamous carcinomas, 74% (20/27) responded to MIC but only one expressed P-GP before and after treatment." | ( Darnton, SJ; Ferry, DR; Jenner, K; Matthews, HR; Steyn, RS, 1995) |
| "Fifty-six patients with squamous cell carcinomas of the esophagus were treated between April 1989 and September 1993 in the Centre Hospitalier Universitaire in Brest, France with two courses of preoperative concomitant radiochemotherapy, separated by a 2-week interval, and followed by surgery (each course 18." | ( Labat, JP; Lozac'h, P; Lucas, B; Malhaire, JP; Simon, H; Topart, P; Volant, A, 1996) |
| "The tongue derived squamous carcinoma cell line, SCC-25, was treated with three leukotriene synthesis inhibitors and indomethacin." | ( Adams, GL; Juhn, SK; Ondrey, FG, 1996) |
| "Twenty-three patients with advanced squamous cell carcinoma of the head and neck who had received no prior chemotherapy were treated with carboplatin 350 mg/m2 followed by cisplatin 50 mg/m2 every 28 days." | ( Inabinet, RT; Muss, HB; Patton, JF; Powell, BL; Russell, GB; White, DR, 1996) |
| "Thirty-one patients with squamous cell carcinoma of the vulva were treated with two courses of combination chemotherapy mitomycin C, 15 mg/m2 intravenously (i." | ( di Re, F; Fontanelli, R; Kenda, R; Lupi, G; Paladini, D; Raspagliesi, F; Zucali, R, 1996) |
| "Sixty-three patients with squamous cell carcinoma of the head and neck determined as potentially curable were prospectively evaluated before treatment and compared to 17 patients with apparent cure of head and neck squamous cell cancer who served as controls." | ( Hoffman, HT; Krause, CJ; Talmi, YP; Wolf, GT, 1996) |
| "The treatment of locally advanced squamous cell carcinomas of the head and neck presents a challenge for oncologists." | ( Afridi, N; DeLaney, TF; Faller, DV; Fuleihan, NS; Nogueira, CP; Sanders, DA; Taghian, AG, 1996) |
| "Patients with locally advanced squamous cell carcinoma of the cervix have a poor prognosis when treated by standard radiotherapy (RT) alone." | ( Anderson, PS; Beitler, J; Fields, AL; Goldberg, GL; Runowicz, CD; Sood, B; Wadler, S, 1996) |
| "All patients were required to have squamous cell carcinoma of the head and neck that had recurred following surgery or radiotherapy or both." | ( Benner, SE; Dimery, IW; Dunnington, JS; Hong, WK; Huber, MH; Lippman, SM; Shirinian, M, 1996) |
| "Advanced head and neck squamous cell carcinomas (HNSCCs) have a poor prognosis despite aggressive multimodal therapy." | ( Davidson, BL; Goebel, EA; Graham, SM; Kern, JA; Zabner, J, 1996) |
| "Patients presenting with squamous cell carcinoma of the pyriform sinus, epilarynx or postcricoid area with indication of pharyngolaryngectomy, without previous treatment, distant metastasis, multiple primaries or general contraindications for surgery and chemotherapy were included in the study." | ( Domenge, C; Eschwège, F; Leridant, AM; Luboinski, B; Mamelle, G; Wibault, P, 1996) |
| "All patients had verified squamous cell carcinoma and were referred for primary radiation therapy." | ( Dobrowsky, E; Dobrowsky, W; Grasl, M; Kautzky, M; Köhler, W; Millesi, W; Naudé, J; Pavelka, R; Reichel, M; Wilson, GD, 1996) |
| "Results of 21 cases of squamous cell carcinoma of anal canal treated by continuous infusion of 5-fluorouracil 1000 mg/sqm for 4 days and mitomycin-C 15 mg/sqm on 1st day by i." | ( Mishra, RC; Sai, PL; Senapati, S, 1996) |
| "We report two patients with recurrent squamous cell carcinoma (SCC) of the cervix who had small-volume progressive metastatic disease, and were treated with a combination of IFN-alpha and 13-cis-retinoic acid." | ( Aapro, MS; Bianca, J; DeCaro, L; Delclos, L; Edwards, CL; Freedman, RS; Kavanagh, JJ; Kudelka, AP; Mountain, CF; Piamsomboon, S; Termrungruanglert, W; Verschraegen, CF, 1996) |
| "333 patients with squamous cell carcinoma of the oral cavity were treated with a short radical radiotherapy regime to the primary site and involved lymph node groups at the Christie Hospital, Manchester, between 1980 and 1987." | ( Gupta, NK; Slevin, NJ; Swindell, R; Turner, SL, 1996) |
| "Forty-one patients with squamous cell carcinoma of the oral cavity (including soft palate) were treated preoperatively with cisplatin or carboplatin, and 5-fluorouracil or peplomycin in combination with simultaneous irradiation to a target volume of 40Gy, and 2-6 weeks later, curative surgery was performed." | ( Kamikaido, N; Kirita, T; Ohgi, K; Sugimura, M; Tsuyuki, M; Yamamoto, K, 1996) |
| "Thirteen patients with advanced squamous cell carcinoma of the esophagus were treated with 1,000 mg/m2/day 5-fluorouracil days 1-5 continuously and 100 mg/m2 cisplatin on day 1." | ( Davis, EB; Hussain, MA; Krasnow, SH; Lunzer, S; Sharma, D; Wadleigh, RG, 1997) |
| "Patients with head and neck squamous cell carcinoma (HNSCC) treated with cisplatin show a large inter-individual variation in tumor response." | ( Baan, RA; Braakhuis, BJ; Cloos, J; Fichtinger-Schepman, AM; Hermsen, MA; van der Vijgh, WJ; Welters, MJ, 1997) |
| "In contrast, murine squamous cell carcinoma SCC-VII tumors are relatively resistant to radiation and paclitaxel and exhibit relatively little apoptosis following treatment." | ( Hittelman, WN; Jibu, T; Li, D; Milas, L; Milross, CG; Peters, LJ; Saito, Y, 1997) |
| "A human squamous cell carcinoma (SCC) cell line has been established from the surgical specimen of an untreated, upper aero-digestive tract tumour, diagnosed as a squamous carcinoma, grade III, of the pyriform fossa." | ( Deo, MG; Goud, AP; Mahimkar, MB; Mulherkar, R; Naresh, KN; Pradhan, SA; Thomas, SM; Wagle, AS, 1997) |
| "Patients with squamous cell carcinoma treated on the CT + RT arm had a significant reduction of first DM other than brain, but there was difference in survival." | ( Byhardt, RW; Cox, JD; Curran, WJ; Dar, AR; Emami, B; Johnson, DH; Komaki, R; Lee, JS; Sause, WT; Scott, CB; Taylor, SG, 1997) |
| "Twenty patients with squamous cell carcinoma of the lower lip were treated using this modified reconstruction technique." | ( Hardt, N; Kuttenberger, JJ, 1997) |
| "Oral and oropharyngeal squamous cell carcinoma in 38 patients were treated over a period of 7 years (1988-1994) by HDR interstitial brachytherapy using Gammamed 12i equipment." | ( Friedrich, RE; Krüll, A; Plambeck, K; Schmelzle, R; Schwarz, R; Thurmann, H, 1997) |
| "Early-stage squamous cell carcinoma of the larynx is usually treated with local field radiotherapy." | ( Harper, CS; Hedland-Thomas, B; Latham, MM; Smart, GP, 1997) |
| "Three KGFR-positive human squamous cell carcinoma xenografts in nude mice, and a murine KGFR-negative melanoma tumor in Balb/c mice treated with 1." | ( Benson, W; Khan, WB; Knox, SJ; Lacey, DL; Ning, S; Shui, C, 1998) |
| "A new experimental therapy for squamous carcinoma was tested by sensitizing human tumor cells with light-sensitive anticancer drugs followed by laser illumination at visible or infrared wavelengths." | ( Arshadnia, S; Castro, DJ; Eshraghi, AA; Graeber, IP; Jongewaard, N; Lamas, G; Paiva, MB; Saxton, RE; Soudant, J, 1997) |
| "Multimodal therapy of oral squamous cell carcinomas today is based on surgery, radiotherapy and chemotherapy." | ( Girod, SC; Kaupe, M; Pape, HD; Pfeiffer, P, 1998) |
| "Thirty-one early squamous cell carcinomas (Tis or T1a) of the esophagus were treated by photodynamic therapy in 24 patients." | ( Braichotte, D; Fontolliet, C; Grosjean, P; Monnier, P; Savary, JF; van den Bergh, H; Wagnieres, G, 1998) |
| "Photodynamic therapy eradicates early squamous cell carcinomas (Tis and T1a) of the esophagus efficiently." | ( Braichotte, D; Fontolliet, C; Grosjean, P; Monnier, P; Savary, JF; van den Bergh, H; Wagnieres, G, 1998) |
| "Since squamous cell carcinoma is a malignant cutaneous neoplasm that can metastatize, the surveillance of skin changes is advisable during hydroxyurea treatment." | ( De Simone, C; Guerriero, C; Guidi, B; Rotoli, M; Tartaglione, R; Venier, A, 1998) |
| "For photodynamic therapy (PDT), human squamous cell carcinoma cells (HSC-2) were treated with 3 microg/ml of photofrin 24 h prior to irradiating the cultures with the excimer dye laser at a dose of 2 J/cm2." | ( Hayakawa, A; Matsumoto, Y; Tajiri, H; Yokoyama, I; Yoshida, S, 1998) |
| "For patients with squamous cell carcinoma of the head and neck (HNSCC), persistence of cervical adenopathy following organ-preservation therapy is a strong predictor of locoregional failure." | ( Eisele, DW; Forastiere, AA; Lee, DJ; Westra, WH, 1998) |
| "In this study, TE3 human squamous cell carcinoma cell line was treated with a 4-day cycle of cisplatin (cis-diamminedichloroplatinum (II); CDDP) at a concentration yielding 10% cell survival." | ( Komori, K, 1998) |
| "Sixty primary untreated squamous cell carcinomas were studied for C-erbB2 gene amplification by non-fluorescence in situ hybridization technique." | ( Bhambhani, S; Khan, IU; Mitra, AB; Pratap, M; Sawhney, VM; Sharma, A, 1999) |
| "All cases of acanthomatous epulides and squamous cell carcinoma treated with simple marginal surgical resection recurred within a short time." | ( Ishikawa, K; Iwasaki, T; Kati, S; Lackner, AA; Masegi, T; Ohta, J; Sakai, H; Yanai, T; Yoshida, K, 1999) |
| "Since the prognosis of patients with T4 squamous cell carcinoma (SCC) of the esophagus is extremely poor, an effective multimodal treatment needs to be established." | ( Doki, Y; Inoue, M; Inoue, T; Monden, M; Shiozaki, H; Tanaka, E; Tsujinaka, T; Yamamoto, M; Yano, M, 1999) |
| "Due to the superficial growth of squamous cell carcinoma of the head and neck (HNSCC) are readily accessible for direct intratumoral injection and therefore an optimal target for such a gene therapy approach." | ( Andratschke, M; Ihrler, S; Lang, S; Mayer, A; Mundl, H; Naujoks, K; Pauli, C; Rollston, R; Schaumberg, J; Wollenberg, B; Zeidler, R, 1999) |
| "Five patients, three with squamous cell carcinoma and two with basal cell carcinoma, were treated before surgery with three cycles of cisplatin 20 mg/m2 daily for 4 days and bleomycin 20 mg/day for 4 days by continuous infusion every 3 weeks." | ( Denic, S, 1999) |
| "We report a case of squamous cell carcinoma of the lower lip showing an excellent response to chemotherapy with UFT." | ( Kasai, N; Mutoh, Y, 1999) |
| "Nude mice with xenografted squamous cell carcinoma were treated with cisplatin 10 mg/kg." | ( Johnsson, A; Los, G; Strand, C, 1999) |
| "UCLA-P3 human squamous cell carcinoma tumors were grown as subcutaneous transplants in nude mice and treated by intratumor injection of 2 mg/mL cisplatinum in a slow-release, collagen-based gel carrier 4 hours before interstitial implantation of Nd:YAG laser fiberoptics to induce local tumor hyperthermia." | ( Castro, DJ; Eshraghi, AA; Graeber, IP; Jovanovic, S; Paek, WH; Paiva, MB; Saxton, RE; Scherer, H; Soudant, J, 1999) |
| "In the squamous cell carcinoma patients, the presence of occult lymph node metastasis did not correlate significantly with any clinical or pathologic parameter, except that patients with occult lymph node metastasis were more likely to have received preoperative chemotherapy or radiation therapy." | ( Glickman, JN; Odze, RD; Richards, WG; Shahsafaei, A; Sugarbaker, DJ; Torres, C; Turner, JR; Wang, HH, 1999) |
| "Patients with previously untreated squamous cell carcinoma of the oral cavity were eligible for this trial." | ( Hsu, CY; Jan, JS; Lin, JC; Wong, DY, 1999) |
| "Chemoradiotherapy for patients with squamous cell carcinoma offers survival rates equivalent to surgical therapy and preserved sphincter function." | ( Klas, JV; Madoff, RD; Rothenberger, DA; Wong, WD, 1999) |
| "The resistance of head and neck squamous carcinoma cells (HNSCCs) to cis-Diamminedichloroplatinum(II) (CDDP), which is widely used for the treatment of many malignancies, is a serious problem in the clinic." | ( Higuchi, E, 1999) |
| "Between 1981 and 1994, 34 patients with squamous cell carcinoma of the supraglottis were treated by transoral carbon dioxide laser resection, 12 of them palliatively." | ( Höft, S; Rudert, HH; Werner, JA, 1999) |
| "Treatment regimens for advanced squamous cell carcinoma of the head and neck require both attention to local tumor burden as well as contingencies for control of disseminated disease." | ( Sharma, VM; Wilson, WR, 1999) |
| "Prognosis for advanced head and neck squamous cell carcinoma remains poor despite advances in treatment, although a small number of patients may benefit from induction therapy leading to increased local control." | ( Alvarez-Vicent, JJ; Ballestín, C; Benito, A; Brandáriz, JA; Colomer, R; de la Cruz, J; Gómez, C; Hitt, R; Lassaletta, L, 1999) |
| "In patients with squamous cell carcinoma, those treated with ICT + CCT + SRT had dramatically improved MST (25." | ( Andras, E; Byhardt, R; Cox, J; Dar, AR; Johnson, D; Komaki, R; Lawton, C; Lee, JS; Movsas, B; Roach, M; Sause, W; Scott, C; Wasserman, T, 1999) |
| "For locally unresectable recurrent squamous cell carcinoma of the head and neck, we investigated two salvage chemotherapy regimens as second-line chemotherapy." | ( Kawaida, M; Kitahara, S; Kohno, N; Ohmuma, T, 1999) |
| "Sixty-eight patients with squamous cell carcinoma of the head and neck (93% UICC stage IV) were treated with a simultaneous concomitant boost radiochemotherapy with Carboplatin as part of a prospective non-randomised multicenter study at the University of Heidelberg." | ( Conradt, C; Dietz, A; Flentje, M; Nollert, J; Rudat, V; Wannenmacher, M; Weber, KJ, 1999) |
| "The 18 patients, who had oral squamous cell carcinomas (5 of the tongue, 4 of the mandibular gingiva, 3 of the maxillary gingiva, 1 of the floor of the mouth, 3 of the buccal mucosa, and 2 others), were treated with this combination of adjuvant therapy with Ancer 20 injection, from March, 1991 to March, 1997." | ( Fujitsuka, H; Hyodo, I; Ichihara, H; Kato, Y; Okutomi, T; Tatematsu, N; Yasuda, S, 2000) |
| "Eight patients affected by conjunctival squamous cell carcinoma (three recurrent cases, three incompletely excised, and two untreated cases) were treated with 1% 5-FU eye drops." | ( Angeli, CD; Boccato, P; de Belvis, V; Midena, E; Valenti, M, 2000) |
| "Eight patients with squamous cell carcinoma of the head and neck and stage IV disease (N2 or N3 neck adenopathy) or recurrent local-regional disease and who were previously and definitively treated were included in the study." | ( Chang, P; Formenti, SC; Grunberg, SM; Jozsef, G; Rice, DM; Sapozink, MD; Streeter, OE, 2000) |
| "All patients had squamous cell carcinoma of the larynx and were treated with primary radiation to a total median dose of 66 Gy in daily fractions of 2 Gy, without surgery or chemotherapy." | ( Carter, D; Glazer, PM; Haffty, BG; Sasaki, CT; Son, YH; Turner, BC; Wilson, LD; Yoo, SS, 2000) |
| "Standard treatment for squamous cell carcinomas in the head and neck consists of surgery and/or radiotherapy." | ( Tsukuda, M, 2000) |
| "A 47-year-old Hispanic man with squamous cell carcinoma of the larynx had undergone surgical resection, radiation treatment, and chemotherapy." | ( Albuquerque, F; Eng, D; Gruen, JP; Loskota, WJ; Teitelbaum, GP; Wang, MY, 2000) |
| "All tumors induced were squamous cell carcinomas, and the skin between the tumors on mice treated with retinoic acid was found to contain carcinoma in situ upon histologic diagnosis." | ( Barnetson, RS; Halliday, GM; Robertson, BO, 2000) |
| "We tested for squamous cell carcinoma-related antigen (SCC), carcinoembryonic antigen (CEA), ferritin, immunosuppressive acid protein (IAP) and sialic acid in the serum from 247 patients with head and neck squamous cell carcinoma prior to therapy." | ( Fujieda, S; Kimura, Y; Saito, H; Sugimoto, C; Takabayashi, T; Tanaka, T, 2000) |
| "We measured tumor control using squamous cell carcinoma (SCC) VII murine squamous cell flank tumors (50-125 mm(3)) treated with the same regimens used in the mouth irradiation model." | ( Davis, MA; Eisbruch, A; Fields, MT; Lawrence, TS; Normolle, D; Orfali, A; Pu, AT, 2000) |
| "In a KLN-205 squamous cell carcinoma mouse model, daily oral administration of EPA resulted in a significant reduction of tumor size and expression of cyclin D1 in the tumor tissues." | ( Aktas, H; Changolkar, AK; Flückiger, R; Halperin, JA; Harneit, S; Kilic, E; Palakurthi, SS; Shahsafaei, A, 2000) |
| "59 oesophageal squamous cell carcinoma (SCC) patients received cisplatin 30 mg/m2/week treatment of two to five cycles, followed by oesophagectomy." | ( Fukumoto, M; Imamura, M; Itami, A; Kaganoi, JI; Kanda, Y; Kawabe, A; Maeda, M; Shimada, Y; Watanabe, G; Yamasaki, S, 2000) |
| "In the patients with squamous cell carcinoma, 100 mg/m2 of cisplatin was infused intravenously, followed immediately by five consecutive daily administrations of 5-fluorouracil, 1,000 mg/m2/day, each infused intravenously over 24 hr." | ( Kim, GE; Kim, SN; Kim, SW; Park, TK; Suh, CO, 2000) |
| "The risk of posttransplant cutaneous squamous cell carcinoma in Norwegian heart transplant recipients (n = 148) and kidney transplant recipients (n = 1020) on triple immunosuppressive therapy with cyclosporine, azathioprine, and prednisolone, transplanted between 1983 and 1992, were studied." | ( Fauchald, P; Geiran, O; Gjersvik, P; Hansen, S; Leivestad, T; Møller, B; Pfeffer, P; Simonsen, S, 2000) |
| "In the present study, we treated squamous cell carcinoma in rabbits with FFs bound to mitoxantrone (FF-MTX) that was concentrated with a magnetic field." | ( Alexiou, C; Arnold, W; Bergemann, C; Erhardt, W; Hulin, P; Klein, RJ; Lübbe, AS; Parak, FG; Wagenpfeil, S, 2000) |
| "With some advanced squamous cell carcinomas (SCCs) of the head and neck, chemoradiation therapy may obviate the need for surgical intervention." | ( Ahmed, A; Hengesteg, A; Israel, M; Koseki, Y; Robbins, KT; Samant, S; Sweatman, TW; Wani, MK; Yarber, RH, 2000) |
| "Forty-seven patients with squamous cell carcinomas of the esophagus had undergone radiation therapy, followed by surgical resection." | ( Doki, Y; Fujiwara, Y; Inoue, M; Kishi, K; Miyata, H; Monden, M; Nishioka, K; Shiozaki, H; Yamamoto, H; Yano, M, 2000) |
| "Eighty-eight patients with squamous cell carcinoma of the oral cavity and treated between September 1985 and November 1995 by preoperative radiochemotherapy and definitive surgery were included in this analysis." | ( Flentje, M; Haberl, M; Koelbl, O; Müller, J; Reuther, J; Rosenwald, A, 2001) |
| "Patients with a squamous cell carcinoma of the oropharynx for whom curative radiotherapy or surgery was considered feasible were entered in a multicentric randomized trial comparing neoadjuvant chemotherapy followed by loco-regional treatment to the same loco-regional treatment without chemotherapy." | ( Coche-Dequeant, B; De Raucourt, D; Domenge, C; Hill, C; Lefebvre, JL; Luboinski, B; Marandas, P; Rhein, B; Sancho-Garnier, H; Stromboni-Luboinski, M; Wibault, P, 2000) |
| "Thirty-four patients with advanced squamous cell carcinoma of the thoracic esophagus (T2-4 N0-1 M0), who underwent one cycle of cisplatin and 5-fluorouracil therapy followed by subtotal esophagectomy, were studied." | ( Chibowski, D; D browski, A; Szumilo, J, 2000) |
| "Human-derived head-and-neck squamous cell carcinoma xenografts (implanted in nude mice/nine groups of 10 mice) were treated with various treatment modalities and combinations of them (radiation with 5 x 2 or 10 x 2 Gy, hyperthermia at 41 degrees C or 41." | ( Feyerabend, T; Ressel, A; Weiss, C, 2001) |
| "We recently treated 2 patients with squamous cell carcinoma in the anal canal with bilateral inguinal nodal metastases using chemoradiotherapy." | ( Furutani, K; Fuwa, N; Kamata, M; Kodaira, T; Matsumoto, A; Sasaoka, M, 2001) |
| "28 patients with squamous cell carcinomas of the head and neck received adjunctive or primary radiotherapy (5 days per week with daily fractions of 2 Gy, up to a total dose of 60 Gy) in conjunction with carboplatin (70 mg/m2) on days 1-5 and days 21-26." | ( Bennett, CL; Buntzel, J; Glatzel, M; Lane, D; Stinson, T, 2001) |
| "A total of 13 squamous cell carcinomas were treated, including 10 nasal planum lesions, two pinnal lesions and one eyelid lesion." | ( Dobson, JM; Langmack, K; Stell, AJ, 2001) |
| "We report an elderly patient with squamous cell carcinoma who was successfully treated with chemotherapy using vinorelbine." | ( Hagiwara, K; Maemondo, M; Narumi, K; Nukiwa, T; Saijo, Y; Tazawa, R; Usui, K; Watanabe, A, 2001) |
| "43 patients with Stage IV squamous cell carcinoma of the head and neck have been treated neoadjuvantly with two cycles chemotherapy (ifosfamide 1." | ( Christoph, B; Esser, E; Hartlapp, J; Hermann, RM; Krech, R; Müller, MK; Wagner, W, 2001) |
| "A-431 squamous cell carcinoma cells were treated in vitro with either 4 Gy radiation of 15 (or 45) microg/ml dibromodulcitol (DBD), as well as with combined 4 Gy irradiation and DBD, with the latter as either a pretreatment or post-treatment." | ( Hidvégi, E; Kraxner, H; Oláh, I; Répássy, G; Ribári, O; Sáfrány, G; Szende, B; Tamás, L, 2001) |
| "In oral and oropharyngeal squamous cell carcinoma treated with surgery and postoperative radiotherapy, VEGF and EGFR expression may influence clinical outcome." | ( Carter, D; DiGiovanna, MP; Haffty, BG; Kasowitz, KM; Sasaki, CT; Smith, BD; Smith, GL, 2001) |
| "We report a typical case with a squamous cell carcinoma of the tongue and classical cutaneous symptoms disappearing with the treatment of the tumour." | ( Buxtorf, K; Hübscher, E; Panizzon, R, 2001) |
| "As the use of chemotherapy in squamous carcinoma of the head and neck has expanded, investigators have been interested in identifying new active agents." | ( Burkey, B; Cmelak, A; Douglas, S; Murphy, BA; Netterville, J; Shyr, Y; Smith, W, 2001) |
| "All of them had stage IV, unresectable squamous cell carcinoma of the pharynx and they received continuous bid radiotherapy (two daily fractions of 1." | ( Bensadoun, RJ; Chauvel, P; Courdi, A; Dassonville, O; Demard, F; Ettore, F; Falewee, MN; Lagrange, JL; Magné, N; Marcy, PY; Milano, G; Pivot, X; Poissonnet, G; Santini, J; Schneider, M; Vallicioni, J, 2001) |
| "A 73-year-old male with squamous cell carcinoma of the oral floor (T1N0M0), who had not consented to radical treatment was treated with UFT by oral administration alone." | ( Fujisawa, A; Ikeda, H; Inokuchi, T; Kitamura, A; Nonaka, M; Ohba, S; Tobita, T; Uehara, M, 2001) |
| "Multiple treatments for squamous cell carcinoma in situ (SCCIS) of the penis have been used with variable success and morbidity." | ( Schroeder, TL; Sengelmann, RD, 2002) |
| "In this study, oral squamous carcinoma cells (SCC2/88) had a two-fold increase in PTHrP mRNA stability (from 45 to 90 min) in response to treatment with TGFbeta1." | ( Capen, CC; Rosol, TJ; Sellers, RS, 2002) |
| "The subjects were patients with squamous cell carcinoma of the oral cavity who had not received any therapy, comprising 7 patients with carcinoma of the tongue, 2 with buccal carcinoma, 2 with maxillary gingival carcinoma, and 1 with carcinoma of the oral floor." | ( Ando, T; Fukada, K; Hoshino, M; Kuwazawa, T; Maruoka, Y; Nishihara, N; Ogiuchi, H; Ogiuchi, Y; Okamoto, T, 2002) |
| "Three patients presenting with squamous cell carcinomas of the scalp were treated with surgery and radiotherapy for recurrent or incomplete resection of squamous cell carcinomas of the head." | ( Avril, MF; Ibrahim, M; Kerob, D; Kolb, F; Mamelle, G; Margulis, A; Spatz, A, 2002) |
| "Incidence and risk factors for second squamous cell carcinomas and basal cell carcinomas were studied in a cohort of 1380 psoralen + ultraviolet A-treated psoriasis patients prospectively followed for over 20 y; 264 had a squamous cell carcinoma and 258 a basal cell carcinoma after beginning psoralen + ultraviolet A therapy." | ( Katz, KA; Marcil, I; Stern, RS, 2002) |
| "Treatment of squamous cell carcinoma of the oral cavity, salivary gland tumors, and Hodgkin's disease may include radiation therapy to the head and neck region." | ( Zlotolow, IM, 1997) |
| "Fifty-two patients with advanced oral squamous cell carcinoma who received neoadjuvant chemotherapy followed by surgery participated in this study." | ( Kinjyo, H; Kohama, G; Kubota, H; Miyazaki, A; Noguchi, M, 2002) |
| "The majority of head and neck squamous cell carcinomas express EGFR, indicating the importance of studying the efficacy of anti-cancer therapy through this pathway." | ( Chan, AT; Hsu, HC; Lai, GM; Lee, CS; Lee, YS; Lin, L; Lin, X; Millward, M; Putti, TC; To, KF; Tse, G; Whang-Peng, J, 2002) |
| "To describe a case of conjunctival squamous cell carcinoma in situ that was successfully treated with adjunctive topical cidofovir." | ( Farahmand, SM; Feldman, KA; Margolis, TP; Sherman, MD, 2002) |
| "The ratios of squamous cell carcinomas to papillomas and of sebaceous gland adenomas to papillomas plus squamous cell carcinomas were increased markedly in transgenic mice treated with DMBA alone compared with DMBA/phorbol 12-myristate 13-acetate-treated transgenic and wild-type mice." | ( Berger, I; Furstenberger, G; Marks, F; Muller-Decker, K; Neufang, G; Neumann, M, 2002) |
| "Human lung squamous cell carcinoma cell line, H520, was treated with antioxidant mixture (vitamin C, vitamin E and beta carotene), paclitaxel and carboplatin, individually and in combination of different doses in different sequences." | ( Khanna, N; Kochupillai, V; Pathak, AK; Prasad, KN; Reddy, VG; Singh, N, 2002) |
| "In a variety of squamous cell carcinoma cell lines of the head and neck (HNSCCs), we found that treatment with the GPCR agonists lysophosphatidic acid (LPA), bradykinin, thrombin, and carbachol results in rapid tyrosine phosphorylation of the EGFR." | ( Gschwind, A; Prenzel, N; Ullrich, A, 2002) |
| "All had squamous cell carcinomas of the oral cavity in stage III or in nonmetastatic stage IV and were selected for surgery or radiation therapy (if located in the tonsils or in the base of the tongue)." | ( Alós, L; Blanch, JL; Castro, V; Domingo, J; Estapé, J; Grau, JJ; Nadal, A; Verger, E, 2002) |
| "In locally advanced squamous cell carcinoma of the oral cavity, neoadjuvant chemotherapy induces a high response rate that may facilitate definitive surgery or radiotherapy." | ( Alós, L; Blanch, JL; Castro, V; Domingo, J; Estapé, J; Grau, JJ; Nadal, A; Verger, E, 2002) |
| "Treatment of oral squamous cell carcinoma cells with 15-PGJ(2) induced an initial reduction and eventual elimination of both phosphorylated and unphosphorylated Stat3 protein levels." | ( Hamburger, AW; Hebert, C; Nikitakis, NG; Reynolds, MA; Sauk, JJ; Siavash, H, 2002) |
| "Thus, in squamous carcinoma cells, NO increases the activity of COX-2 pathway and this effect is probably mediated by endocellular cGMP level, with potential implications on tumor growth, angiogenesis, and therapy." | ( Boddi, V; Fabbroni, V; Franchi, A; Gallo, O; Magnelli, L; Sardi, I, 2002) |
| "Twenty patients with squamous cell carcinomas of the head and neck treated with primary surgery were injected with pimonidazole and IdUrd the evening before operation." | ( Balm, AJ; Begg, AC; Blijweert, E; Blommestijn, G; Delaere, P; Haustermans, KM; Hoebers, FJ; Hofland, I; Janssen, HL; Raleigh, JA; Sciot, R; Semenza, GL; Sprong, D; van Velthuysen, ML; Varia, MA, 2002) |
| "A 63-year-old woman with stage Ib2 squamous cell carcinoma of the cervix was treated with intraarterial cisplatin infusion in a neoadjuvant setting." | ( Aoki, Y; Ishii, K; Sasaki, M; Tanaka, K, 2002) |
| "Compared with adenocarcinoma, squamous cell carcinoma might be a favorable target for 5-FU-based chemotherapy in the treatment of nonsmall-cell lung cancer." | ( Koga, T; Ninomiya, S; Takeo, S; Yano, T, 2002) |
| "We encountered a case of extensive squamous cell carcinoma ranging from the tongue to the mouth floor, in which chemotherapy using a combination of nedaplatin and 5-FU was effective." | ( Inoda, H; Nishida, T; Nishikawa, M; Shimada, T; Takigami, K; Tanaka, A; Tsuda, Y; Yamamoto, G; Yoshitake, K, 2002) |
| "Human lung squamous carcinoma cell line(TUL cell) was treated with 5 x 10(-6) mol." | ( Hu, CP; Su, XL; Wu, ES, 2000) |
| "Patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN) are often treated with induction chemotherapy or chemoradiotherapy, but to date without major impact on survival." | ( Lefebvre, JL; Posner, MR, 2003) |
| "Causes of failure of radiotherapy in squamous cell carcinoma of the head and neck probably include repopulation and hypoxia." | ( Bishop, K; Henk, JM; Shepherd, SF, 2003) |
| "Here we report two cases of squamous cell carcinoma of the skin, which appeared in the photo-exposed areas in two elderly patients treated for advanced chronic myeloid leukemia with imatinib." | ( Audring, H; Baskaynak, G; Dörken, B; Kreuzer, KA; le Coutre, P; Riess, H; Schwarz, M; Zuber, J, 2003) |
| "192 patients suffering from squamous cell carcinoma of the uterine cervix in Stages Ib-IIb were randomized to one of the following treatments: three courses of neoadjuvant chemotherapy with cisplatin, vincristine, bleomycin (NACT arm; n = 106); conventional surgery or radiotherapy alone (CO arm; n = 86)." | ( Framarino, ML; Imperato, F; Marzetti, L; Marziani, R; Mossa, B; Napolitano, U, 2003) |
| "A 64-year-old male with primary squamous cell carcinoma of the tongue (T3N0M0) was treated with the novel fluoropyrimidine oral anticancer drug TS-1 and selective intra-arterial infusion of CDDP." | ( Takeda, M; Tanaka, N; Yoshioka, H, 2003) |
| "The induction of apoptosis in two tongue squamous carcinoma cells treated by arsenic trioxide was investigated." | ( Guo, J; Zhang, ZY, 2003) |
| "Ten patients with esophageal squamous cell carcinoma (SCC) and three with adenocarcinoma (AC) were treated with CPT-11." | ( Hinkelbein, W; Mühr-Wilkenshoff, F; Ohnesorge, I; Riecken, EO; Scherübl, H; Wolf, KJ; Zeitz, M, 2003) |
| "Human tongue squamous carcinoma cells (Tca8113 cell line) and its xenografts in BALB/c nude mice were treated with AdCMVCD/5-FC system." | ( Huang, H; Li, S; Wang, A, 2003) |
| "Confluent human head and neck squamous cell carcinoma cell lines designated SCC61 and SQD9 were treated with 5 microM dFdC for 3 or 24 h prior to irradiation." | ( Ameye, G; Cedervall, B; Grégoire, V; Libouton, JM; Michaux, L; Octave-Prignot, M; Rosier, JF; Scalliet, P; Verellen-Dumoulin, C, 2003) |
| "The treatment of squamous cell carcinoma of the lip with surgery is usually curative but incomplete/inadequate excision may be associated with recurrence and poor outcome." | ( Babington, S; Cakir, B; Gebski, VJ; Morgan, GJ; Veness, MJ, 2003) |
| "Patients treated for squamous cell carcinoma of the lip at Westmead Hospital, Sydney, between 1980 and 2000 were eligible for inclusion." | ( Babington, S; Cakir, B; Gebski, VJ; Morgan, GJ; Veness, MJ, 2003) |
| "Human lung squamous carcinoma cells L78 treated with 5 mmol/L alpha-difluoromethylornithine (DFMO) for 5 days showed significant growth inhibition and apoptosis induction." | ( Cao, SL; Chen, ZH; Fan, MZ; Fang, Q; Ke, HP; Li, HY, 2002) |
| "We included 100 patients with advanced squamous cell carcinoma of the head and neck region before each kind of treatment." | ( Büntzel, J; Fröhlich, D; Glatzel, M; Micke, O, 2003) |
| "Serum levels of squamous cell carcinoma antigen and the proliferative potential and subsets of peripheral T cells before and after celecoxib treatment were also analyzed." | ( Battaglia, A; Ferrandina, G; Gessi, M; Lauriola, L; Legge, F; Navarra, P; Ranelletti, FO; Salutari, V; Scambia, G; Testa, AC; Tringali, G; Werner, U, 2003) |
| "122 patients with primary squamous cell carcinoma of the lip, the oral cavity and the oropharynx have been treated with 100 mg/m2 cisplatin bolus infusion and 120-h continuous infusion of 1000 mg/m2 5-fluorouracil following radical surgery; 99 patients completed all 3 cycles." | ( Bitter, K; Ghahremani, MT; Kovács, AF; Stefenelli, U, 2003) |
| "Bowen's disease (BD; intraepithelial squamous cell carcinoma) is a challenging condition to treat because lesions, which can be multiple, are often located at sites that heal poorly, such as the shin." | ( Chen, K; Shumack, S, 2003) |
| "As the first stage of squamous cell carcinoma, actinic keratosis is worthy of prompt evaluation and active treatment." | ( Alam, M; Goldberg, LH; Silapunt, S, 2003) |
| "We report the first two cases of squamous cell carcinoma successfully treated with imiquimod 5% cream as a monotherapy." | ( Oster-Schmidt, C, 2004) |
| "Seventy patients with inoperable squamous cell carcinoma of the oropharynx were prospectively treated by concomitant regimen of conventional radiotherapy and chemotherapy with Mitomycin C and Bleomycin." | ( Budihna, M; Oblak, I; Smid, L; Strojan, P; Zakotnik, B, 2003) |
| "The human oral squamous cell carcinoma cell line SAS was treated with adenovirus vector containing HSVtk gene (AdHSVtk) and GCV in vitro." | ( Fukuhara, H; Fukui, T; Hayashi, Y; Mitsudo, K; Mizuno, M; Nishikawa, M; Tohnai, I; Ueda, M; Yamamoto, N; Yoshida, J, 2003) |
| "Immunochemotherapy for oral squamous cell carcinomas may play an important role in increasing local immunity." | ( Hu, Q; Tang, E; Zhou, B, 2003) |
| "Fifteen patients with advanced squamous cell carcinoma of the thoracic esophagus were treated with neoadjuvant chemoradiotherapy (NAC) combined with concurrent radiation (30 Gy/12 f) and 3 courses of 5-FU and CDDP (CDDP 5 mg/m2/day + 5-FU 250 mg/m2/day: day 1-5: div)." | ( Honnma, S; Kohashi, S; Kondo, M; Kudo, T; Maeda, Y; Sato, Y; Shimokuni, T; Shinohara, T; Takahashi, S; Todo, S, 2004) |
| "A woman developed squamous cell carcinoma on the scalp 67 years after radiotherapy for tinea capitis." | ( Avram, MR; Ronel, DN; Schwager, RG, 2004) |
| "Patients with locally advanced squamous carcinoma of the head and neck who also presented with nodal disease and underwent hyperfractionated radiotherapy and concurrent cisplatin/5-fluorouracil chemotherapy constituted the study population." | ( Brizel, DM; Clough, RL; Downey, MA; Fisher, SR; Hunter, S; Prosnitz, RG; Scher, RL, 2004) |
| "Treatments of the head and neck squamous cell carcinoma cells with these retinoids for 24 h resulted in increased levels of 14, 22, and 22 proteins and decreased levels of 5, 10, and 7 proteins, respectively." | ( Kim, HJ; Lotan, R, 2004) |
| "We report a case of advanced squamous cell carcinoma in the left buccal mucosa, upper gingiva, and maxillary sinus (T4N0M0) showing a complete response to oral chemotherapy with TS-1." | ( Mishima, K; Nakamura, H; Obara, S; Yamamoto, K; Yoshimura, Y, 2004) |
| "Chemoprevention of oral squamous cell carcinomas is based on two conditions: Premalignant mucosa lesions are treated with chemopreventive agents in order to prevent malignant conversion (primary prevention)." | ( Kuebler, AC; Scheer, M; Zöller, JE, 2004) |
| "Patients with squamous cell carcinoma of the head and neck (HNSCC) after being treated radically remain at high risk for both recurrent and second primary tumours." | ( Antonelli, A; Balzarini, F; Beatrice, F; Benazzo, M; Bonelli, L; Caroggio, A; Cavalot, AL; Cortesina, G; Gandolfo, S; Garozzo, A; Giordano, C; Margarino, G; Miani, P; Mira, E; Sartoris, A; Schenone, G; Serafini, I; Sirotovà, Z; Spadini, N; Toma, S; Zibordi, F, 2004) |
| "In a group of 33 patients with squamous cell carcinoma of the pharynx and larynx (T1-4 N0-3 M0) CYFRA 21-1, SCC-Ag and acute phase proteins such as prealbumin, albumin, alpha-1 acid glycoprotein, alpha-1 antytrypsin, transferrin, ceruloplasmin and C-reactive protein (CRP) determinations were performed before radiotherapy." | ( Kulpa, J; Pudełek, K; Rychlik, U; Skołyszewski, J; Stasik, Z; Wójcik, E, 2004) |
| "rhLF inhibited the growth of squamous cell carcinoma (O12) tumors in T cell-immunocompromised nu/nu mice by 80% when administered at 1,000 mg/kg (2." | ( Curcio, C; Forni, G; O'Malley, BW; Pericle, F; Petrak, K; Spadaro, M; Varadhachary, A; Wolf, JS, 2004) |
| "Treatment of oral squamous cell carcinoma cells with TGF-beta1 promoted MMP-dependent cell scattering and collagen invasion, increased expression of MMP-2 and MT1-MMP, and enhanced MMP-2 activation." | ( Koblinski, JE; Mukhopadhyay, S; Munshi, HG; Ottaviano, AJ; Platanias, LC; Sassano, A; Stack, MS; Wu, YI, 2004) |
| "Twenty-nine patients with stages II-IV squamous cell carcinoma treated with radiation therapy or chemotherapy and radiation therapy (n = 20) or with total laryngectomy (n = 9) were enrolled." | ( Daisne, JF; Duprez, T; Grégoire, V; Hamoir, M; Lonneux, M; Reychler, H; Weynand, B, 2004) |
| "Treatment strategies for squamous cell carcinoma of the head and neck (SCCHN) are based on the TNM classification." | ( Adams, M; Akervall, J; Bradford, CR; Carey, TE; Fisher, SG; Kurnit, DM; Zhu, S, 2004) |
| "Patients with locally advanced squamous cell carcinoma of the esophagus, who respond to preoperative neoadjuvant combined radiochemotherapy, seem to have more benefit from subsequent resection than non-responding patients." | ( Brücher, BL; Busch, R; Dittler, HJ; Fink, U; Molls, M; Sarbia, M; Siewert, JR; Stein, HJ; Werner, M; Zimmermann, F, 2004) |
| "Advanced squamous cell carcinomas of the head and neck region were often treated with combined radio-chemotherapy." | ( Alexiou, C; Bergemann, C; Erhardt, W; Iro, H; Jurgons, R; Parak, F; Schmid, R, 2005) |
| "Case 2: A 74-year-old female with anal squamous cell carcinoma Stage II was treated by chemoradiotherapy with tegafur/uracil, external irradiation (30 Gy) and interstitial irradiation (24 Gy)." | ( Fujitani, K; Hirao, M; Ikenaga, M; Kashiwazaki, M; Masuda, N; Mishima, H; Sawamura, T; Takeda, Y; Takeno, A; Tsujinaka, T, 2004) |
| "Avascular-differentiated regions in squamous cell carcinoma offer sanctuary to some hypoxic but viable tumor cells (carbonic anhydrase IX and Ki67 positive) that escape therapy because of limited drug delivery." | ( Azrak, R; Bhattacharya, A; Cao, S; Durrani, FA; Mazurchuk, R; Pendyala, L; Rustum, YM; Slocum, HK; Spernyak, JA; Tóth, K, 2004) |
| "In a xenograft model of squamous cell carcinoma of the head and neck (SCCHN), daily administration of the STAT3 decoy (25 microg) resulted in decreased tumor volumes, abrogation of STAT3 activation, and decreased expression of STAT3 target genes (VEGF, Bcl-xL, and cyclin D1) compared to treatment with a mutant control decoy." | ( Gooding, WE; Grandis, JR; Xi, S, 2005) |
| "The human tongue well-differentiated squamous carcinoma cell line, SCC-25, shows Fas-dependent apoptosis by treatment with carboplatin (CBDCA)." | ( Mishima, K; Nariai, Y; Yoshimura, Y, 2005) |
| "The choice of treatment for squamous cell carcinoma of the head and neck (SCCHN) is still primarily based on the tumor-node-metastasis classification." | ( Akervall, J; Anderson, H; Bradford, C; Carey, T; Cole, A; Guo, X; Kort, E; Leeser, B; Qian, CN; Resau, J; Schoumans, J; Teh, BT; Tennvall, J; Wennerberg, J, 2004) |
| "Head and neck squamous cell carcinomas have been reported to overexpress hypoxia-inducible factor (HIF)-1alpha, a transcription factor that promotes expression of angiogenesis factors and resistance to programmed and therapy-induced cell death." | ( Chen, Z; Pribluda, VS; Ricker, JL; Swartz, GM; Van Waes, C; Yang, XP, 2004) |
| "Image localization of head-and-neck squamous cell carcinoma lags behind current techniques to deliver a precise radiation dose with intensity-modulated radiotherapy." | ( Anzai, Y; Coltrera, MD; Eary, J; Ford, E; Haynor, D; Kinahan, P; Krohn, K; Laramore, GE; Leblanc, M; Lewellyn, B; Mattes, D; Meyer, J; Phillips, M; Rajendran, J; Schwartz, DL; Virgin, J; Yueh, B, 2005) |
| "Treatment of SCC25 oral squamous carcinoma cells with sodium butyrate (SB) at 0." | ( Hashimoto-Tamaoki, T; Hashitani, S; Kishimoto, H; Kuroda, J; Nishimura, N; Noguchi, K; Sakurai, K; Urade, M, 2005) |
| "The patient had squamous cell carcinoma on the scalp and underwent preoperative neoadjuvant chemotherapy with peplomycin." | ( Enomoto, H; Ogasawara, M; Umebayashi, Y, 2004) |
| "In mice bearing transplants of a squamous cell carcinoma (ASB XIII), treatments with PCNU were followed by CRs in 3 of 38 animals on 15 mg/kg regimens and in 3 of 28 animals on 8 mg/kg regimens." | ( Baylouny, RA; Bissell, EC; Holiat, SM; Hubert, DD; Smith, WE; Sobel, HJ; Watts, LM; Yazdi, E, 2005) |
| "While multiple squamous cell carcinomas are often observed in the esophagus and the head and neck region and confound us about the favorable treatments, the reason why some patients are more likely to develop multiple cancers remains obscure." | ( Ebihara, S; Esumi, H; Muto, M; Ohtsu, A; Takahashi, M; Yoshida, S, 2005) |
| "Forty patients with uterine cervical squamous cell carcinoma treated with CCRT using HDR-ICBT were analyzed." | ( Kakinohana, Y; Kanazawa, K; Maehama, T; Moromizato, H; Murayama, S; Ogawa, K; Toita, T, 2005) |
| "241 patients with squamous cell carcinoma of the oropharynx were treated between 1984-1995 in Radiotherapy Department II of Centre of Oncology in Warsaw." | ( Hliniak, A; Kawecki, A; Kraszewska, E; Szutkowski, Z; Wasilewska-Teśluk, E, 2004) |
| "Seventeen oral squamous cell carcinoma (SCC) patients underwent chemotherapy with TS-1 (8 males and 9 females, mean age; 75." | ( Hosogai, N; Obara, S; Yamamoto, K; Yoshimura, Y, 2005) |
| "The study included cervical squamous cell carcinomas treated by radiotherapy alone (n=45) or chemoradiotherapy (concurrent once-a-week cisplatin 30 mg/m2, n=13)." | ( Akine, Y; Hata, M; Igaki, H; Kagei, K; Ohara, K; Oki, A; Onishi, K; Satoh, T; Sugahara, S; Tanaka, YO; Tokuuye, K; Tsunoda, H; Yoshikawa, H, 2005) |
| "Patients with locally advanced squamous cell carcinoma (SCC) of the esophagus were randomly allocated to either induction chemotherapy followed by chemoradiotherapy (40 Gy) followed by surgery (arm A), or the same induction chemotherapy followed by chemoradiotherapy (at least 65 Gy) without surgery (arm B)." | ( Budach, W; Franke, C; Klump, B; Lehmann, N; Meyer, HJ; Schmitt, G; Schmitt, M; Seeber, S; Stahl, M; Stuschke, M; Teichmann, R; Walz, MK; Wilke, H, 2005) |
| "A total of 40 patients with intact squamous cell carcinoma arising in the head-and-neck region underwent intensity-modulated radiotherapy (IMRT) at one department." | ( Davis, LW; Howell, R; Koshy, M; Paulino, AC; Schuster, D, 2005) |
| "Basal and squamous cell carcinoma, lentigo maligna and lentigo maligna melanoma, dermatofibrosarcoma protuberans, and Merkel cell carcinoma are malignant lesions for which surgical excision is the recommended treatment." | ( Padgett, JK, 2005) |
| "In the syngeneic squamous cell carcinoma-bearing mouse model, a single administration of TX-1877 significantly inhibited the primary tumor growth as well as lung metastasis." | ( Ahmed, SU; Furuichi, S; Hori, H; Kan, S; Kasai, S; Nagasawa, H; Okamoto, M; Oshikawa, T; Sasai, A; Sato, M; Tano, T; Uto, Y, 2005) |
| "All patients had stage III or IV squamous cell carcinoma of the head and neck and had been treated with surgical resection, radiation, or both." | ( Francisco, M; Hong, WK; Khuri, FR; Kim, E; Murphy, B; Richards, T; Seixas-Silva, JA; Shin, DM; Wieand, HS, 2005) |
| "A 66-year-old man was diagnosed with squamous cell carcinoma in the lung, classified as clinical stage IIIA (T2N2M0), and underwent induction chemotherapy." | ( Hirabayashi, H; Maeda, J; Matsuda, H; Ohta, M, 2005) |
| "Treatment of head and neck squamous carcinoma cells with clinically relevant concentrations of imatinib-induced changes in cell morphology and growth similar to changes associated with epidermal growth factor receptor (EGFR) activation." | ( Donato, NJ; Johnson, FM; Saigal, B, 2005) |
| "The treatment of vulvar squamous cell carcinoma patients is often mutilating." | ( Bjørge, T; Holm, R; Knopp, S; Nesland, JM; Tropé, C, 2005) |
| "We present the first reported case of a squamous cell carcinoma recurrence on a reconstructed flap in the pharynx treated successfully with topical chemotherapy." | ( Banga, R; Cox, G; Ramsden, J, 2005) |
| "Radiotherapy for oral squamous cell carcinomas is limited in its efficacy and in its ability to improve the survival rate in patients at an advanced stage." | ( Imai, Y; Kajiwara, A; Kirita, T; Ohnishi, K; Ohnishi, T; Takahashi, A; Yamakawa, N; Yasumoto, J, 2005) |
| "With the use of HSC-3 human oral squamous cell carcinoma cells, the present study showed that treatment with Se for 72 h, in the form of SeO2 and Na2SeO3, but not Na2SeO4, markedly induced apoptosis in a dose-dependent manner." | ( Echigo, S; Rikiishi, H; Sato, T; Shinohara, F; Takahashi, M, 2005) |
| "Patients with either adenocarcinoma or squamous cell carcinoma of the esophagus could enroll; however, patients could not have received prior chemotherapy for metastatic disease." | ( Ahuja, H; Bailey, H; Berlin, JD; Hansen, R; Jumonville, A; Kim, K; McFarland, T; Morgan-Meadows, S; Mulkerin, D; Saphner, T; Thomas, JP, 2005) |
| "Unknown primary squamous cell carcinoma in the neck has been treated by combination therapy consisting of chemotherapy, radiation therapy and surgery." | ( Fujitani, K; Hirao, M; Ikenaga, M; Kashiwazaki, M; Masuda, N; Mishima, H; Nakamori, S; Sawamura, T; Tsujinaka, T; Yamashita, S, 2005) |
| "Using the radiosensitive human cervical squamous cell carcinoma cell line ME180 and SN38, a major active metabolite of CPT-11, both the SN38 effects on radiosensitivity and irradiation effects on SN38 sensitivity were investigated to optimize the chemoradiotherapy protocol for CPT-11." | ( Tanaka, T; Umesaki, N; Yukawa, K, 2005) |
| "Esophageal squamous cell carcinoma is generally sensitive to chemoradiotherapy (CRT), but some cases are not." | ( Itabashi, M; Ohkura, H; Okumura, T; Sunada, F, 2005) |
| "Histological analysis of skin showed squamous cell carcinoma in the AFB1/TPA treated group." | ( Das, M; Dogra, RK; Khanna, SK; Rastogi, S, 2006) |
| "Cultured squamous carcinoma cells were treated with exogenous osteopontin or with RNA interference to knockdown osteopontin expression." | ( Castellone, MD; Celetti, A; De Rosa, G; Galli, V; Guarino, V; Iovine, R; Mansueto, G; Melillo, RM; Merolla, F; Santoro, M; Somma, P; Staibano, S; Testa, D, 2005) |
| "Treatment of squamous carcinoma cells with recombinant osteopontin sharply increased proliferation and Matrigel invasion in comparison with the untreated cells parallel to activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase signaling cascade." | ( Castellone, MD; Celetti, A; De Rosa, G; Galli, V; Guarino, V; Iovine, R; Mansueto, G; Melillo, RM; Merolla, F; Santoro, M; Somma, P; Staibano, S; Testa, D, 2005) |
| "In well-differentiated squamous cell carcinoma induced after 20 weeks of treatment with 4NQO, bcl-2 was expressed in some cells of tumour islands." | ( Marques, ME; Ribeiro, DA; Salvadori, DM, 2005) |
| "Therapy of recurrent/metastatic squamous cell carcinoma of the head and neck results in median progression-free survival (PFS) of 2 months." | ( Burtness, B; Flood, W; Forastiere, AA; Goldwasser, MA; Mattar, B, 2005) |
| "We treated xenografted A-431, a human squamous cell carcinoma cell line, with SU6668 to investigate the efficacy of tumor dormant therapy using angiogenesis inhibitors for patients with squamous cell carcinoma." | ( Kitagawa, Y; Kitajima, M; Kubota, T; Nakamura, T; Ozawa, S; Ueda, M, 2006) |
| "Twenty-five squamous cell carcinomas, 1 melanoma, 2 basocellular carcinomas and 2 adenoid cystic carcinomas were treated." | ( Delalande, C; Dumas, G; Lavieille, JP; Reyt, E; Righini, Ch; Schmerber, S; Soriano, E, 2005) |
| "Seven cutaneous squamous cell carcinomas in cats were treated." | ( Buchholz, J; Kaser-Hotz, B; Laluhová, D; Ohlerth, S; Roos, M; Walt, H, 2006) |
| "Human laryngeal squamous cell carcinoma strain Hep-2 can be inhibited and induced into apoptosis by treated with hypericin combination with light irradiation." | ( Dong, Z; Meng, Y; Sun, YX; Yang, ZQ, 2005) |
| "45 patients with resected oral cavity squamous carcinoma were selected, for whom this was the initial treatment and who were followed up for 5 years or until death." | ( Hoffman, HT; Muirhead, DM; Robinson, RA, 2006) |
| "Eligible patients had squamous cell carcinoma of the cervix, measurable disease, one prior chemotherapy regimen which did not include an anthracycline, absolute neutrophil count (ANC) > 1500/microl, platelet count > 100,000/microl, and adequate hepatic function." | ( Abulafia, O; Blessing, JA; Lele, S; Rose, PG, 2006) |
| "Two patients with unresectable squamous cell carcinoma of the esophagus were treated with 1 mL of absolute (95 g/L) alcohol injections once a week for 4 weeks, followed by chemoradiation therapy consisting of concomitant 5-fluorouracil 300 mg/m/d and radiation therapy (total of 60 Gy over 6 weeks)." | ( Abbasi, S; Korman, L; Wadleigh, RG, 2006) |
| "Eighteen patients with squamous cell carcinoma of the oropharynx or larynx/hypopharynx were treated with curative intent by forward planning IMRT." | ( Daisne, JF; Duprez, T; Geets, X; Grégoire, V; Lonneux, M; Tomsej, M, 2006) |
| "Cetuximab has activity in squamous cell carcinoma and enhances both chemotherapy and radiotherapy." | ( Aliff, TB; Kraus, DH; Lake, S; Lis, E; Needle, MN; Pfister, DG; Shah, JP; Shaha, AR; Su, YB; Wolden, SL; Zahalsky, AJ; Zelefsky, MJ, 2006) |
| "Human laryngeal squamous cell carcinoma strain Hep-2 can be inhibited and induced into apoptosis by treated with hypericin combination with radiotherapy." | ( Dong, Z; Meng, Y; Sun, Y; Tang, S; Xu, H; Yang, Z, 2005) |
| "In vivo, the response of human KB squamous cell carcinoma xenografts was measured after treatment with perifosine, irradiation, and the combination." | ( Begg, AC; Lagerwerf, S; Mesman, E; Schellens, JH; van Blitterswijk, WJ; Verheij, M; Vink, SR, 2006) |
| "Combination treatment of head and neck squamous cell carcinoma via cell cycle inhibition and cisplatin holds promise as a potential therapy in the clinical setting." | ( Chakrabarti, R; Chopra, R; Ramamurthy, B; Srivatsan, ES; Veena, MS; Wang, MB; Yip, HT, 2006) |
| "An oral squamous cell carcinoma cell line (HSC-3) was treated with sodium butyrate (NaB), suberoylanilide hydroxamic acid (SAHA) or MS-275 on the day of, the day before, or the day after addition of CDDP." | ( Echigo, S; Rikiishi, H; Sato, T; Sato, Y; Suzuki, M, 2006) |
| "Here we report that in vitro treatment of human epidermoid carcinoma A431 cells with berberine, a naturally occurring isoquinoline alkaloid, decreased cell viability (3-77%, P < 0." | ( Katiyar, SK; Mantena, SK; Sharma, SD, 2006) |
| "Patients with biopsy-proven squamous cell carcinoma of the oral cavity, oropharynx, hypopharynx, or larynx were randomly assigned to one of the following treatments: prophylactic trolamine emulsion, interventional trolamine emulsion, or declared institutional preference." | ( Ang, K; Berk, L; Bucci, MK; Elliott, EA; Garden, AS; Greenberg, M; Hug, EB; Kim, H; Nguyen-Tân, F; Ryu, J; Saxton, JP; Swann, RS; Takita, C; Wright, JR, 2006) |
| "In esophageal squamous cell carcinoma (ESCC), chemoradiotherapy (CRT) has a curative potential even in cases of locally advanced carcinoma." | ( Aoyagi, K; Ashida, A; Boku, N; Minashi, K; Muto, M; Ochiai, A; Ohtsu, A; Sasaki, H; Sato, H; Tsubosa, Y; Yoshida, S; Yoshida, T, 2006) |
| "To study a new method for treating squamous cell carcinoma of the head and neck using a survivin antisense gene." | ( Hayashi, N; Iida, M; Kojima, H; Manome, Y; Moriyama, H; Suzuki, R; Yaguchi, Y, 2006) |
| "Patients with intermediate-stage squamous cell carcinoma of the head and neck traditionally have been treated with initial surgical resection followed by radiotherapy (RT) alone or chemoradiotherapy." | ( Brockstein, B; Cohen, EE; Haraf, DJ; Kies, MS; Kocherginsky, M; List, MA; Mittal, BB; Rosen, F; Stenson, KM; Vokes, EE; Williams, R; Witt, ME, 2006) |
| "We report a case of squamous cell carcinoma (SCC) of the bladder treated successfully with intraarterial chemotherapy using nedaplatin." | ( Kitagawa, Y; Nakashima, T; Shigehara, K; Shimamura, M, 2006) |
| "Lscc-02 human laryngeal squamous cell carcinoma cell line was treated with 1,25(OH)2D3." | ( Cai, P; Li, J; Wu, Z, 2006) |
| "Five human head and neck squamous cell carcinoma cell lines (HNSCCs) xenografted in nude mice were treated with a clinically relevant irradiation protocol with 30 fractions within 6 weeks." | ( Baumann, M; Mueller-Klieser, W; Quennet, V; Rosner, A; Walenta, S; Yaromina, A; Zips, D, 2006) |
| "76 patients with eyelid squamous cell carcinoma treated in an oncology referral hospital between 1997 and 2006 were reviewed retrospectively." | ( Markoç, F; Soysal, HG, 2007) |
| "The incidence of tongue squamous cell carcinomas (SCC) in the 4-NQO-treated rats was 64%, while that in the rats given ONO-8711 after 4-NQO exposure was 29 (P<0." | ( Fujitsuka, H; Kobayashi, A; Makita, H; Maruyama, T; Miyamoto, S; Mutoh, M; Shibata, T; Suzuki, R; Tanaka, T; Toida, M; Wakabayashi, K; Yasui, Y; Yonemoto, K, 2007) |
| "Fifty patients with advanced squamous cell carcinoma of the head and neck (SSCHN) who underwent MRI volumetry before and after neoadjuvant chemotherapy consisting of docetaxel, cisplatin, and 5-fluorouracil (TPF) were included in this study." | ( Baghi, M; Bisdas, S; Gstoettner, W; Hambek, M; Knecht, R; Mack, MG; Muerthel, R; Vogl, T; Wagenblast, J, 2007) |
| "In 20 patients with histological proven squamous cell carcinoma of the upper and middle oesophagus, FDG-PET was performed in standard technique prior to therapy." | ( Bartenstein, P; Brochhausen, C; Buchmann, I; Hansen, T; Junginger, T; Kneist, W; Oberholzer, K; Schreckenberger, M, 2006) |
| "Neoadjuvant chemotherapy (NAC) for oral squamous cell carcinoma has a positive impact on organ preservation and/or survival only in patients who achieve an excellent anti-tumour effect with this therapy." | ( Hiratsuka, H; Kido, Y; Kubota, H; Nakamori, K; Noguchi, M; Takemura, K; Tsuji, T, 2007) |
| "First-line chemotherapy for 32 advanced squamous cell carcinomas of the esophagus is not effective, and early recurrences after chemotherapy were examined." | ( Aoyama, N; Minamide, J; Oota, Y; Takada, K, 2007) |
| "Treatment of the clinical N0 neck in squamous cell carcinoma (SCC) of oral cavity and oropharynx remains a dilemma." | ( Dijkstra, PU; Gravendeel, JP; Krabbe, CA; Pruim, J; Roodenburg, JL; van der Laan, BF; van der Wal, JE, 2008) |
| "13 patients with recurrent squamous cell carcinoma of the head-and-neck region after initial radiochemotherapy were treated." | ( Bathe, K; Bottke, D; Hinkelbein, W; Wiegel, T, 2007) |
| "Locally advanced operable oral squamous cell carcinoma (OSCC) continues to be a major therapeutic challenge despite the implementation of novel multi-modal treatment approaches." | ( Engel, M; Flechtenmacher, C; Freier, K; Hassfeld, S; Hofele, C; Lindel, K; Mühling, J, 2008) |
| "A resected case of squamous cell carcinoma associated with ductal carcinoma in the hemilateral breast successfully treated by FU plus cisplatin (CDDP) adjuvant therapy against recurrent metastases is reported with some discussion." | ( Akagawa, T; Fujioka, S; Hara, T; Hiramatsu, K; Hirata, A; Ito, T; Kato, K; Kutsuna, Y; Machiki, Y; Matsuba, H; Miyata, T, 2007) |
| "We herein report on a case of pure squamous cell carcinoma of the prostate approached with combined-modality treatment, with the administration of 3 courses of cisplatin 75 mg/m(2) on day 1 and continuous infusion 5-fluorouracil 750 mg/m2 on day 1 to 5 and, subsequently, radiotherapy, with the delivery of a total dose of 46 Gy to the whole pelvis, with additional boost doses of 20 Gy to the prostatic bed and adjunctive 6 Gy to the prostate gland (72 Gy in total)." | ( Ciammella, P; Clerico, M; Filippi, AR; Franco, P; Giudici, M; Munoz, F; Ricardi, U, 2007) |
| "Here, we report that in vitro treatment of human epidermoid carcinoma A431 cells with GSPs inhibited cellular proliferation (13-89%) and induced cell death (1-48%) in a dose (5-100 mug/ml)- and time (24, 48 and 72 h)-dependent manner." | ( Katiyar, SK; Meeran, SM, 2007) |
| "In advanced head and neck squamous cell carcinoma (HNSCC), there is a need for an adjuvant treatment." | ( Anniko, M; Cheng, J; Ekberg, T; Engström, M; Jensen, HJ; Nestor, M; Tolmachev, V, 2007) |
| "Seventy-four with squamous cell carcinomas of the cervical esophagus not previously treated who underwent cervical esophagectomy or total esophagectomy with or without laryngectomy were retrospectively analyzed." | ( Asai, M; Daiko, H; Ebihara, S; Hayashi, R; Miyazaki, M; Oyama, W; Saikawa, M; Sakuraba, M; Ugumori, T; Yamazaki, M, 2007) |
| "The golden hamster cheek pouch squamous cell carcinoma model was employed for in vivo studies; encapsulated lactone and open ring-carboxylated forms of HCPT were administered intraperitoneally, followed by determinations of tumor growth rate and inhibition ratio." | ( Chen, D; Chen, Y; Ding, XQ; Li, S; Wang, AX; Wang, J, 2007) |
| "Ten patients with pharyngo-laryngeal squamous cell carcinoma were treated by concomitant chemo-radiation delivered in 7 weeks." | ( Coche, E; Cosnard, G; Duprez, T; Geets, X; Grégoire, V; Lee, JA; Lonneux, M; Tomsej, M, 2007) |
| "Patients with esophageal squamous cell carcinoma (ESCC) are commonly at high risk of recurrence within 2 y after initial treatment." | ( Fu, Z; Guo, H; Huang, Y; Li, L; Xi, Y; Yang, G; Yu, J; Yuan, S; Zhang, B; Zhang, J; Zhu, H, 2007) |
| "Treatment of head and neck squamous cell carcinoma (HNSCC) addresses the primary tumor and the lymphatic drainage." | ( Buck, G; Huguenin, P; Stoeckli, SJ, 2008) |
| "This drug, approved for treatment of squamous cell carcinoma of the upper aerodigestive tract as well as colorectal cancer, is well tolerated." | ( Bauman, JE; Eaton, KD; Martins, RG, 2007) |
| "A 76-year-old patient with oral squamous cell carcinoma was treated by chemotherapy with S-1." | ( Bando, T; Harada, K; Tamatani, T; Yoshida, H, 2007) |
| "Current management of N0 stage lip Squamous Cell Carcinoma (SCC) are prophylactic neck dissection, radiotherapy, or "watch and see" policy." | ( Afifi, A; Alsayed, Y; El-Refaie, KM; Elaffandi, AH; Khalil, HH; Mahboub, T, 2008) |
| "Induction chemotherapy for squamous cell carcinoma of the head and neck has long been known to be highly active with tumor responses observed in a high percentage of patients." | ( Kies, MS, 2007) |
| "Pre-treatment serum squamous cell carcinoma antigen [SCC] levels are elevated in 28-88% of patients with squamous cell cervical cancer, and are related to tumour stage, tumour size, depth of stromal invasion, lymph-vascular space status, parametrial involvement and lymph node status." | ( Cosio, S; Gadducci, A; Genazzani, AR; Tana, R, 2008) |
| "Treatment of oral squamous cell carcinoma (OSCC) is currently based on surgery and radiotherapy." | ( Bachran, C; Bachran, D; Dassler, K; Ervens, J; Fuchs, H; Heisler, I; Melzig, MF, 2008) |
| "Blocking HIF-1alpha in esophageal squamous cell carcinoma cells may reverse the multidrug resistance of the tumor cells, so it may offer an avenue for gene therapy." | ( Fan, QX; Sun, Y; Wang, LX; Wang, RL; Wu, XA; Zhang, L, 2007) |
| "50 patients with squamous cell carcinoma (90%) or adenocarcinoma and mostly advanced tumor stage were treated (82% T3/T4 and 70% N1)." | ( Brunner, TB; Grabenbauer, GG; Melzner, W; Rupp, A; Sauer, R, 2008) |
| "134 patients with resectable squamous cell carcinoma of the oral cavity stage II-IV received neoadjuvant radiochemotherapy consisting of 39." | ( Bongartz, R; Eich, HT; Kocher, M; Löschcke, M; Müller, RP; Scheer, M; Wacker, S; Zöller, JE, 2008) |
| "7 patients with squamous cell carcinoma of the larynx treated at ENT Department Medical University of Lodź between 2003-2005 were analyzed." | ( Głowacka, E; Józefowicz-Korczyńska, M; Lukomski, M; Starska, K, 2007) |
| "Surgical treatment of epidermoid carcinoma of the lower lip occasionally involves resection of a large part of this anatomic area." | ( Barrera, MV; Bosch, RJ; Herrera, E, 2008) |
| "We present a case of a patient with squamous cell carcinoma of the scalp with neck node involvement treated with surgery followed by adjuvant radiotherapy." | ( Bajaj, GK; Latronico, D; Lin, SH; Teslow, T, 2008) |
| "Survival fraction of esophageal squamous carcinoma cells after administrating SN-38, active metabolite of CPT-11, and combination of hyperthermia and SN-38 was compared using data measured by MTT assay." | ( Honda, M; Imutsuka, S; Korenaga, D; Nozoe, T; Yasuda, M, 2007) |
| "To compare the treatment outcomes of squamous cell carcinoma (SCC) of buccal mucosa in India and Canada." | ( Abdoh, AA; Nason, RW; Pathak, KA; Talole, SD, 2008) |
| "Oral squamous cell carcinoma is the most common malignancy of the oral cavity, and treatment approaches are inadequate." | ( Chang, HR; Chu, SC; Hsieh, YS; Yang, SF; Yang, WE, 2008) |
| "Laminin-332 is critical for squamous cell carcinoma (SCC) tumorigenesis, but targeting it for cancer therapy has been unachievable due to key role of laminin-332 in promoting tissue integrity." | ( Fincher, EF; Marinkovich, MP; Nguyen, NT; Nokelainen, P; Rousselle, P; Tallapragada, S; Tran, M, 2008) |
| "Three head and neck squamous cell carcinoma cell lines, chosen on the basis of their diverse EGFR expression levels, were treated with docetaxel, erlotinib, or both." | ( Glisson, BS; Johnson, FM; Saigal, B, 2008) |
| "Thirty-six patients with esophageal squamous cell carcinoma treated with radical surgery were enrolled." | ( Fu, Z; Han, A; Kong, FM; Li, D; Li, H; Mu, D; Song, P; Yang, G; Yu, J; Zhang, B; Zhang, W; Zhong, X, 2009) |
| "We investigated the role of squamous cell carcinoma (SCC) at presentation (pre-SCC) and after treatment (post-SCC) as predictor of pathological response and outcome in locally advanced cervical cancer (LACC) patients undergoing preoperative chemoradiation." | ( Carone, V; Deodato, F; Digesù, C; Ferrandina, G; Forni, F; Legge, F; Macchia, G; Morganti, AG; Scambia, G, 2008) |
| "FaDu human head and neck squamous cell carcinoma xenografts were treated with MSC (0." | ( Bhattacharya, A; Oven, SD; Rustum, YM; Seshadri, M; Tóth, K; Vaughan, MM, 2008) |
| "Head and neck squamous cell carcinomas (HNSCC) are characterized by resistance to chemotherapy and overexpression of antiapoptotic Bcl-2 family members, including Bcl-X(L) and Bcl-2." | ( Grandis, JR; Johnson, DE; Li, C; Li, R, 2008) |
| "Patients with advanced esophageal squamous cell carcinoma receive neoadjuvant chemotherapy or chemoradiotherapy to improve survival, but benefits are observed only in those with histologic response." | ( Doki, Y; Fujiwara, Y; Fukunaga, H; Hatazawa, J; Higuchi, I; Miyata, H; Monden, M; Takiguchi, S; Tatsumi, M; Yano, M; Yasuda, T, 2008) |
| "In advanced-stage head and neck squamous cell carcinoma treated with concurrent chemoradiation, primary tumor volume is associated with locoregional control and survival." | ( Balm, AJ; de Bois, J; Heemsbergen, W; Hoebers, FJ; Pameijer, FA; Rasch, CR; Schornagel, JH, 2008) |
| "Cultured human laryngeal squamous cell carcinoma SNU-46 cells were treated with different concentrations of silibinin, and the degree of cell growth and apoptosis was analyzed." | ( Bang, CI; Joo, YH; Kim, MS; Paik, SY; Sun, DI, 2008) |
| "Head-and-neck squamous cell carcinoma (HNSCC) represents a heterogeneous group of patients in terms of subsite, treatment, and biology." | ( Cresswell, J; Homer, JJ; Price, P; Ryder, D; Silva, P; Slevin, NJ; Sloan, P; Valentine, H; West, CM, 2008) |
| "In early-stage cervical squamous cell carcinoma, lymphatic vascular space invasion and higher pretreatment plasma levels of fibrinogen are risk factors of pelvic lymph node metastasis." | ( Lü, WG; Tian, QF; Wang, XY; Xie, X; Ye, F, 2008) |
| "All patients had squamous cell carcinoma of the tongue and received interstitial radiotherapy with small sources." | ( Ariji, E; Ariji, Y; Fuwa, N; Kodaira, T; Nakamura, T; Satoh, Y; Tachibana, H, 2009) |
| "Six patients with advanced oral squamous cell carcinoma were treated with preoperative concurrent chemoradiotherapy." | ( Hoshi, K; Ito, H; Jinbu, Y; Kusama, M; Matsumoto, K; Matsumura, T; Noguchi, T; Osano, H; Tsuchiya, Y, 2009) |
| "C3H/HeN mice inoculated with murine squamous cell carcinomas were treated with a single dose of x-ray irradiation at 2, 6, 20, or 60 Gy." | ( Fukumoto, D; Harada, N; Kakiuchi, T; Kamijo, A; Kawaguchi, AT; Murayama, C; Tsukada, H, 2009) |
| "Patients with resectable advanced squamous cell carcinoma of the larynx (tumor stage T3-T4) or hypopharynx (T2-T4), with regional lymph nodes in the neck staged as N0-N2 and with no metastasis, were randomly assigned to treatment in the sequential (or control) or the alternating (or experimental) arm." | ( Bardet, E; Barzan, L; Bernier, J; Bogaerts, J; Chevalier, D; de Raucourt, D; Geoffrois, L; Horiot, JC; Hupperets, P; Lacombe, D; Leemans, CR; Lefebvre, JL; Licitra, L; Lunghi, F; Rolland, F; Stupp, R; Tesselaar, M; Vermorken, JB, 2009) |
| "Feline oral squamous cell carcinoma (SCC) is a devastating disease with an extremely poor long-term prognosis even with aggressive therapy." | ( Fulmer, AK; Mauldin, GE; Mauldin, GN, 2008) |
| "BALB/c mice bearing squamous cell carcinoma tumors were treated with radium 224 ((224)Ra-)-loaded stainless steel wires, releasing short-lived, alpha-emitting atoms from their surface." | ( Arazi, L; Cooks, T; Efrati, M; Keisari, Y; Kelson, I; Marshak, G; Schmidt, M, 2009) |
| "Cutaneous squamous cell carcinoma (SCC) and inflammation of actinic keratosis (AK) were reported in 2 patients treated with sorafenib (Lacouture et al), but the scope of this observation has not been evaluated." | ( Dubauskas, Z; Hwu, P; Jonasch, E; Kunishige, J; Prieto, VG; Tannir, NM, 2009) |
| "Advanced oropharyngeal squamous cell carcinoma is treated primarily with chemoradiation, with the goal of excellent disease control and preservation of swallowing and articulation functions of the oropharynx." | ( Bumpous, JM, 2009) |
| "Treatment of base of tongue (BOT) squamous cell carcinoma (SCC) has traditionally been associated with poor prognosis and significant morbidity." | ( Cano, ER; Carrau, RL; Caylakli, F; Ferris, RL; Gooding, WE; Johnson, JT; Lai, SY; Myers, EN; Simenthal, AA; Snyderman, CH, 2009) |
| "Poorly differentiated human squamous cell carcinoma FaDu growing in nude mice was treated with BIBF 1120 and investigated by functional histology." | ( Baumann, M; Dörfler, A; Eicheler, W; Geyer, P; Hilberg, F; Le, K; Yaromina, A; Zhou, X; Zips, D, 2009) |
| "Treatment options for recurrent squamous cell carcinoma of the head and neck (SCCHN) following platinum-based therapy are limited." | ( Feng, L; Ginsberg, LE; Glisson, BS; Hanrahan, EO; Hong, WK; Khuri, FR; Kies, MS; Kim, ES; Tran, HT; Truong, MT, 2009) |
| "The esophageal squamous carcinoma cell line (TE-13) was treated with different concentrations of nicotine (100 microg/mL and 200 microg/mL) or 200 microg/mL nicotine plus 100 micromol/L nimesulide." | ( Zhang, ST; Zhu, ST; Zong, Y, 2009) |
| "The treatment of squamous cell carcinoma of the head and neck cell lines with erlotinib time-dependently increased the expression of cell cycle regulatory proteins p21 and p27 and apoptosis regulatory protein Bim." | ( Amin, AR; Chen, ZG; Khuri, FR; Shin, DM, 2009) |
| "Head and neck squamous cell carcinomas (HNSCC) are commonly resistant to conventional chemotherapy drugs and exhibit overexpression of signal transducer and activator of transcription 3 (STAT3)." | ( Grandis, JR; Johnson, DE; Leeman-Neill, RJ; Li, C; Man, DS; Sen, M; Zang, Y, 2009) |
| "Pure primary squamous cell carcinoma (SCC) of the breast is rare and difficult to treat." | ( Bhatt, L; Fernando, I, 2009) |
| "Patients with oral squamous cell carcinoma (OSCC) and poor prognosis may benefit from an intensification of the initial therapy scheme." | ( Buchmann, I; Freier, K; Haberkorn, U; Hofele, C; Thiele, OC, 2009) |
| "Head and neck squamous cell carcinoma (HNSCC) cells (FaDu, UT-SCC15, UT-SCC45), lung cancer cells (A549), colorectal carcinoma cells (DLD-1, HCT-116) and pancreatic tumor cells (MiaPaCa2, Panc1) were treated with different concentrations of TAE226 (0-1mum; 1 or 24h) without or in combination with irradiation (0-6Gy, X-ray, single dose)." | ( Cordes, N; Eke, I; Hehlgans, S; Lange, I, 2009) |
| "We analyzed 29 cases of Stage III squamous cell carcinoma of the uterine cervix treated with radiotherapy and IAIC of CDDP from 1991 to 2006." | ( Fujiwara, H; Hashimoto, Y; Ito, K; Kakizawa, H; Kaneyasu, Y; Kenjo, M; Kudo, Y; Murakami, Y; Nagai, N; Nagata, Y; Toyota, N; Yuki, S, 2009) |
| "The hypertrophic actinic keratoses and squamous cell carcinoma were treated with cryotherapy and excision, respectively." | ( Akanay-Diesel, S; Hanneken, S; Hoff, NP; Pippirs, U; Schulte, KW, 2009) |
| "Treatment of human head and neck squamous cell carcinoma (HNSCC) cell lines with guggulsterone, a widely available, well-tolerated nutraceutical, demonstrated dose-dependent decreases in cell viability with EC(50)s ranging from 5 to 8 microM." | ( Cai, Q; Freilino, ML; Grandis, JR; Hahm, ER; Johnson, DE; Joyce, SC; Leeman-Neill, RJ; Li, C; Neill, DB; Panahandeh, MC; Seethala, RR; Sen, M; Singh, SV; Thomas, SM; Wheeler, SE, 2009) |
| "Three human oral squamous cell carcinoma cell lines, Tca8113, TSCC and NT, were treated with GA alone, celastrol alone or GA plus celastrol." | ( Chen, W; Duan, W; He, D; Xu, Q; Yan, M; Ye, D; Zhang, P; Zhang, Z; Zhong, L; Zhou, X, 2009) |
| "The mouse squamous cell carcinoma was irradiated with gamma-ray before BSH ((10)B-enriched borocaptate sodium) administration." | ( Kashino, G; Kinashi, Y; Liu, Y; Maruhashi, A; Masunaga, S; Nagata, K; Ono, K; Sakurai, Y; Suzuki, M; Tanaka, H, 2009) |
| "Thirteen patients with squamous cell carcinoma (SCC) and 3 patients with non-SCC who had recurrent/metastatic disease received S-1 monotherapy as outpatients." | ( Ishikawa, K; Suzuki, S, 2009) |
| "We studied the HMGA1 expression in squamous cell carcinoma of skin in mice followed by the treatment with Cisplatin, which is often used in combination therapies of cancers." | ( Rajeswari, MR; Ray, R; Sharma, A, 2010) |
| "Recurrent squamous cell carcinoma after major surgery and microvascular reconstruction with a free-flap transfer is difficult to handle via conventional treatment methods." | ( Castro, DJ; Joo, J; Paiva, MB; Paolini, AA; Sercarz, JA, 2009) |
| "Rare squamous cell carcinoma (SCC) cases associated with voriconazole therapy have been reported, but this risk may not receive enough consideration from clinicians." | ( Beani, JC; Charles, J; Epaulard, O; Leccia, MT; Roch, N; Saint-Raymond, C; Villier, C, 2010) |
| "In well-differentiated squamous cell carcinoma induced after 20 weeks of treatment with 4NQO, Wnt1 was expressed in the majority of the dysplasic cells and tumor cells." | ( Fracalossi, AC; Oshima, CT; Ribeiro, DA; Silva, Mde S, 2010) |
| "With regard to squamous cell carcinoma, treatment with 5-fluorouracil, methotrexate, interferon, and bleomycin are reviewed." | ( Good, LM; High, WA; Miller, MD, 2011) |
| "Human head and neck squamous cell carcinoma (HNSCC) cells with different p53 status, and HSC4 (p53 wild-type) and CAL27 (p53 mutant type) cells were treated with docetaxel and irradiation using three schedules: i) concurrent treatment, ii) docetaxel pretreatment and iii) pre-radiation." | ( Adachi, M; Furuse, S; Ijichi, K; Mitsudo, K; Miura, S; Nakazawa, M; Ohta, S; Tohnai, I; Torigoe, S, 2010) |
| "Oral squamous cell carcinoma (OSCC) is the most common malignancy of the oral cavity; however the treatment approaches are still unsatisfactory." | ( Chang, YF; Chen, HW; Hwang, JJ; Kuo, YC; Lee, YJ; Lin, YC, 2010) |
| "Seventeen patients with primary squamous cell carcinomas of the oral cavity underwent an (18)F-FLT PET/CT scan before surgery, and iododeoxyuridine was administered 20 min before tumor resection." | ( Bussink, J; Kaanders, JH; Merkx, MA; Oyen, WJ; Peeters, WJ; Slootweg, PJ; Troost, EG; van der Kogel, AJ, 2010) |
| "Cetuximab is active in the treatment of squamous cell carcinoma of the head and neck (SCCHN), enhancing both radiotherapy and chemotherapy effects." | ( Dunst, J; Engenhart-Cabillic, R; Flentje, M; Grabenbauer, G; Kuhnt, T; Lammering, G; Pirnasch, A; Sandner, A; Schreiber, A; Wendt, T, 2010) |
| "Among head-and-neck squamous cell carcinoma patients treated with chemoradiotherapy, the pretreatment SUV of nodal disease was one of the strongest prognostic factors and also provided important information for the selection of patients suitable for planned neck dissection." | ( Fuwa, N; Inokuchi, H; Kodaira, T; Mizoguchi, N; Nakahara, R; Nakamura, T; Tachibana, H; Takada, A; Tamaki, T; Tomita, N, 2011) |
| "Esophageal squamous cell carcinoma (ESCC) is one of the most aggressive human cancers, and novel treatment modalities are required." | ( Akagi, Y; Fujii, T; Kage, M; Kusukawa, J; Miyagi, M; Sayers, TJ; Seki, N; Shirouzu, K; Toh, U; Yamana, H, 2010) |
| "All the adenocarcinomas and squamous cell carcinomas were treated by radiotherapy due to the advanced stage of the disease while the myeloid sarcoma received chemotherapy." | ( Azrif, M; Cheok, LB; Hong, GE; Kong, CH; Singam, P; Tamil, AM; Zainuddin, ZM, 2010) |
| "Recurrent head and neck squamous cell carcinoma (HNSCC) remains a difficult cancer to treat." | ( Aulino, J; Burkey, BB; Chung, CH; Murphy, B; Palka, K; Parker, J; Pohlmann, PR; Puzanov, I; Rothenberg, ML, 2011) |
| "Cutaneous squamous cell carcinoma (CSCC) is the second most common skin cancer with a substantial risk of metastasis which causes clinical treatment failure." | ( Chen, W; Koeffler, HP; Leiter, A; Louw, VJ; Meiring, M; Yin, D, 2010) |
| "Non-melanoma skin cancers, such as squamous cell carcinoma and basal cell carcinoma, also represent sun-related conditions that require early and aggressive treatment." | ( Goldsmith, A; Han, A; Marmur, ES; Penrose, C, 2010) |
| "Ocular lesions in horses, confirmed as squamous cell carcinoma, were treated topically with mitomycin C." | ( Knottenbelt, D; Malalana, F; McKane, S, 2010) |
| "Six patients treated for hypopharyngeal squamous cell carcinoma were extracted from archives." | ( Aznar, M; Bender, E; Bentzen, SM; Berthelsen, AK; Due, AK; Korreman, S; Kristensen, CA; Specht, L; Tomé, W; Vogelius, I, 2010) |
| "HNSCC cell lines squamous cell carcinoma (SCC)-15 and SCC-25 were treated with SphK1 inhibitor SKI-II and siRNA targeting SphK1 with and without radiation, and the cell viability was assessed." | ( Chinn, SB; Hochstim, C; Masood, R; Schorn, VJ; Sinha, UK; Zhu, S, 2011) |
| "For the in vitro study, 5 oral squamous cell carcinoma cell lines (Ca9-22, HSC-3, HSC-4, SAS, and KON) were treated with 25 mmol/L D-allose." | ( Hoshikawa, H; Mori, N; Mori, T, 2010) |
| "To update our experience in treating squamous cell carcinoma of the anal margin with definitive radiotherapy (RT)." | ( Balamucki, CJ; George, TJ; Kirwan, JM; Mendenhall, WM; Morris, CG; Newlin, HE; Rout, WR; Zlotecki, RA, 2011) |
| "Patients with squamous cell carcinoma of the anal margin have a high probability of cure with sphincter preservation after RT with or without concurrent chemotherapy." | ( Balamucki, CJ; George, TJ; Kirwan, JM; Mendenhall, WM; Morris, CG; Newlin, HE; Rout, WR; Zlotecki, RA, 2011) |
| "HIV-positive patients with squamous cell carcinoma of the canal treated at Continuum Cancer Centers-affiliated hospitals were identified from tumor registries." | ( Ennis, RD; Evans, A; Grossbard, M; Hauerstock, D, 2010) |
| "Systemic treatment of head and neck squamous cell carcinoma (HNSCC) includes a variety of antineoplastic drugs." | ( Albers, AE; Bas, M; Bergmann, C; Bier, H; Bölke, E; Brandau, S; Greve, J; Hoffmann, TK; Lang, S; Lehnerdt, G; Mattheis, S; Schuler, PJ; Trellakis, S; Whiteside, TL, 2010) |
| "To compare outcomes in patients with squamous cell carcinoma (SCC) of the vulva treated with radiation (RT) and concurrent weekly platinum-based or every-3-4-week regimens containing 5-fluorouracil (5-FU)." | ( Ancukiewicz, M; Halasz, LM; Mak, RH; Russell, AH; Schultz, DJ; Tanaka, CK; Viswanathan, AN, 2011) |
| "288 patients with squamous cell carcinoma of the uterine cervix, FIGO Stage IB-IIIB were randomized to one of the following treatments: three courses of neoadjuvant chemotherapy with cisplatin, vincristine, bleomycin (NACT arm; n = 159); conventional surgery or exclusive radiotherapy (CONV arm; n = 129)." | ( Corosu, L; Marziani, R; Mossa, B; Mossa, S, 2010) |
| "He was diagnosed with conjunctival squamous cell carcinoma and treated with topical mitomycin C (MMC)." | ( Amorese, L; Foster, S; Gonzalez-Gonzalez, LA; Shaikh, M; Siddique, SS, 2011) |
| "Patients with newly diagnosed squamous cell carcinoma of the head and neck, who were eligible for radiotherapy and who were not receiving concurrent chemotherapy, were randomly assigned to receive either IV amifostine (200 mg/m(2) daily for 3 minutes, 15 to 30 minutes before irradiation) or SC amifostine (500 mg; two sites; 20 to 60 minutes before irradiation)." | ( Alfonsi, M; Aupérin, A; Bardet, E; Boisselier, P; Bourhis, J; Calais, G; Dessard-Diana, B; Feham, NE; Garaud, P; Martin, L; Seng, SH; Tuchais, C, 2011) |
| "We report three cases of anal canal squamous cell carcinoma treated with radiotherapy combined with S-1 and mitomycin C(MMC)." | ( Akaike, M; Motohashi, O; Nakayama, N; Nakayama, Y; Nishimura, K; Nonaka, T; Shiozawa, M; Takagi, S; Yoshii, T, 2010) |
| "Human oral squamous carcinoma cell line Tca8113 was treated with different concentration of NaB." | ( Gong, L; Ji, Y; Li, DW; Wang, WM; Wang, Y, 2010) |
| "Fifteen patients with esophageal squamous cell carcinoma underwent CDDP/5-FU chemoradiotherapy." | ( Haga, N; Ishibashi, K; Ishida, H; Kumamoto, K; Sobajima, J, 2010) |
| "Head and neck squamous cell carcinoma (HNSCC) patients are at an increased risk of developing a second primary tumor (SPT) or recurrence following curative treatment." | ( Gu, J; Hildebrandt, MA; Hong, WK; Khuri, FR; Kim, E; Lee, JJ; Lotan, R; Spitz, MR; Wu, X; Yang, H; Ye, Y, 2011) |
| "Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide and treatment protocols include disfiguring surgery, platinum-based chemotherapy and radiation, all of which may result in tremendous patient morbidity." | ( Srivatsan, ES; Veena, MS; Wang, MB; Wilken, R, 2011) |
| "Primary squamous cell carcinoma (SCC) associated with ovarian endometriosis is extremely rare and has a poor prognosis due to insufficient information on the optimal postoperative treatment." | ( Kato, K; Ushijima, M; Yamakawa, Y, 2011) |
| "Keratoacanthoma and squamous cell carcinoma should be considered in any patient developing rapidly growing keratotic nodules in association with recent imiquimod therapy." | ( Delaney, T; Foxton, G, 2011) |
| "Since head and neck squamous cell carcinoma (HNSCC) preferentially metastasizes to the locoregional lymphatics, treatment of the tumor-draining cervical lymph nodes is paramount." | ( Cai, S; Cohen, MS; Davies, NM; Forrest, ML; Xie, Y, 2010) |
| "Resistance of oral squamous cell carcinomas (OSCC) to conventional chemotherapy or radiation therapy might be due to cancer stem cells (CSCs)." | ( Brockhoff, G; Driemel, O; Ettl, T; Felthaus, O; Gosau, M; Hautmann, M; Morsczeck, C; Reck, A; Reichert, TE; Schmalz, G; Zeitler, K, 2011) |
| "The treatment of squamous cell carcinoma of the lung has not advanced sufficiently." | ( Goto, K; Kubota, K; Naito, Y; Niho, S; Ohe, Y; Ohmatsu, H; Yoh, K, 2011) |
| "Eligible patients with advanced squamous cell carcinoma of the lung were treated with docetaxel (60 mg/m(2)) and nedaplatin (100 mg/m(2)) administered i." | ( Goto, K; Kubota, K; Naito, Y; Niho, S; Ohe, Y; Ohmatsu, H; Yoh, K, 2011) |
| "Patients with oral squamous cell carcinoma treated with preoperative CRT and surgery were enrolled." | ( Chikui, T; Hatakenaka, M; Kawano, S; Kawazu, T; Koga, S; Matsuo, Y; Obara, M; Ohga, M; Shioyama, Y; Sugiura, T; Sunami, S; Yoshiura, K, 2011) |
| "Treating human squamous cell carcinoma (SCC) cells with the anti-cancer compounds, resveratrol and doxorubicin, triggered p53-independent premature senescence by invoking oxidative stress-mediated DNA damage." | ( Athar, M; Back, JH; Guyonnet-Duperat, V; Kim, AL; Ratner, D; Rezvani, HR; Zhu, Y, 2011) |
| "Treatment of SCCVII mouse squamous carcinoma cells using the silicone phthalocyanine Pc 4 for PDT induced increases in the prodeath global ceramides/dihydroceramides (DHceramides), and no changes in the prosurvival sphingosine-1-phosphate (S1P)." | ( Bai, A; Bhatti, G; Bielawska, A; Bielawski, J; Breen, P; Buren, EV; Joseph, N; Pierce, JS; Saad, ZH; Separovic, D, 2011) |
| "Head and neck squamous cell carcinoma cell lines UMSCC-1 and SQ20B were treated with docetaxel at increasing concentrations to develop resistant cell lines." | ( Dai, Y; Fan, CY; Neis, JP; Spring, PM; Vural, E; Xie, CH, 2011) |
| "Head and neck squamous cell carcinoma (HNSCC) is usually fatal, and innovative approaches targeting growth pathways are necessary to effectively treat this disease." | ( Gooding, WE; Grandis, JR; Gubish, CT; Siegfried, JM; Stabile, LP; Xu, H, 2011) |
| "Esophageal squamous cell carcinoma (ESCC) is a highly malignant disease that is generally not responding to chemotherapy." | ( Cho, CH; Fu, J; Liu, S; To, KK; Yu, L, 2012) |
| "Two well-characterized oral squamous cell carcinoma cell lines, CAL27 and SCC4, and premalignant leukoplakia cells were treated with different concentrations of Sal B." | ( Ge, PJ; Jiang, L; Li, FL; Yang, Y; Zhu, QY, 2011) |
| "The management of low risk squamous cell carcinoma with topical therapies, photodynamic therapy, systemic retinoids, and capecitabine is reviewed." | ( Brown, M; O'Reilly Zwald, F, 2011) |
| "Standard treatment of advanced squamous cell carcinoma of the head and neck (SCCHN) is concurrent chemoradiation." | ( Arias de la Vega, F; Arrazubi, V; Calvo, FA; Contreras, J; de la Torre, A; de Las Heras, M; García-Saenz, JA; Herruzo, I; Prieto, I; Romero, J, 2012) |
| "Cutaneous squamous cell carcinoma (CSCC) is the second most common skin cancer in whites, with a relatively low metastatic potential and a general amenability to local treatment." | ( Abu-Serriah, M; Ahn, JH; Ameerally, P, 2011) |
| "Eighteen patients with esophageal squamous cell carcinoma with and without neoadjuvant chemotherapy were analyzed using immunohistochemical methods for human leukocyte antigen (HLA) class I heavy chain, CD4-, CD8-, and Foxp3-positive cell infiltration." | ( Hirano, S; Kondo, S; Miyamoto, M; Shichinohe, T; Tsuchikawa, T; Yamamura, Y, 2012) |
| "Patients with head and neck squamous cell carcinoma (SCC) respond very differently to radiotherapy (RT)." | ( Blandamura, S; Fasanaro, E; Giacomelli, L; Koussis, H; Lionello, M; Loreggian, L; Lovato, A; Marioni, G; Staffieri, A, 2011) |
| "The role of chemotherapy (CHX) in squamous cell carcinoma of the head and neck (SCCHN) has been expanding." | ( Ekblad, L; Kjellén, E; Mineta, H; Sasaki, Y; Wahlberg, P; Wennerberg, J, 2012) |
| "Here, Japanese patients with esophageal squamous cell carcinoma (ESCC) were followed up for 5 years after treatment with a definitive 5-FU/cisplatin (CDDP)-based chemoradiotherapy (CRT), and the association between prognosis and the plasma concentration of 5-FU was evaluated." | ( Kadoyama, K; Kuwahara, A; Miki, I; Nakamura, T; Nishiguchi, K; Okuno, T; Omatsu, H; Sakaeda, T; Tamura, T; Yamamori, M, 2011) |
| "A major problem in treating oesophageal squamous cell carcinoma (ESCC) with cisplatin is the development of drug resistance." | ( Ji, Z; Liu, Z; Sun, C; Yang, G; Zhang, Y, 2011) |
| "Consecutive patients with nonmetastatic squamous cell carcinoma of the anus treated by CRT with curative intent between February 1983 and March 2008 were identified through the institutional database." | ( Chander, S; Chu, J; Foo, M; Heriot, A; Lee, MT; Leong, T; Link, E; Lynch, CA; Mackay, J; Michael, M; Ngan, SY; Tomaszewski, JM; Tran, P; Vazquez, M, 2012) |
| "Mice bearing SCCVII tumors (syngeneic squamous cell carcinomas) were treated by PDT with photosensitizer Foscan." | ( Korbelik, M; Separovic, D; Zhang, W, 2011) |
| "We clinically analyzed 8 oral squamous cell carcinoma patients showing a complete response(CR)to chemotherapy with S-1 alone." | ( Aoki, M; Iwamoto, O; Koga, C; Koga, M; Kusukawa, J; Nakamura, M, 2011) |
| "Head and neck squamous cell carcinoma cell lines, human keratinocyte and HNSCC xenograft models were treated with histone deacetylase inhibitors (HDACIs) and new generation PI3K and dual PI3K-mTOR inhibitors either alone or in combination." | ( Cameron, S; Dahler, A; de Long, LM; Endo-Munoz, L; Erlich, RB; Guminski, A; Hazar-Rethinam, M; Kherrouche, Z; Rickwood, D; Saunders, NA; Wooley, K, 2012) |
| "10 patients with maxillary squamous cell carcinoma (T3 n = 6, T4a n = 4) without regional or distant metastasis were treated by SSIACRT." | ( Fujisaka, M; Fukuoka, J; Kanazawa, Y; Kawabe, H; Otani, K; Seto, H; Shojaku, H; Tachino, H; Takakura, H; Tomizawa, G; Watanabe, Y, 2012) |
| "Nine patients with oral squamous cell carcinoma who were treated using this combined technique were analyzed retrospectively." | ( Chatani, M; Fujiwara, K; Tachimoto, R; Tsuboi, K; Yagi, M; Yoshioka, H, 2012) |
| "We report a case with perianal squamous cell carcinoma, which showed a complete response more than five years after chemoradiotherapy." | ( Imada, S; Ishikawa, O; Kishi, K; Miyashiro, I; Motoori, M; Nishiyama, K; Noura, S; Ohue, M; Shingai, T; Yano, M, 2011) |
| "Cells from a cutaneous squamous carcinoma cell line, A431, were treated with baicalein at 0-60 μM to establish the non-cytotoxic concentration (NCC) range for baicalein." | ( Chen, Y; Huang, D; Li, J; Liao, Y; Tang, F; Tang, X; Wang, W; Wu, B; Xie, H, 2011) |
| "In patients with squamous cell carcinoma (SCC), ATM, p53, PARP1, ERCC1, and MSH2 displayed significant (borderline) predictive values, mainly on DFS with chemotherapy efficacy limited to low marker levels." | ( Andre, F; Brambilla, E; Chen, Y; Filipits, M; Jiang, C; Kutok, JL; Le Chevalier, T; Olaussen, KA; Pierceall, WE; Pignon, JP; Pirker, R; Rousseau, V; Soria, JC; Sprott, KM; Ward, BE; Weaver, DT, 2012) |
| "Concurrent radiochemotherapy of oral squamous cell carcinoma was shown to drive the composition of inflammatory cells in a direction which is supposed to be prognostically favourable." | ( Büttner, M; Distel, LV; Fietkau, R; Grabenbauer, GG; Lubgan, D; Nkenke, E; Tabachnyk, M, 2012) |
| "The effective targeted therapy for lung squamous cell carcinoma (SCC) is needed." | ( Chang, GC; Chen, HY; Chen, KC; Hsu, KH; Tseng, JS; Yang, TY, 2012) |
| "In case of Head and Neck Squamous Cell Carcinoma, chromosomal changes are detectable at all stages of tumor development providing excellent opportunity for chromosomal prognosis and therapy." | ( Desai, B; Gadhia, P, 2012) |
| "Data of all patients diagnosed with squamous cell carcinoma (SCC) and adenocarcinoma (AC) of the oesophagus, treated between 1983 and 2007 in the department of radiation oncology of the LMU, were obtained." | ( Belka, C; Hölzel, D; Schmidt, M; Wolf, MC; Zehentmayr, F, 2012) |
| "Head and neck squamous cell carcinoma (HNSCC) is a group of tumors known to be sensitive to chemotherapy and radiotherapy in patients who are treatment naive." | ( Alifieris, C; Dalezis, P; Geromichalos, G; Sitaras, NM; Trafalis, DT, 2012) |
| "Head and neck squamous cell carcinoma (HNSCC) is often resistant to conventional chemotherapy and thus requires novel treatment regimens." | ( Choi, HJ; Kim, CH; Kim, YS; Park, KJ; Sung, ES, 2012) |
| "Induction chemotherapy in head and neck squamous cell carcinoma does not compromise delivery of definitive radiotherapy with or without concurrent chemotherapy." | ( Geropantas, K; Loo, SW; Martin, C; Roques, TW; Tasigiannopoulos, Z, 2013) |
| "Human head and neck squamous cell carcinoma Tu212 xenograft tumors were established in athymic nude mice and treated with EF31 i." | ( Arrendale, RF; Chen, ZG; Culver, D; Evers, TJ; Fu, H; Howard, RB; Khuri, FR; Lin, X; Mancini, A; Moore, TW; Morii, N; Reddy, P; Shin, DM; Shoji, M; Sica, G; Snyder, JP; Sun, A; Zhang, H; Zhu, S, 2012) |
| "Because metastatic cutaneous squamous cell carcinoma (CSCC) is rare, standard chemotherapy has not been fully established." | ( Nakamura, K; Okuyama, R; Saida, T; Uhara, H, 2013) |
| "However, 24 patients with sinonasal squamous cell carcinomas treated with intra-arterial infusion of cis-diamminedichloroplatinum showed a significant association between decreased expression of miR-34a and poor disease specific survival (P = 0." | ( Chen, N; Fukushige, S; Hashimoto, S; Horii, A; Kobayashi, T; Matsuura, K; Nagase, H; Ogawa, T; Saijo, S; Saiki, Y; Shiga, K; Sunamura, M, 2012) |
| "Head and neck squamous cell carcinomas (HNSCC) present a unique set of challenges in both the treatment of the disease and in support of the patient afflicted with the cancer." | ( Gee, AC; Kiraly, L; Martindale, R; McCarthy, MS, 2012) |
| "We review the association of squamous cell carcinoma with immunosuppressive agents used for the treatment of chronic plaque psoriasis." | ( Oakley, A; Simpkin, S, 2013) |
| "One challenge of squamous cell carcinoma of the head and neck (SCCHN) chemotherapy is a small percentage of tumor cells that arrest in the G0 phase of the cell cycle and are thus not affected by chemotherapy." | ( Arnoldner, C; Diensthuber, M; Eckardt, A; Geissler, C; Hambek, M; Stöver, T; Wagenblast, J, 2012) |
| "The cases with nevi and squamous cell carcinoma underwent local resection with cryotherapy as primary treatment." | ( Barman, M; Finger, PT; Milman, T, 2012) |
| "Pathologically diagnosed esophageal squamous cell carcinoma patients who could not tolerate concurrent chemoradiotherapy were enrolled." | ( Chen, B; Hui, Z; Liang, J; Lv, J; Wang, J; Wang, L; Wang, X; Zhai, Y; Zhu, H; Zou, S, 2013) |
| "An oral squamous cell carcinoma Ca9-22 cell line was treated with 11-dehydrosinulariolide, an active compound isolated from the soft coral Sinularia leptoclados, in order to evaluate the effect of this compound on cell growth and protein expression." | ( Chen, JC; Chen, JY; Chiu, CC; Lin, JJ; Liu, CI; Su, JH; Wang, RY; Wu, YJ, 2012) |
| "Treatment of oropharyngeal squamous cell carcinoma with chemoradiotherapy can now accomplish excellent locoregional disease control, but patient overall survival (OS) remains limited by development of distant metastases (DM)." | ( Eaton, A; Fury, M; Lee, NY; Lim, R; Ohri, N; Rao, S; Schöder, H; Setton, J; Wong, R, 2012) |
| "Human head and neck squamous cell carcinoma (HNSCC) is a major cause of cancer-related death during the last decade due to its related metastasis and poor treatment outcomes." | ( Amagaya, S; Chang, CM; Chang, PY; Chen, MY; Jao, HY; Kuo, SC; Lee, CY; Lu, CC; Tu, MG; Yang, JS, 2012) |
| "Patients with squamous cell carcinoma of the head and neck were treated with ACPF (nab-paclitaxel 100 mg/m(2) /week; cetuximab 250 mg/m(2) /week; cisplatin 75 mg/m(2) on day 1; 5-FU 750 mg/m(2) /day on days 1 through 3) every 21 days for 3 cycles followed by CRT (cisplatin 100 mg/m(2) on days 1, 22, and 43 of radiation therapy [RT])." | ( Adkins, D; Dehdashti, F; Gay, H; Lewis, J; Ley, J; Mehan, P; Nussenbaum, B; Siegel, BA; Thorstad, W; Trinkaus, K; Wildes, T, 2013) |
| "In the squamous cell carcinoma (SCC) cell lines SCC9 and SCC25, lovastatin treatment (1-25 µM, 24 hrs) induced LKB1 and AMPK activation similar to metformin (1-10 mM, 24 hrs), a known inducer of this pathway." | ( Dayekh, K; Dimitroulakos, J; Gorn-Hondermann, I; Ma, L; Niknejad, N, 2012) |
| "Mortality in head and neck squamous cell carcinoma (HNSCC) is high due to emergence of therapy resistance which results in local and regional recurrences that may have their origin in resistant cancer stem cells (CSCs) or cells with an epithelial-mesenchymal transition (EMT) phenotype." | ( Johansson, AC; La Fleur, L; Roberg, K, 2012) |
| "In a head and neck squamous cell carcinoma cell line, cisplatin-induced apoptosis was augmented by pretreatment with the HDAC inhibitor trichostatin A." | ( Eriksson, I; Joosten, M; Ollinger, K; Roberg, K, 2013) |
| "Head and neck squamous cell carcinoma (HNSCC) is characterized by overexpression of the epidermal growth factor receptor (EGFR) where treatments targeting EGFR have met with limited clinical success." | ( Barr, S; Cassell, A; Freilino, ML; Grandis, JR; Lee, J; Panahandeh, MC; Thomas, SM; Wang, L, 2012) |
| "A patient with multiple areas of squamous cell carcinoma over the scalp was treated using 60 Gy in 2." | ( Paravathaneni, U; Parvathaneni, U; Sponseller, P, 2013) |
| "Patients who had squamous cell carcinoma (SCC) or adenocarcinoma (AC) were treated in four referral centers in the north-east Netherlands with definitive chemoradiotherapy (dCRT) or radiotherapy (dRT) between 1996 and 2008." | ( Beukema, JC; Burgerhof, JG; Hospers, GA; Langendijk, JA; Muijs, CT; Mul, VE; Muller, K; Paardekooper, G; Plukker, JT; Smit, JK; Timmer, PR; van Dijk, BA; Woutersen, D, 2013) |
| "Sixty-four patients with squamous cell carcinoma of the glottic larynx underwent treatment of the primary tumor using induction chemotherapy with two cycles of intra-arterial docetaxel and cisplatin, plus continuous intravenous infusion of 5-fluorouracil for 120 h starting on day 2; followed by two cycles of concurrent chemoradiation therapy." | ( Furusaka, T; Ikeda, M; Matsuda, A; Matsuda, H; Tanaka, A, 2013) |
| "Human head and neck squamous cell carcinoma (HNSCC) is known to be difficult to treat and has only a 50% five-year survival rate." | ( Bian, Y; Hall, B; Husain, SR; Kulkarni, AB; Nakashima, H; Puri, RK; Sato, Y; Sun, ZJ, 2013) |
| "He had a history of invasive squamous cell carcinoma that was fully treated 2 years earlier." | ( Burns, DK; Georgescu, MM; Greenberg, T; Navalkele, DD; Vernino, S, 2013) |
| "Head and neck squamous cell carcinoma (HNSCC) is a common malignancy that continues to be difficult to treat and cure." | ( Barnes, L; Cardesa, A; Devaney, KO; Ferlito, A; Gnepp, DR; Hunt, JL; Lewis, JS; Mahfouz, ME; Rinaldo, A; Rodrigo, JP; Slootweg, PJ; Takes, RP; Thompson, LD; Triantafyllou, A; Westra, WH; Woolgar, JA, 2014) |
| "All patients with squamous cell carcinoma of the oropharynx treated with primary IMRT with or without chemotherapy over a 5-year period were reviewed." | ( Boutrid, H; Caudell, JJ; Deconti, R; Han, G; Kish, J; May, JT; McCaffrey, JC; McCaffrey, TV; Merchant, F; Padhya, TA; Rao, N; Sabater, RD; Tanvetyanon, T; Trotti, A, 2013) |
| "Treatment of human oral squamous cell carcinoma (OSCC) KB cells with either terbinafine or siRNA to knockdown KSR1 reduced proliferation and induced apoptosis, which was accompanied by suppression of the Raf-MEK-ERK pathway." | ( Guo, Y; Li, B; Liu, CY; Lu, L; Tan, XX; Yi, X; Zhong, M, 2013) |
| "Optimal treatment for locally advanced squamous cell carcinoma of the oropharynx (SCCOP) is not well defined." | ( Bellile, E; Bradford, CR; Byrd, S; Carey, TE; Chepeha, DB; Cordell, KG; Dobrosotskaya, IY; Eisbruch, A; Feng, F; Kumar, B; Maxwell, JH; McHugh, JB; Moyer, JS; Prince, ME; Spector, ME; Teknos, T; Urba, S; Walline, HM; Ward, PD; Wolf, GT; Worden, FP, 2014) |
| "Patients with squamous carcinoma of head and neck with documented progression after initial treatment were enrolled." | ( Alcaraz, D; Caballero, M; Feliz, L; Grau, JJ; Muñoz-García, C; Pereira, V; Sosa, AE, 2014) |
| "The treatment for esophageal squamous cell carcinoma (SCC) depends on its etiology." | ( Kato, H; Nakajima, M, 2013) |
| "Cutaneous squamous cell carcinoma (cSCC) is a concerning toxicity with BRAF inhibitors in the treatment for melanoma." | ( Kefford, RF; Long, GV; Menzies, AM, 2013) |
| "Eighty-one patients with oral squamous cell carcinoma (OSCC) received oral fluoropyrimidine UFT and radiotherapy (RT) with or without an immunotherapeutic agent OK-432." | ( Bando, T; Fujita, T; Goda, H; Hamakawa, H; Homma, S; Kan, S; Kawakami, Y; Koido, S; Nakashiro, K; Okamoto, M; Sato, M; Shimodaira, S; Tano, T; Yamashita, N, 2013) |
| "Most head and neck squamous cell carcinomas (HNSCCs) overexpress epidermal growth factor receptor (EGFR) and EGFR inhibitors are routinely used in the treatment of HNSCC." | ( Case, AJ; Domann, FE; Fletcher, EV; Love-Homan, L; Miller, FJ; Raeburn, A; Schickling, BM; Simons, AL; Sobhakumari, A, 2013) |
| "We report a patient with squamous cell carcinoma (SQCC) of the lung and a discoid-receptor-2 (DDR2) kinase domain mutation that responded to dasatinib treatment." | ( Altavilla, G; Arrigo, C; Di Mirto, C; Mondello, P; Pitini, V, 2013) |
| "Human oral squamous cell carcinoma (OSCC) is a common form of malignant cancer, for which radiotherapy or chemotherapy are the main treatment methods." | ( Chang, CC; Hsu, YC; Hung, CM; Ko, SY; Lin, CW, 2013) |
| "We present a case of an invasive squamous cell carcinoma of the glans penis, which was treated with topical antifungals and corticosteroids for 2 years prior to diagnosis, necessitating partial glansectomy." | ( Aires, D; Blackmon, J; Laarman, R; Rajpara, A, 2013) |
| "For the head and neck squamous cell carcinoma (HNSCC), surgery in combination with radiation therapy is the current standard treatment." | ( Chen, LW; Chen, TC; Chiang, KC; Flanagan, JN; Hsu, JT; Huang, CC; Juang, HH; Kittaka, A; Kuo, SF; Pang, JH; Sun, CC; Takano, M; Yang, SW; Yeh, CN, 2013) |
| "Head and neck squamous cell carcinoma (HNSCC) can become resistant to some chemotherapy and becomes a clinical challenge when it recurs." | ( Montero, M; Stack, BC; Ye, J, 2013) |
| "Between 2009 and 2011, 46 patients with squamous cell carcinoma of head and neck receiving PET-CT were treated with definitive radiotherapy, with or without chemotherapy." | ( Ekmekcioglu, O; Elicin, O; Halac, M; Uzel, EK; Uzel, OE, 2013) |
| "Patients with advanced esophageal squamous cell carcinoma who had failed first-line chemotherapy with cisplatin and 5-fluorouracil were enrolled in this study." | ( Li, X; Lin, S; Lin, W; Lin, Y; Wang, H, 2013) |
| "A 54-year-old man with metastatic squamous cell carcinoma to the parotid gland developed vitiligo within 1 month of starting gefitinib therapy." | ( Cohen, PR; Jalalat, SZ, 2013) |
| "Head and neck squamous cell carcinoma (HNSCC) remains difficult to treat, and despite of advances in treatment, the overall survival rate has only modestly improved over the past several years." | ( Crawford, S; Gonzalez, JG; Nerurkar, P; Rajamoorthi, A; Ray, RB; Shrivastava, S; Steele, R; Varvares, M, 2013) |
| "Currently, unresectable esophageal squamous cell carcinoma (ESCC) is primarily treated by chemoradiotherapy." | ( Cai, J; Dai, S; Liu, J; Liu, Z; Lu, J; Ma, J; Qin, Q; Sun, X; Tao, G; Xu, L; Yang, X; Zhan, L; Zhang, C; Zhang, X; Zhu, H; Zuo, Y, 2014) |
| "Thirty women with untreated invasive squamous cell carcinoma of the cervix of stage IIB to stage IVA were enrolled in the study in the Radiation Oncology Department of Imam Khomeini Hospital in Tehran from September 2009 to September 2010." | ( Akbari, EH; Esmati, E; Hashemi, FA; Kalaghchi, B, 2013) |
| "Treatment of patients with squamous cell carcinoma of head and neck is hampered by resistance of tumor cells to irradiation." | ( Blechert, B; Brockhoff, G; Bruchertseifer, F; Essler, M; Kopping, S; Mißlbeck, M; Morgenstern, A; Pickhard, A; Piontek, G; Seidl, C, 2014) |
| "More than half of head and neck squamous cell carcinoma (HNSCC) patients are initially treated with curative intent, but will relapse over the course of their disease and have poor prognosis with a median survival of approximately 6months." | ( Grandis, JR; Johnson, DE; Li, C; Yazbeck, VY; Zang, Y, 2014) |
| "In advanced cutaneous squamous cell carcinoma (cSCC), efficient medical treatment options are limited in case surgery and radiotherapy failed, particularly since most patients are of higher age and suffer from comorbidities." | ( Alter, M; Gutzmer, R; Kapp, A; Mattern, A; Satzger, I, 2013) |
| "Head and neck squamous cell carcinomas (HNSCCs) are characterized by marked heterogeneity in their biological behavior and response to treatment." | ( Fresno, MF; García-Pedrero, JM; Hermsen, M; Moreno-Galindo, C; Rodrigo, JP; Suárez, C, 2014) |
| "Human head and neck squamous cell carcinoma (HNSCC) fundamentally vary in their susceptibility to different cytotoxic drugs and treatment modalities." | ( Bechmann, I; Dietz, A; Gerlach, MM; Kubick, C; Lordick, F; Merz, F; Wichmann, G; Wittekind, C, 2014) |
| "Between 1998 and 2012, 56 patients with squamous cell carcinoma were treated at our institution and included in the analysis." | ( Blanchard, P; Bourhis, J; Daly-Schveitzer, N; Janot, F; Lévy, A; Tao, Y; Temam, S, 2014) |
| "Oral squamous cell carcinoma specimens were obtained from 61 patients who underwent surgery following 5-fluorouracil-based chemoradiotherapy at Kumamoto University Hospital between October 2003 and January 2009." | ( Hiraki, A; Hirosue, A; Kawahara, K; Kojima, T; Matsuoka, Y; Nagata, M; Nakagawa, Y; Nakayama, H; Shinohara, M; Takamune, Y; Tanaka, T; Yoshida, R; Yoshitake, Y, 2014) |
| "Keratoacanthomas (KAs) and cutaneous squamous cell carcinomas (cuSCCs) develop in 15-30% of patients with BRAF(V600E) metastatic melanoma treated with BRAF inhibitors (BRAFi)." | ( Atefi, M; Avramis, E; Cass, A; Cochran, AJ; Comin-Anduix, B; Escuin-Ordinas, H; Fu, Y; Graeber, TG; Herschman, HR; Huang, RR; Lo, RS; Marais, R; Ng, C; Ribas, A; Yashar, S, 2014) |
| "Chemoradiotherapy (CRT) for squamous cell carcinoma of the anus (SCCA) may cause significant toxicity, and concerns exist about its tolerability in the elderly." | ( Chander, S; Chu, J; Foo, M; Heriot, A; Lee, MT; Leong, T; Link, E; Michael, M; Ngan, SY; Tomaszewski, JM; Tran, PK, 2014) |
| "Endoscopic diagnostics of early squamous cell carcinoma (SCC) in the laryngo-esophageal region have dramatically improved together with development of less invasive endoscopic treatment." | ( Akazawa, Y; Hayashi, T; Inoue, H; Isomoto, H; Minami, H; Nakao, K; Nakayama, T; Ohnita, K; Takeshima, F; Yamaguchi, N, 2014) |
| "Patients with stage Ib2 to IIIb squamous cell carcinoma of the uterine cervix were treated with concurrent radiotherapy and chemotherapy." | ( An, J; Huang, M; Li, N; Wu, L; Yuan, G, 2014) |
| "The synchronized oral squamous cell carcinoma cell lines (Cal27, GNM, and WSU-HN6) were treated with different concentrations of NaHS and then subjected to cell proliferation, cell cycle, and Western blot analyses." | ( Bi, Q; Ma, Z; Wang, Y, 2015) |
| "Skin squamous cell carcinoma was induced in female CD-1 mice by 7,12-dimethylbenzanthracene and 12-O-tetradecanoyl-phorbol-13-acetate followed by an ICG/PDT treatment." | ( El Denshary, ES; El-Daly, SM; El-Hussieny, EA; Fouad, LM; Gamal-Eldeen, AM, 2014) |
| "Advanced unresectable squamous cell carcinoma of the skin (SCCS) is a rare condition, which is difficult to treat." | ( Bejar, C; Maubec, E, 2014) |
| "Suicide gene therapy of oral squamous cell carcinoma (OSCC) may be a viable approach to the treatment of this cancer." | ( Bernt, W; Duzgunes, N; Gebremedhin, S; Konopka, K; Koons, S; Singh, A, 2014) |
| "Currently, unresectable esophageal squamous cell carcinoma (ESCC) is primarily treated by chemoradiotherapy." | ( Chen, X; Cheng, H; Ge, Y; Liu, J; Liu, Z; Lu, J; Qin, Q; Sun, X; Xu, L; Yang, X; Zhan, L; Zhang, C; Zhang, H; Zhu, H, 2014) |
| "In head and neck squamous cell carcinoma (HNSCC), resistance to single-agent targeted therapy may be overcome by co-targeting of compensatory signaling pathways." | ( Axelrod, MJ; Capaldo, B; Conaway, M; Gioeli, DG; Jameson, MJ; Khalil, A; Leimgruber, SS; Mendez, RE; Sharlow, ER; Weber, MJ, 2015) |
| "We report a rare case in which primary squamous cell carcinoma of the nipple skin was successfully treated with S-1 alone." | ( Ishikawa, M; Miyoshi, K; Murakami, S; Nakano, R; Ohuchi, K; Sozaki, M; Uchiyama, A; Umeda, S, 2014) |
| "To report three cases of canine corneal squamous cell carcinoma (SCC) treated with strontium 90 beta radiation as an adjunct to surgical excision." | ( Hurn, SD; McCowan, C; Nevile, JC; Turner, AG, 2015) |
| "We describe the occurrence of a giant squamous cell carcinoma in a patient receiving vemurafenib for the treatment of late melanoma mestastases." | ( Altimari, A; Dika, E; Fanti, PA; Fiorentino, M; Gruppioni, E; La Placa, M; Melotti, B; Patrizi, A; Piraccini, BM; Vaccari, S; Venturoli, S, 2015) |
| "As the overall survival rates of squamous cell carcinoma of the head and neck (HNSCC) remain poor due to limitations in surgery and irradiation and chemotherapy resistance, SphK1 is an important enzyme to investigate." | ( Brockhoff, G; Doescher, J; Haug, A; Mißlbeck, M; Pickhard, A; Piontek, G; Reiter, R; Rudelius, M; Schiefler, C; Schuettler, D, 2014) |
| "There is large variability among lung squamous cell carcinoma patients in response to treatment with cisplatin based chemotherapy." | ( Fang, X; Hou, Z; Xie, H; Xu, C; Xu, H; Yu, L; Zhan, P, 2014) |
| "Esophageal squamous cell carcinoma is a common malignant tumor in recent years, and the key for improving the survival rate is early diagnosis and treatment." | ( Li, YX; Luo, HS; Shen, L; Yu, HG; Yu, JP, 2014) |
| "Treatment of a human tongue squamous cell carcinoma cell line, HSC-3, with alisertib to inhibition of Aurora-A kinases reduced proliferation and induced apoptosis, which was accompanied by activation of the ATM/Chk2/p53 pathway." | ( Qi, L; Zhang, Y, 2015) |
| "Metastatic squamous cell carcinoma (SCCA) of the anal canal is a rare malignancy for which no standard treatment algorithm exists." | ( Chang, GJ; Crane, CH; Das, P; Eng, C; Ohinata, A; Pathak, P; Phillips, JK; Rodriguez-Bigas, M; Rogers, JE; Sethi, S; Vauthey, JN; Wolff, RA; Xing, Y; You, YN, 2014) |
| "Advanced squamous cell carcinoma (SCC) is a challenge for treatment." | ( Wollina, U, 2015) |
| "Head and neck squamous cell carcinoma (HNSCC) is frequently characterized by high resistance to radiotherapy, which critically depends on both altered signaling pathways within tumor cells and their dynamic interaction with the tumor microenvironment." | ( Dyckhoff, G; Freier, K; Freudlsperger, C; Grabe, N; Hess, J; Hoffmann, J; Horn, D; Plinkert, P; Saure, D; Sharma, S; Weber, KJ; Weichert, W; Weißfuß, S, 2015) |
| "Subcutaneous Cal 27 squamous cell carcinoma xenografts received photothermal nanotherapy treatments, radial injections of polyethylene glycol (PEG)-ylated gold nanorods and one NIR 785 nm laser irradiation for 10 minutes at 9." | ( Crockett, SD; Green, HN; Grizzle, WE; Martyshkin, DV; Mirov, SB; Rosenthal, EL; Singh, KP, 2014) |
| "Esophageal squamous cell carcinoma is increasingly treated with trimodality therapy." | ( Di, ZL; Ke, Y; Ma, HB; Ren, J; Sun, X; Wen, J, 2015) |
| "Patients with esophageal squamous cell carcinoma received radiochemotherapy (50 Gy/25 fractions during Weeks 1-5) using a three-dimensional conformal radiation therapy or intensity-modulated radiation therapy technique together with weekly docetaxel (20 mg/m(2) at dose levels 1 and 2, 25 mg/m(2) at dose level 3 on Weeks 1-5) and cisplatin (30 mg/m(2) at dose level 1, 40 mg/m(2) at dose levels 2 and 3 on Weeks 1-5) from January 2009 to December 2011." | ( Di, ZL; Ke, Y; Ma, HB; Ren, J; Sun, X; Wen, J, 2015) |
| "Ten patients with esophageal squamous cell carcinoma (SCC), candidate to curative-intent concomitant chemo-radiotherapy (CRT), had FDG-PET/CT performed in treatment position, before and during (Day 21) radiotherapy (RT)." | ( Benyoucef, A; Doyeux, K; Dubray, B; Edet-Sanson, A; Gardin, I; Michel, P; Nkhali, L; Thureau, S; Vera, P, 2015) |
| "The radioresistance of esophageal squamous cell carcinoma (ESCC) remains an obstacle for the effective radiotherapy of ESCC." | ( Guo, Q; He, J; Hu, D; Huang, G; Kang, Y; Li, D; Ma, J; Ma, Z; Mao, W; She, R; Sun, X; Wang, J; Wang, Z; Xiao, C; Yang, X; Zhang, C; Zhang, Q; Zhou, X, 2015) |
| "The treatment of head and neck squamous cell carcinoma (HNSCC) with N3 (>6cm) lymph nodes remains difficult, and the best treatment strategy has not been elucidated." | ( Hanai, N; Hasegawa, Y; Hirakawa, H; Nakashima, T; Nishikawa, D; Ozawa, T; Suzuki, H, 2015) |
| "Four patients with squamous cell carcinoma, 1 with sebaceous carcinoma, and 1 with metachronous bilateral lymphomas were treated." | ( Abramson, DH; Barker, CA; Cohen, GN; Marr, BP; McCormick, B; Williamson, MJ, 2015) |
| "Primary ovarian squamous cell carcinoma is uncommon, and the optimal treatment strategy for this disease has not yet been established." | ( Kamei, T; Miwa, I; Nakamura, Y; Sakamoto, Y; Shinagawa, M, 2015) |
| "In Stage III/IV head and neck squamous cell carcinoma of the head and neck, multidisciplinary treatment is not standardized." | ( Cassir, J; Davis, MA; Fanelle, J; Nazha, NT; Sachdeva, K; Slotman, GJ; Smith, G; Sudhindra, R; Tyrrell, J; Wurzer, JV, 2015) |
| "We report three cases of cutaneous squamous cell carcinoma that were treated with Mohs' chemosurgery for palliative purposes." | ( Katoh, N; Nakai, N; Okuzawa, Y, 2015) |
| "Patients with esophageal squamous cell carcinoma were treated with escalating radiation dose of 4 levels, with a simultaneous integrated boost (SIB) to the pre-treatment 50% SUVmax area of the primary tumor." | ( Cai, XW; Feng, W; Fu, XL; Liu, Q; Yao, ZF; Yu, W; Zhang, Q; Zhang, YJ; Zhu, ZF, 2015) |
| "Patients with inoperable squamous cell carcinoma (SCC) of the oropharynx, oral cavity, or hypopharynx, were randomized between radiotherapy (RT) + IA cisplatin 150 mg/m(2) , followed by systemic rescue or RT + I." | ( Balm, AJ; Buter, J; de Boer, JP; Gregor, T; Heukelom, J; Lopez-Yurda, M; Rasch, CR; Sonke, JJ; Tan, IB; Verheij, M; Wiggenraad, R; Wijers, OB, 2016) |
| "The majority of anal cancers are squamous cell carcinomas, and they are treated according to stage." | ( Abdayem, P; Antoun, J; Ghosn, M; Kourie, HR; Nasr, D, 2015) |
| "All newly diagnosed patients with squamous cell carcinoma of head and neck (HNSCC) referred for treatment to the Oncology Unit at UMMC from 2003-2010 were retrospectively analyzed." | ( Alip, A; Phua, VC; Wan Ishak, WZ; Wong, YF; Yusof, MM, 2015) |
| "In several head and neck squamous cell carcinoma (HNSCC) cell lines, we observed a pattern of oscillating decrease and increase of intracellular ATP level after cetuximab treatment, and the magnitude and kinetics of which varied by cell line and appeared to be linked to the extent of cellular response to cetuximab." | ( Fan, Z; Hong, Y; Li, X; Lu, H; Lu, Y; Luo, J, 2015) |
| "Moreover, a case of squamous cell carcinoma arising from HeNe laser therapy after a chemical burn has never been reported." | ( Cho, HR; Chung, S; Kie, JH; Kwon, SS, 2015) |
| "Genomic analyses of squamous cell carcinoma (SCC) have yet to yield significant strategies against pathway activation to improve treatment." | ( Bi, C; Chng, WJ; Chua, KN; Goh, BC; Ho, J; Huynh, H; Kong, LR; Ng, HC; Nga, ME; Ong, WR; Pang, YH; Sim, WJ; Soo, RA; Thiery, JP, 2015) |
| "Between 2006 and 2011, 34 patients with squamous cell carcinoma of the temporal bone were treated at Kobe University Hospital." | ( Ejima, Y; Hasegawa, S; Hashikawa, K; Kenji, Y; Kiyota, N; Kohmura, E; Nibu, K; Nomura, T; Otsuki, N; Sakakibara, S; Sasaki, R; Shinomiya, H; Yamashita, D, 2016) |
| "Cultured human oral squamous carcinoma Tca8113 cells were treated with 2." | ( Jiao, K; Li, J; Wu, F; Yu, Z; Zhang, K; Zhu, Y, 2015) |
| "In recurrent head and neck squamous cell carcinoma ineligible for resection or irradiation, treatment aims primarily at symptom control and quality of life enhancement with an expected outcome of 6-12 months." | ( Carp, L; Corthouts, B; Specenier, P; Szturz, P; Van Den Weyngaert, D; Van Laer, C; Van Marck, E; Vanderveken, O; Vermorken, JB, 2016) |
| "Forty-three patients of squamous cell carcinoma of EAC were analyzed for clinical presentation, stage, surgical procedures and radiotherapy (RT) modalities employed." | ( Bhasker, S; Biswas, A; Gandhi, AK; Mohanti, BK; Raza, MW; Roy, S; Saxena, T; Sharma, A; Thakar, A, 2016) |
| "The treatment for squamous cell carcinoma of the anus changed dramatically during the study period." | ( Aravani, A; Downing, A; Finan, PJ; Lawton, S; Morris, EJ; Sebag-Montefiore, D; Thomas, JD, 2015) |
| "Esophageal squamous cell carcinomas (ESCC) have become a severe threat to health and the current treatments for ESCC are frequently not effective." | ( Cai, X; Chen, C; Chen, X; Cheng, W; Guan, Y; Hu, X; Jing, X; Tan, X; Wang, Q, 2015) |
| "Five different human squamous cell carcinoma cell lines (SiHa, FaDuDD, UTSCC5, UTSCC14 and UTSCC15) were treated with hypoxia, acidosis (pH 6." | ( Alsner, J; Busk, M; Horsman, MR; Overgaard, J; Sørensen, BS, 2015) |
| "Overall, 346 patients with resectable squamous cell carcinoma of esophagus were randomly assigned to receive surgery plus perioperative chemotherapy (175, arm A) or preoperative chemotherapy (171, arm B)." | ( Dai, Z; Kang, H; Min, W; Ren, H; Sui, X; Wang, XJ; Zhang, Y; Zhao, Y, 2015) |
| "In patients with operable esophageal squamous cell carcinoma, perioperative regimen of PCF can significantly improve 5-year relapse-free and overall survival comparing with preoperative chemotherapy alone." | ( Dai, Z; Kang, H; Min, W; Ren, H; Sui, X; Wang, XJ; Zhang, Y; Zhao, Y, 2015) |
| "Primary squamous cell carcinoma of the thyroid is a rare and aggressive type of neoplasm, which is routinely treated with surgery; however, despite this, survival time is not commonly more than six months." | ( Chen, G; Dai, C; Li, R; Liu, C; Ren, P; Wang, Y; Xue, B; Yan, M; Yu, J; Yu, XF; Zhong, T, 2015) |
| "Understanding the characteristics of squamous cell carcinoma of the head and neck, as imaged by FDG PET/CT, is crucial for determining treatment strategy, because it helps to avoid incorrect staging and also provides an accurate assessment of treatment response." | ( Barron, BJ; Brandon, DC; Corey, AS; Halkar, RK; Harrison, CE; Karagulle Kendi, AT; Plaxton, NA, 2015) |
| "For in vitro studies, human esophageal squamous cell carcinoma (ESCC) cell lines were treated with sunitinib 24 hours before irradiation." | ( Chen, XC; Ding, YQ; Gao, L; Luo, JD; Qin, Q; Sun, XC; Yang, X; Yang, Y; Yang, YH; Zhang, H; Zhou, XF; Zhu, HC, 2016) |
| "In contrast, the squamous cell carcinoma-associated biomarker CD44v6, visualized with (124)I-AbD19384 as well as (18)F-FDG uptake, were not significantly altered by AT13387 treatment." | ( Eriksson, O; Mortensen, AC; Nestor, M; Selvaraju, RK; Spiegelberg, D; Stenerlöw, B, 2016) |
| "Increased risk for cutaneous squamous cell carcinomas after vismodegib therapy highlights the importance of continued skin surveillance after initiation of this therapy." | ( Chang, AL; Chang, J; Henry, AS; Li, S; Mohan, SV; Wood, DJ, 2016) |
| "The treatment of squamous carcinoma, especially multidrug resistance (MDR) tumors, represents one of the most formidable challenges in oncology." | ( Chen, Y; Fang, X; Gao, F; Huang, Y; Zhang, W, 2016) |
| "Ninety patients, 65 with squamous cell carcinoma (SCC) and 25 with non-SCC (NSCC), who underwent pretreatment ¹⁸F-FDG PET/CT and pelvic MRI, were studied retrospectively." | ( Chino, Y; Kimura, H; Kurokawa, T; Okazawa, H; Rahman, T; Shinagawa, A; Tsuchida, T; Tsujikawa, T; Yamamoto, M; Yoshida, Y, 2016) |
| "Objectives Squamous cell carcinoma (SCC) is the most common oral tumor in cats and typically carries a poor prognosis with current treatment options." | ( Farrelly, J; Olmsted, GA; Post, GS; Smith, J, 2017) |
| "Patients with squamous cell carcinoma of the head and neck (SCCHN) typically present with locally advanced (LA) stage III or IV disease and are treated with combined-modality therapy with chemotherapy, radiotherapy, and surgery (if resectable)." | ( Mehra, R; Zibelman, M, 2016) |
| "The human squamous carcinoma cell line, SCL-1, was either untreated or treated with various combinations of ALA, PDT light source and inhibitors of MAPK signaling components." | ( Ge, X; Jiao, Y; Jing, L; Li, PA; Liu, J; Shi, Z; Wang, Y; Yu, N; Zhang, X, 2016) |
| "Patients with head and neck squamous cell carcinoma (HNSCC) present different responses to chemotherapy and radiotherapy." | ( Caballero, M; Cordón-Cardo, C; de la Iglesia-Vicente, M; de la Oliva, J; Domingo-Domenech, J; Grau, JJ; Larque, AB; Mesía, R; Taberna, M; Williams, ES, 2016) |
| "Human esophageal squamous carcinoma cell lines Eca109 and TE-13 were exposed to hypoxia and/or ionizing radiation (IR) with or without treatment of bortezomib." | ( Jiang, QJ; Qin, Q; Wang, D; Wang, DF, 2016) |
| "Due to the unique location of the squamous cell carcinoma (SCC) of the lip, using a single method such as extended resection or radiotherapy probably causes morphological and functional defects." | ( Lu, Y; Wang, Y; Yang, Y, 2016) |
| "Although locally advanced head and neck squamous cell carcinoma (HNSCC) can be effectively treated using chemoradiotherapy (CRT) with docetaxel (DTX), and cisplatin (CDDP) plus 5-fluorouracil (TPF-CRT), severe adverse events (especially neutropenia) can limit treatment adherence." | ( Arai, Y; Hata, M; Komatsu, M; Nishimura, G; Oridate, N; Sano, D; Shiono, O; Taguchi, T; Takahashi, H; Takahashi, M; Yabuki, K, 2016) |
| "In patients with R/M- Squamous cell carcinoma of the head and neck (SCCHN) who had progressed on/after first-line platinum-based therapy, afatinib induced significantly higher disease control rate, longer progression-free survival and improved patient-reported outcome compared to methotrexate." | ( Specenier, P; Vermorken, J, 2016) |
| "Women with primary untreated squamous cell carcinoma of the cervix with FIGO stages IB2 to IIIB were treated with weekly injections of cisplatin 30 mg/m2 and paclitaxel 35 mg/m2 for 5-6 weeks along with radiotherapy." | ( Abdi, R; Alikhasi, A; Amouzegar-Hashemi, F; Esmati, E; Kalaghchi, B, 2016) |
| "Primary explants from oral squamous cell carcinoma tissues further confirmed significant inhibition of proliferation (Ki67) in Lupeol-treated explants as compared to untreated control at 48 h." | ( Alam, N; Bhattacharyya, S; Biswas, J; Mehrotra, DG; Mondal, G; Murmu, N; Nath, P; Rauth, S; Ray, S; Roy, A, 2016) |
| "Patients with advanced esophageal squamous cell carcinoma were treated with paclitaxel 175 mg/m2 over 3 hours day 1 and cisplatin 75 mg/m2 day 1, every 3 weeks." | ( Chen, YS; Li, K; Liu, Y; Qiao, L; Wu, XY; Xu, SN; Yuan, L, 2016) |
| "Cutaneous squamous cell carcinoma (cSCC) is a frequent side-effect of vemurafenib treatment." | ( Aractingi, S; Avril, MF; Boitier, F; Carlotti, A; Chanal, J; Dupin, N; Herms, F; Kramkimel, N; Regnier-Rosencher, E, 2016) |
| "Oral squamous cell carcinoma (OSCC) exhibited high chemoresistance to current treatments." | ( Gavard, J; Tjioe, KC; Tostes Oliveira, D, 2016) |
| "mucogenicum mimicking a squamous cell carcinoma; an excellent response to combined therapy with rifampicin and clarythromicin was observed." | ( Galan-Gutierrez, M; Martinez-Peinado, CM; Ruiz-Villaverde, R; Sanchez-Cano, D, 2016) |
| "Many patients with locally advanced squamous cell carcinoma of the head and neck (LASCCHN) receive cisplatin-based radiochemotherapy." | ( Bajrovic, A; Hakim, SG; Janssen, S; Kazic, N; Rades, D; Schild, SE; Seidl, D; Strojan, P; Wollenberg, B, 2016) |
| "JQ1 may be a new drug for oral squamous cell carcinoma treatment." | ( Huang, P; Lv, Z; Qi, Y; Wang, L; Wei, X; Wu, X; Yang, P; Zhang, F, 2016) |
| "Human head and neck squamous cell carcinoma (HNSCC) is usually treated by surgical resection with adjuvant radio-chemotherapy." | ( Chang, CH; Chang, CY; Chiou, SH; Lee, TW; Lee, YJ; Lin, LT; Liu, RS; Wang, HE, 2016) |
| "Oral squamous cell carcinoma (OSCC) is genetically highly heterogeneous, which contributes to the challenges of treatment." | ( Ames-Draycott, A; Benaich, N; Cai, W; Goldie, SJ; Hayes, TF; Sipilä, K; Watt, FM; Yin, G, 2016) |
| "Head and neck squamous cell carcinomas from 81 patients were analyzed; clinical factors, histologic parameters, and expression of p16 and p53 were correlated with response to chemotherapy and prognosis." | ( Dumollard, JM; Forest, F; Fournel, P; Froudarakis, M; Gavid, M; Giroult, JB; Karpathiou, G; Monaya, A; Peoc'h, M; Prades, JM, 2016) |
| "Treatment of rectal squamous cell carcinoma should be similar to anal carcinoma, based on exclusive chemoradiation, displaying a 5-year overall survival rate over 80%, while it was 32% in surgical series." | ( Bosset, JF; Huguet, F; Loganadane, G; Schernberg, A; Servagi-Vernat, S; Touboul, E, 2016) |
| "Locoregional recurrences of squamous cell carcinoma of the head and neck (SCCHN) are difficult to treat." | ( Hakim, SG; Rades, D; Schild, SE; Seidl, D; Wollenberg, B, 2016) |
| "Recurrent/metastatic squamous cell carcinoma of the head and neck (SCCHN) has a poor prognosis and the combination of cisplatin and cetuximab, with or without 5-fluorouracil, is the gold standard treatment in this stage." | ( Aversa, C; Botti, G; Bruzzese, F; Budillon, A; Calogero, E; Caponigro, F; Cavalcanti, E; D'Aniello, R; Daponte, A; De Cecio, R; De Feo, G; Di Gennaro, E; Di Marzo, M; Ionna, F; Longo, F; Losito, NS; Maglione, MG; Maiolino, P; Montano, M; Muto, P; Pavone, E; Perri, F; Petrillo, A; Pontone, M; Sandomenico, F; Scala, S; Trotta, A; Zotti, AI, 2016) |
| "Head and neck squamous cell carcinoma (HNSCC) is a particularly challenging malignancy and requires more effective treatment strategies and a reduction in the debilitating morbidities associated with the therapies." | ( Katiyar, SK, 2016) |
| "Patients with advanced esophageal squamous cell carcinoma (ESCC) is received chemoradiotherapy or chemotherapy for clinical management." | ( Arigami, T; Ishigami, S; Kijima, T; Kijima, Y; Kita, Y; Kurahara, H; Maemura, K; Mori, S; Natsugoe, S; Okumura, H; Owaki, T; Uchikado, Y; Uenosono, Y, 2017) |
| "Using a mouse model of lung squamous cell carcinoma (SCC), we performed transcriptome sequencing (RNA-Seq) to profile bronchial airway gene expression and found activation of the PI3K and Myc signaling networks in cytologically normal bronchial airway epithelial cells of mice with preneopastic lung SCC lesions, which was reversed by treatment with the PI3K Inhibitor XL-147 and pioglitazone, respectively." | ( Lubet, RA; Miller, MS; Pan, J; Szabo, E; Wang, Y; Xiong, D; You, M; Zhang, Q, 2017) |
| "We present a case of a squamous cell carcinoma of the tongue with rare site of bilateral adrenal metastases on F-FDG PET/CT with response evaluation after chemotherapy." | ( Agarwal, KK; Bal, CS; Kumar, R; Parida, GK; Sahoo, MK; Thakar, A; Tripathi, M, 2017) |
| "Oesophageal squamous cell carcinoma is a deadly disease where systemic therapy has relied upon empiric chemotherapy despite the presence of genomic alterations pointing to candidate therapeutic targets, including recurrent amplification of the gene encoding receptor tyrosine kinase epidermal growth factor receptor (EGFR)." | ( Bass, AJ; Chen, T; Diehl, JA; Liu, JB; Nagaraja, A; Pectasides, E; Rustgi, AK; Sanchez-Vega, F; Sicinska, E; Stachler, M; Wong, G; Wong, KK; Wu, Z; Xu, X; Zhang, H; Zhou, J, 2017) |
| "His poorly differentiated HPV positive squamous cell carcinoma was treated with chemoradiotherapy." | ( Asimakopoulos, P; Fragkandrea Nixon, I; Mumford, C; Yong, L, 2017) |
| "Although cutaneous squamous cell carcinomas are by far the most frequent, emergence of potentially life-threatening secondary tumors from other sites following prolonged therapy is a growing concern." | ( Blackmon, JT; Conry, RM; Dhawan, R; Terry, NL, 2017) |
| "BACKGROUND Squamous cell carcinoma (SCC) is the second most common type of skin cancer, for which non- or mini-invasive treatment is of critical importance." | ( Dai, Y; Feng, W; Luo, X; Peng, J; Wang, T; Xiang, W; Zheng, J; Zhu, J, 2017) |
| "Ninety-six patients with cN0 lingual squamous cell carcinoma were recruited to undergo surgical treatment were randomly divided into two groups, namely, the carbon nanoparticle-labeled group (the experimental group, 50 cases) and the control group (46 cases)." | ( Canhua, J; Jie, C; Limeng, W; Ruipu, Z; Tingting, L; Xinchun, J, 2016) |
| "Treatment of recurrent maxillary squamous cell carcinoma usually includes tumor resection and free flap reconstruction." | ( Guo, CB; Liu, XJ; Peng, X; Yu, GY; Yu, Y; Zhang, WB, 2017) |
| "Oral squamous cell carcinoma is the fifth most common epithelial cancer in the world, and its current clinical treatment has both low efficiency and poor selectivity." | ( Arango-Rodríguez, ML; Conget, P; García, JE; Rivera, ZJ; Rosas, JE; Solarte, VA; Vernot, JP, 2017) |
| "Esophageal squamous cell carcinoma (ESCC) patients are at risk for local failure (LF) following treatment." | ( Fan, B; Fan, P; Fu, Z; Hu, M; Kong, L; Ma, L; Sun, X; Wang, S; Yu, J; Zhao, S; Zheng, J, 2017) |
| "Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide and is difficult to transfect for gene therapy." | ( Xu, L; Yang, H; Yeudall, WA, 2017) |
| "The responsiveness of head and neck squamous cell carcinoma (HNSCC) to chemotherapy widely affects prognosis." | ( Chung, IJ; Joo, YE; Kim, SA; Lee, DH; Lee, JK; Lee, KH; Lim, SC; Park, YL; Yoon, TM, 2017) |
| "Accordingly, leptin-treated oral squamous cell carcinoma cells show decreased messenger RNA caspase-3 expression, and increased levels of E-cadherin, Col1A1, matrix metalloproteinase-2, matrix metalloproteinase-9, and mir-210." | ( Cangussu, LMB; Cardoso, CM; de Jesus, SF; de Paula, AMB; Farias, LC; Fraga, CAC; Gomez, RS; Guimarães, ALS; Guimarães, TA; Santos, HO; Santos, SHS; Sobrinho Santos, EM, 2017) |
| "In the case of lung squamous cell carcinoma (LSCC), the treatment progress is slower than adenocarcinoma, for which several targeted agents have been already approved." | ( Altavilla, G; Bulotta, A; Gonzalez-Cao, M; Gregorc, V; Karachaliou, N; Lazzari, C; Rosell, R; Santarpia, M; Verlicchi, A, 2017) |
| "Despite advances in the head and neck squamous cell carcinoma (HNSCC) treatment modalities, drug resistance and cancer recurrence are often reported." | ( Alexandersson, L; Hansson, KT; Jönsson, JI; Roberg, K; Wiechec, E, 2017) |
| "Nowadays esophageal squamous cell carcinoma (ESCC) is primarily treated by a comprehensive approach combining surgical resection and neoadjuvant chemo- or radiotherapy." | ( Cai, J; Ge, Y; Guan, Z; Qian, X; Tan, C; Wang, F; Yang, B, 2017) |
| "The treatment for giant cutaneous squamous cell carcinoma (cSCC) is challenging." | ( Bu, W; Chen, X; Fang, F; Wang, Y, 2017) |
| "Oral squamous cell carcinoma (OSCC) cells are usually resistant to doxorubicin, resulting in limited application of doxorubicin in OSCC treatment." | ( Chai, J; Du, L; Ma, S; Wen, X; Zhou, D, 2017) |
| "Stage IV squamous cell carcinoma of the anus outcomes are poor, but first-line chemotherapy can enable good response rates." | ( Benezery, K; Cavaglione, G; Doyen, J; Evesque, L; Follana, P; François, E; Reure, J; Tuan Falk, A, 2017) |
| "We report a case of perianal squamous cell carcinoma and left inguinal lymph node metastasis that showed a complete response more than 5 years after chemotherapy and concomitant proton beam therapy." | ( Abe, T; Azami, A; Honda, M; Nakamura, T; Sato, A; Suzuki, N; Tada, T; Takano, Y; Teranishi, Y; Todate, Y; Waragai, M, 2017) |
| "In men with advanced penile squamous cell carcinoma receiving first-line chemotherapy, visceral metastases (VM) and Eastern Cooperative Oncology Group performance status ≥1 are poor prognostic factors for overall survival (OS)." | ( Bae, S; Chandrashekar, D; Chen, D; Colecchia, M; Cooper, T; Eigl, BJ; Giannatempo, P; Gordetsky, J; Mehta, A; Naik, G; Necchi, A; Sonpavde, G; Varambally, S; Wei, S; Yang, ES, 2018) |
| "Head and Neck squamous cell carcinoma is a widespread cancer that responds poorly to anticancer treatments such as chemotherapy and radiotherapy." | ( Chauvin, J; Judee, F; Merbahi, N; Vicendo, P, 2018) |
| "Effective treatments for esophageal squamous cell carcinoma (ESCC), one of the most common cancers in China, are lacking." | ( Che, Y; Chen, Z; He, J; Li, Y; Lu, Z; Pu, J; Sun, H; Wan, J; Wang, J; Yuan, Z; Zhang, J; Zhang, Z, 2017) |
| "Due to the high incidence of recurrent squamous cell carcinoma of the head and neck and the toxicity profile of current salvage regimens, there is a need for tolerable and effective treatment options." | ( Bellile, E; Bradford, CR; Chepeha, DB; Eisbruch, A; Manohar, PM; Pearson, AT; Prince, ME; Sapir, E; Shuman, AG; Spector, ME; Swiecicki, PL; Wolf, GT; Worden, FP, 2017) |
| "HSC-3 human oral squamous cell carcinoma cells were treated with varying doses of artepillin C for up to 72 hours." | ( Chino, T; Pang, S; Saba, Y; Yee, M, 2018) |
| "The wool hydrolysates decreased squamous cell carcinoma cells viability by up to 67% comparing to untreated cells." | ( Borkowska, JK; Czuwara, J; Damps, T; Konop, M; Kowalkowski, T; Laskowska, AK; Misicka, A; Prokopowicz, M; Puszko, AK; Różycki, K; Rudnicka, L; Sosnowski, P, 2017) |
| "Oral squamous cell carcinoma (OSCC) is an aggressive and treatment-resistant malignancy in both feline and human patients." | ( Arora, A; Dickerson, EB; Khammanivong, A; O'Sullivan, MG; Saha, J; Walz, JZ, 2018) |
| "Lung squamous cell carcinoma (SCC), accounting for approximately 30% of non-small cell lung cancer, is often refractory to therapy." | ( Chen, H; Deng, L; Gao, Y; Hou, S; Hu, G; Huang, H; Ji, H; Li, C; Li, F; Li, P; Li, X; Ma, X; Pan, Y; Xu, J; Zhang, L; Zhang, W, 2017) |
| "Pretreatment serum squamous cell carcinoma antigen (SCCA) is a prognostic biomarker in women with cervical cancer." | ( Chen, S; Dehdashti, F; DeWees, T; Grigsby, PW; Henke, LE; Liu, W; Luke, CJ; Markovina, S; Mutch, D; Pak, SC; Pfeifer, JD; Powell, MA; Schwarz, JK; Siegel, BA; Silverman, GA; Wang, S; Wang, X, 2018) |
| "Ninety-seven patients with oral squamous cell carcinoma, treated preoperatively with radiotherapy in combination with chemotherapy or cetuximab, were included in this retrospective analysis." | ( Eder-Czembirek, C; Fuereder, T; Selzer, E; Sulzbacher, I, 2018) |
| "Oesophageal squamous cell carcinoma (OSCC) is highly prevalent in developing countries but there has been little recent progress into efficacious yet affordable treatment strategies." | ( Damelin, LH; Jivan, R; Mavri-Damelin, D; Peres, J; Prince, S; Veale, RB; Wadee, R, 2018) |
| "Giant cutaneous squamous cell carcinoma (cSCC) in elderly people is difficult to treat." | ( Shi, L; Wang, P; Wang, X; Zhang, G; Zhang, H; Zhang, L; Zhao, Z; Zhou, Z, 2018) |
| "While the majority of cutaneous squamous cell carcinomas (cSCCs) can be treated surgically, the additional work-up and treatments indicated for high-risk cSCC remain undefined." | ( Que, SKT; Schmults, CD; Zwald, FO, 2018) |
| "Esophageal squamous cell carcinoma (ESCC) is an intractable digestive organ cancer that has proven difficult to treat despite multidisciplinary therapy, and a new treatment strategy is demanded." | ( Akimoto, AK; Akutsu, Y; Hanari, N; Hoshino, I; Iida, K; Kano, M; Matsubara, H; Matsumoto, Y; Murakami, K; Okada, K; Otsuka, R; Sakata, H; Sekino, N; Shiraishi, T; Takahashi, M; Toyozumi, T; Yokoyama, M, 2018) |
| "Objective Although lung squamous cell carcinoma (SCC) accounts for 20-30% of lung cancer cases, new treatment options are limited." | ( Amano, H; Fujita, T; Hayama, N; Hirano, S; Hiroishi, T; Nakamura, M; Nakamura, S; Shikano, K; Tabeta, H; Yanagisawa, A, 2018) |
| "The treatment of HPV-positive squamous cell carcinoma has a better response to both radiotherapy and chemotherapy and presents a better prognosis for the patient." | ( Açil, Y; Chu, H; Gerle, M; Gülses, A; Medina, TP; Naujokat, H; Wiltfang, J, 2018) |
| "Esophageal squamous cell carcinoma (ESCC) is one of the most common lethal tumors and is known to be lack of effective therapy." | ( Li, T; Li, Z; Liu, L; Liu, X; Long, F; Lv, Y; Zhan, Q; Zhu, X, 2018) |
| "Primary squamous cell carcinoma of the breast is a very rare disease with no standard treatment approach." | ( Alan, O; Ercelep, O; Hasanov, R; Kaya, H; Mutis, A; Ones, T; Simsek, ET; Telli, TA; Yumuk, PF, 2019) |
| "Treatment choice for lung squamous cell carcinoma could be aided by identifying predictive biomarkers." | ( Ardizzoni, A; Bühnemann, C; Cobo, M; Cseh, A; Ehrnrooth, E; Felip, E; Fülöp, A; Gadgeel, SM; Georgoulias, V; Gibson, N; Göker, E; Goss, GD; Guclu, S; Isla, D; Krämer, N; Lee, KH; Li, W; Lu, S; Min, YJ; Morabito, A; Solca, F; Soria, JC; Syrigos, K, 2018) |
| "In the present study, human primary oral squamous carcinoma cells treated with cisplatin and 5-fluorouracil were analyzed, for the first time, by in vitro FTIR Microspectroscopy (FTIRM), to improve the knowledge on the biochemical pathways activated by these two chemotherapy drugs." | ( Bedolla, DE; Conti, C; Giorgini, E; Mitri, E; Notarstefano, V; Orilisi, G; Rocchetti, R; Rubini, C; Sabbatini, S; Vaccari, L, 2018) |
| "Lung squamous cell carcinoma (LSCC) is a common type of non-small-cell lung cancer (NSCLC) and lacks effective treatment." | ( Chen, ML; Hu, X; Li, YL; Wu, LW; Zhang, C; Zhang, ZY, 2018) |
| "Head and neck squamous cell carcinoma (HNSCC) is an aggressive malignancy characterized by tumor heterogeneity, locoregional metastases, and resistance to existing treatments." | ( Alamoud, KA; Bais, MV; Belkina, AC; Egloff, AM; Feng, H; Kartha, VK; Kukuruzinska, MA; Laroche, F; Lee, J; Monti, S; Nguyen, BC; Pai, SI; Sadykov, K; Snyder-Cappione, JE; Varelas, X, 2018) |
| "Esophageal squamous cell carcinoma (ESCC) exhibits good reactivity to chemoradiation therapy (CRT)." | ( Baatar, S; Gombodorj, N; Kumakura, Y; Kuriyama, K; Kuwano, H; Miyazaki, T; Nishiyama, M; Sakai, M; Shirabe, K; Sohda, M; Suzuki, S; Tanaka, N; Yokobori, T; Yoshida, T, 2018) |
| "Treatment of unresectable canine squamous cell carcinoma (SCC) remains challenging and new therapeutic strategies are needed." | ( Bonkobara, M; Ikeda, T; Ishizaka, M; Kobayashi, M; Kurita, S; Miyamoto, R; Saima, H; Tamura, K; Tani, H, 2018) |
| "Radiotherapy for esophageal squamous cell carcinoma (ESCC) patients is limited by resistance to ionizing radiation (IR)." | ( Chen, M; Fang, Y; Fei, Z; Shen, L; Su, H; Wu, Y; Xie, C, 2019) |
| "Patients with HPV+ oropharyngeal squamous cell carcinoma were assigned to dose and volume de-escalated radiotherapy (RT) or chemoradiotherapy (CRT) based on response to induction chemotherapy in an effort to limit treatment-related toxicity while preserving efficacy." | ( Agrawal, N; Blair, EA; Brisson, RJ; Dekker, A; Foster, CC; Ginat, DT; Gooi, Z; Haraf, DJ; Karrison, TG; Kochanny, S; Lingen, MW; Melotek, JM; Portugal, L; Seiwert, TY; Villaflor, VM; Vokes, EE, 2019) |
| "Oropharyngeal and esophageal squamous cell carcinomas, especially the latter, are a lethal disease, featuring intratumoral cancer cell heterogeneity and therapy resistance." | ( Arigami, T; Avadhani, NG; Bass, AJ; Basu, D; Chandramouleeswaran, PM; Diehl, JA; Doki, Y; Ginsberg, GG; Giroux, V; Hara, T; Kasagi, Y; Kijima, T; Kikuchi, O; Kita, Y; Klein-Szanto, AJ; Mori, M; Muir, AB; Muto, M; Naganuma, S; Nakagawa, H; Natsugoe, S; Ohashi, S; Omoto, I; Rustgi, AK; Sahu, V; Sasaki, K; Shimonosono, M; Shinden, Y; Tanaka, K; Uchikado, Y; Whelan, KA, 2019) |
| "We report a case of well-differentiated squamous cell carcinoma developing on the lower lip of a 59-year-old woman who had previously undergone local radiotherapy for a hemangioma, in which the use of non-invasive imaging techniques such as in vivo reflectance confocal microscopy (RCM) and dermoscopy allowed an early diagnosis and a prompt, effective treatment." | ( Boda, D; Căruntu, A; Căruntu, C; Lupu, M; Moraru, L; Tănase, C; Voiculescu, VM, 2018) |
| "Locally advanced squamous cell carcinoma of the head and neck (LASCCHN) is usually treated with cisplatin (CDDP)-based chemoradiotherapy, except when patients are elderly or have renal, cardiac, or neurogenic dysfunction." | ( Hamauchi, S; Homma, A; Iida, Y; Kamijo, T; Mizumachi, T; Nishimura, T; Ogawa, H; Onitsuka, T; Onoe, T; Onozawa, Y; Yasui, H; Yokota, T, 2019) |
| "FaDu hypopharyngeal squamous cell carcinoma cells treated with miR‑194‑5p mimics exhibited decreased viability, invasion and migration." | ( Hui, L; Jiang, XJ; Wang, Y; Xu, S; Yang, N; Zhao, N, 2019) |
| "The use of EGFR inhibitors on oral squamous cell carcinoma (OSCC) as monotherapy yielded modest clinical outcomes and therefore would benefit from biomarkers that could predict which patient subsets are likely to respond." | ( Cheong, SC; Fadlullah, MZH; Gan, CP; Kelly, GM; Lee, BKB; Lee, HM; Patel, V; Yee, PS; Zainal, NS, 2019) |
| "93 patients with anal squamous cell carcinoma treated with chemoradiotherapy were included in a prospective observational study (NCT01937780)." | ( Guren, MG; Hernes, E; Klotz, D; Malinen, E; Rekstad, BL; Rusten, E; Undseth, C, 2019) |
| "We herein report a 78-year old man with squamous cell carcinoma of the lungs treated with pembrolizumab." | ( Fujiwara, K; Iwamoto, Y; Kayatani, H; Minami, D; Okawa, S; Ozeki, T; Sato, K; Shibayama, T; Takada, K, 2019) |
| "To facilitate studies on mechanisms of squamous cell carcinoma (SCC) evasion of checkpoint blockade immunotherapy, we sought to develop a novel panel of murine syngeneic SCC lines reflecting the heterogeneity of human cancer and its responses to immunotherapy." | ( Adoumie, M; Akhurst, RJ; Arce Vargus, F; Balmain, A; Binnewies, M; Broz, ML; Buchmann, T; Del Rosario, R; Dodagatta-Marri, E; Hann, BC; Krummel, MF; Li, O; Liang, B; Malato, J; Meyer, DS; Mirza, A; Mori, H; Paniagua, R; Quezada, SA; Reeves, MQ; Rosenblum, MD; Sheppard, D; To, MD; Wu, D, 2019) |
| "Standard treatment of squamous cell carcinoma (SCC) of the anterior nasal mucosa is surgical resection with or without postoperative radiation." | ( Barker, CA; Cohen, MA; Cracchiolo, JR; Dunn, LA; Ganly, I; Katabi, N; Lee, A; Lee, N; Mah, D; McBride, S; McGill, M; Mimica, X; Sine, K; Yu, Y, 2019) |
| "Oral squamous cell carcinoma (OSCC) is a challenging disease to treat." | ( Abdul Rahman, ZA; Cheong, SC; Gan, CP; Lee, BKB; Patel, V; Sam, KK; Tan, AC; Yee, PS; Zain, RB; Zainal, NS, 2019) |
| "Here we report new observations that squamous carcinoma (SCC-25) cells, exposed to 24 hours of combined resveratrol and berberine treatment, contain increased ROS levels." | ( Buldak, RJ; Dziedzic, A; Hejmo, T; Hudy, D; Poterala-Hejmo, A; Skonieczna, M, 2019) |
| "In the treatment of squamous cell carcinoma of the head and neck(SCCHN), platinum-based drugs have become a mainstay of drug therapy." | ( Tahara, M, 2019) |
| "In our department, patients with oral squamous cell carcinoma(OSCC)received preoperative chemotherapy containing S-1 to prevent the growth and dissemination of tumors during the waiting time before definitive surgery." | ( Amino, K; Imai, T; Iwai, S; Kanesaki, T; Katou, I; Matsumiya, Y; Meshii, N; Nakazawa, M; Niki, A; Omae, M; Onishi, T; Ota, Y; Suematsu, M; Sumi, T; Takeshita, A; Ueda, M, 2019) |
| "Ten patients with head and neck squamous cell carcinoma (HNSCC) were enrolled in the study between June 2014 and October 2015 and underwent DCE MRI imaging prior to beginning treatment." | ( Deasy, JO; Elkin, R; Hatzoglou, V; Lee, NY; LoCastro, E; Nadeem, S; Paudyal, R; Shukla-Dave, A; Tannenbaum, A, 2019) |
| "Differentiating a KA from a squamous cell carcinoma (SCC) is important for treatment implications but is often challenging." | ( Doerfler, L; Hanke, CW, 2019) |
| "We identified 244 patients with squamous cell carcinoma of the tonsil treated with RT from 2004 to 2013." | ( Estilo, CL; Hilden, P; Huryn, JM; Lee, NY; Leeman, J; Owosho, AA; Tsai, CJ; Verma, N; Yom, S, 2019) |
| "Incidence of anal squamous cell carcinoma (ASCC) is increasing, with curative chemoradiotherapy (CRT) as the primary treatment of non-metastatic disease." | ( Appelt, AL; Brown, PJ; Currie, S; Frood, R; Gilbert, A; Scarsbrook, A; Sebag-Montefiore, D; Zhong, J, 2019) |
| "We experienced a case of eruptive squamous cell carcinoma (SCC) in a patient treated concomitantly with pembrolizumab and imiquimod, a TLR7 agonist." | ( Arimura, A; Kanekura, T; Kirishima, M; Tanimoto, A, 2019) |
| "18 months later, she developed a squamous cell carcinoma treated with chemotherapy and radiotherapy." | ( Bahloul, Z; Frikha, O; Guermazi, M; Jallouli, M; Marzouk, S; Snoussi, M, 2019) |
| "Tongue squamous cell carcinoma Cal27 cells were subcultured, and the logarithmic growth phase cells were selected and divided into blank control group, nicotine-treated group and α7 nicotinic acetylcholine receptor inhibition-treated group (α7nAChR inhibition group)." | ( Duan, XF; He, J; Kang, JY, 2019) |
| "Skin squamous cell carcinoma (SCC) is the second most common skin cancer, and surgical resection is the first choice of treatment." | ( Ma, J; Wang, X, 2020) |
| "HPV infection renders oropharyngeal squamous cell carcinomas more radiosensitive, which results in a favorable prognosis for HPV-positive patients treated with radiation alone or with concurrent platinum-based chemotherapy." | ( Brozic, A; Cemazar, M; Kranjc Brezar, S; Niksic Zakelj, M; Prevc, A; Sersa, G; Strojan, P, 2020) |
| "Cutaneous squamous cell carcinoma (SCC) of the hand presents a treatment challenge because of the anatomical complexity of this location." | ( Council, ML; Hurst, EA; Mull, AB; Mull, JL; Phelan, PS; Russell, AJ, 2020) |
| "Laryngeal squamous cell carcinoma (LSCC) is a common head and neck cancer that is unresponsive to chemotherapy; therefore, understanding the causes of chemotherapy resistance is important." | ( Chen, B; Ding, Y; Fan, J; Gao, W; Nan, X; Wang, B; Wang, J; Wen, S; Wu, Y; Zhao, Q, 2020) |
| "Despite a decline in the incidence of squamous cell carcinomas (SCCs) over the past 20 years, their survival rate has remained nearly the same, indicating that treatment options have not improved relative to other cancer types." | ( Strait, AA; Wang, XJ, 2020) |
| "Although the number of cutaneous squamous cell carcinoma (cSCC) cases is increasing, the effectiveness of systemic therapy for the treatment of advanced cSCC is limited." | ( Aiba, S; Fujimura, T; Hashimoto, A; Kambayashi, Y; Lyu, C; Ohuchi, K; Tono, H, 2020) |
| "Oral squamous cell carcinoma (OSCC) is a very aggressive malignancy, and 50% of patients who receive curative treatment die from the disease or related complications within 5 years." | ( Chen, L; Guo, X; Hu, Y; Li, L; Liang, G; Zhang, G, 2020) |
| "The oral squamous cell carcinoma (OSCC) stands out as a public health problem due to its high incidence and low survival rate, despite advances in diagnosis and treatment." | ( Alvarez Abreu, P; Cardozo Paes de Almeida, E; Carolina Carvalho da Fonseca, A; Cavalcanti Chipoline, I; de Carvalho da Silva, F; de Queiroz, LN; Francisco Ferreira, V; Luiz Ferraz de Souza, T; Pereira de Souza, M; Pontes, B; Ribeiro Machado da Costa, G; Robbs, BK; Won-Held Rabelo, V, 2020) |
| "Oral squamous cell carcinoma cells were treated with or without isorhamnetin." | ( Chen, Q; Feng, X; Ji, N; Jiang, L; Li, J; Shen, Y; Song, S; Wang, Z; Xie, L; Zeng, X; Zhao, H; Zhou, M; Zhou, Y, 2021) |
| "Head and neck squamous cell carcinoma (HNSCC) is an aggressive and difficult-to-treat cancer entity." | ( Bauer, RJ; Ehrenschwender, M; Hammer, KP; Heimer, S; Jantsch, J; Knoll, G; Neubert, P; Wagner, S, 2021) |
| "Cisplatin-resistant oral squamous cell carcinoma (OSCC) cells acquire stem-like characteristics and are difficult to treat." | ( Jha, A; Kashyap, T; Mishra, P; Mishra, R; Nagini, S; Nath, N, 2020) |
| "Advanced cutaneous squamous cell carcinoma (SCC) responds poorly to chemotherapy, leading to significant morbidity or death." | ( Kitamura, S; Maeda, T; Yanagi, T, 2020) |
| "We describe two cases of upper limb squamous cell carcinoma treated with radiotherapy, review the literature on radiotherapy as a primary treatment modality, and discuss the specific difficulties treating SCC in the hand." | ( Brewer, CF; Deutsch, CJ; Jemec, B, 2020) |
| "Curative chemoradiotherapy of squamous cell carcinoma achieves long-term complete remissions in most patients and minimizing treatment toxicity becomes crucial issue." | ( Drbohlavová, T; Jirkovská, M; Lohynská, R; Malinová, B; Mazaná, E; Nýdlová, A; Stankušová, H; Veselský, T, 2020) |
| "We here report a case of vulvar squamous cell carcinoma in a HIV-1-positive patient with first-line antiretroviral therapy (ARV) failure." | ( Dia-Badiane, NM; Diedhiou, M; Dièye, A; Ndong, A; Seck, B; Shinga, BW; Tendeng, JN, 2020) |
| "Lung squamous cell carcinoma (LSCC) remains a challenging disease to treat, and further improvements in prognosis are dependent upon the identification of LSCC-specific therapeutic biomarkers and/or targets." | ( Bilguun, EO; Kaira, K; Kawabata-Iwakawa, R; Nishiyama, M; Oyama, T; Rokudai, S; Shimizu, K; Shirabe, K; Yokobori, T, 2020) |
| "Oral squamous cell carcinoma (OSCC) is a prevalent cancer that develops in the head and neck area and has high annual mortality despite optimal treatment." | ( Chen, L; Jiang, Y; Wang, Y, 2020) |
| "Canine squamous cell carcinoma (SCC) is difficult to treat if local therapy is not feasible." | ( Bonkobara, M; Ikeda, T; Miyamoto, R; Saima, H; Tamura, K; Tani, H, 2021) |
| "Treatment of patients with laryngeal squamous cell carcinoma with radiotherapy or chemoradiation is an established alternative to laryngeal surgery in many cases, but particularly for advanced tumors without cartilage invasion." | ( Bohr, C; Grosse, J; Hackenberg, B; Hautmann, MG; Jung, EM; Künzel, J; Mehanna, H; Michaelides, I; Rennert, J; Seebauer, CT; Ugele, I, 2021) |
| "Twenty-five patients with squamous cell carcinoma of the anal canal were treated at our centre from 2012 to 2019 using IMRT based chemoradiation." | ( Ram, TS; Ramireddy, JK; Sathyamurthy, A; Singh, K, 2022) |
| "OS was analyzed for subgroups with squamous cell carcinomas (SCC) or adenocarcinomas (AC) and stratified for extent of metastatic disease and treatment goals." | ( Gani, C; Gatidis, S; la Fougère, C; Nikolaou, K; Pfannenberg, C; Reinert, CP; Sekler, J, 2021) |
| "Patients with oral squamous cell carcinoma (OSCC) bone invasion are surgically treated with bone resection, which results in severe physical and psychological damage." | ( Chung, WY; Jung, MJ; Kim, H; Kim, KR; Lee, SK; Park, J; Park, KK; Son, SH, 2021) |
| "Incidence of cutaneous squamous cell carcinoma (cSCC) and actinic keratosis has increased worldwide, and non-steroidal anti-inflammatory drugs as celecoxib are considered for treatment." | ( Eberle, J; May, S; Stockfleth, E; Ulrich, C; Zhu, J, 2021) |
| "We report a case of periocular squamous cell carcinoma invading the anterior orbit that significantly reduced in size and regressed from invasive to in situ following treatment with oral acitretin, a second-generation retinoid." | ( Bata, B; Currie, Z; Salvi, S; Tan, J; Wang, H, 2021) |
| "The biopsy confirmed squamous cell carcinoma, and the patient was referred for chemotherapy and radiotherapy." | ( Bajin, MD; Bulut, EG; Katar, O; Sennaroğlu, L, 2021) |
| "Treatment strategies for cutaneous squamous cell carcinoma in situ (cSCCIS) are many but reported cure rates are variable and few studies report 5-year follow-up data." | ( Kerner, JD; Kerner, JV; Ondo, AL; Ondo, IP; Shanler, SD; Trainor, P, 2021) |
| "Of the 6 with anal squamous cell carcinoma, all received 5-fluorouracil and mitomycin C with external beam radiation therapy." | ( Click, B; Hull, TL; Lightner, AL; McMichael, J; Regueiro, M; Steele, SR; Vaidya, P, 2021) |
| "Cutaneous squamous cell carcinoma (SCC) is an increasingly prevalent and potentially fatal disease with considerable implications if not recognized early and treated promptly." | ( Fahy, EJ; Hussey, A; Jones, D; Kelly, J; Kerin, M; McInerney, NM; Potter, S; Regan, P; Sugrue, CM, 2022) |
| "Cutaneous squamous cell carcinoma (cSCC) is a highly prevalent skin malignancy, and the effective therapy still remains a challenge." | ( Bi, X; Jiang, Z; Luan, Z; Qiu, D, 2021) |
| "Oral squamous cell carcinomas (OSCCs) are one of the most prevalent malignancies, with a low five-year survival rate, thus warranting more effective drugs or therapy to improve treatment outcomes." | ( Choi, WS; Su, Y; Wang, L, 2021) |
| "Lung squamous cell carcinoma (LUSC) accounts for one of three of non-small cell lung carcinoma (NSCLC) and 30% of LUSC patients present with locally advanced, unresectable/medically inoperable disease, who are commonly treated with definitive chemoradiation." | ( Duan, W; Shen, C; Shyu, DL; Webb, A; Williams, TM; Xu, M; Yang, L, 2022) |
| "Patients with large cutaneous squamous cell carcinoma of the scalp are a treatment challenge." | ( Gruber, I; Koelbl, O, 2021) |
| "BACKGROUND Primary squamous cell carcinoma of the breast is a rare type of metaplastic breast carcinoma, characterized by resistance to conventional chemotherapy agents." | ( Hanamura, N; Ishitobi, M; Kashikura, Y; Kozuka, Y; Mizuno, T; Noro, A; Ogawa, T; Saito, K; Yamashita, M, 2022) |
| "Anal canal squamous cell carcinoma (ACSCC) is an exceedingly rare malignant neoplasm with challenges in sphincter preservation, treatment toxicities and long-term survival." | ( Cai, P; Chen, B; Gao, Y; Liao, Z; Wang, F; Wang, S; Xiao, W; Yuan, Y; Zeng, Z; Zhang, R, 2021) |
| "Esophageal squamous cell carcinoma (ESCC) is an intractable digestive organ cancer and new treatment strategy is required." | ( Endo, S; Hirasawa, S; Iida, K; Kamata, T; Kano, M; Kinoshita, K; Kobayashi, S; Komatsu, A; Matsubara, H; Matsumoto, Y; Murakami, K; Okada, K; Otsuka, R; Ryuzaki, T; Sakata, H; Sasaki, T; Sekino, N; Shiraishi, T; Suito, H; Takahashi, M; Toyozumi, T; Yokoyama, M, 2022) |
| "With the growing incidence of cutaneous squamous cell carcinoma (CSCC), the treatment-resistant invasive CSCC should be taken seriously." | ( Chu, Z; Cong, Y; Geng, S; Guo, K; Shi, L; Zhang, X; Zhao, Q; Zheng, Y, 2022) |
| "Two cervical squamous carcinoma cell lines (SiHa and Caski) overexpressing APOA1 were constructed, treated with carboplatin, and compared to normal control cells." | ( Han, SB; He, Y; Liu, Y; Wu, YM; Zhang, JJ, 2022) |
| "Treatment of oral squamous cell carcinoma (OSCC) is based on clinical exam, biopsy, and a precise imaging-based TNM-evaluation." | ( Burian, E; Callahan, N; Froelich, MF; Gassert, FG; Makowski, MR; Palla, B; Pyka, T; Rübenthaler, J; Schmid, A; von Schacky, CE; Wolff, C, 2022) |
| "Patients with squamous cell carcinoma of the head and neck who were treated using definitive chemoradiation from 2012 to 2018 were identified." | ( Frizzell, BA; Greven, KM; Hughes, RT; Rush, MC; Russell, GB; Shenker, RF; Steber, CR, 2022) |
| "With high PD-L1 expression, squamous cell carcinoma (SCC), and PS 0-1, clinicians may offer nivolumab and ipilimumab alone or in combination with two cycles of platinum-based chemotherapy." | ( Baker, S; Blanchard, E; Brahmer, JR; Celano, P; Duma, N; Elkins, IB; Ellis, PM; Haddad, RY; Hesketh, PJ; Jain, D; Jaiyesimi, IA; Johnson, DH; Leighl, NB; Mamdani, H; Masters, G; Moffitt, PR; Phillips, T; Riely, GJ; Robinson, AG; Rosell, R; Schiller, JH; Schneider, BJ; Singh, N; Spigel, DR; Temin, S, 2022) |
| "Locally advanced or metastatic squamous carcinoma of the anal canal (SCAC) has poor prognosis following platinum-based chemotherapy." | ( Anandappa, G; Arnold, D; Capdevila, J; Catlett, M; Cornfeld, M; Dahan, L; Demols, A; Evesque, L; Fakih, M; Gilbert, DC; Guren, MG; Jensen, LH; Kayyal, T; Kim, S; Rao, S; Samalin, E; Saunders, MP; Smith, M; Spano, JP; Spindler, KL; Tamberi, S; Tian, C, 2022) |
| "Head and neck squamous cell carcinoma (HNSCC) remains a deadly disease despite concerted efforts to improve its diagnosis and treatment in recent decades." | ( Lang, L; Teng, Y, 2022) |
| "Treatment of oral squamous cell carcinoma (OSCC) cells with the synthetic vitamin A derivative, fenretinide (4HPR), induces numerous cancer-preventive effects including suppression of basement membrane invasion, elimination of anchorage-independent growth, disruption of actin cytoskeletal components and inhibition of the invasion-enabling focal adhesive kinase." | ( Bissonnette, C; Din, C; Lin, YX; Liu, Y; Mallery, SR; Nieto, K; Pei, P; Schwendeman, SP; Shea, FF; Spinney, R; Wang, D, 2022) |
| "Lung squamous cell carcinoma (LUSC) treatment response is poor and treatment alternatives are limited." | ( Dong, C; Li, H; Liu, B; Ou, H; Qi, W; Sun, J; Xiang, W, 2022) |
| "While most cases of cutaneous squamous cell carcinoma (cSCC) are benign, invasive cSCC is associated with higher mortality and is often more difficult to treat." | ( Averitte, RL; Hull, EE; Leyva, KJ; Montgomery, MR; Pulford, CS; Uppalapati, CK, 2022) |
| "We report a rare case of primary squamous cell carcinoma of the thyroid in a 68-year-old White male who underwent chemoradiation and palliative immunotherapy after declining surgery." | ( Besch, BM; Henson, C; Hsieh, ML; Peterson, JEG, 2022) |
| "This case suggested advanced lung squamous cell carcinoma patients who have failed to respond to first-line albumin paclitaxel combined with immunotherapy may still benefit from second-line docetaxel combined with immunotherapy." | ( Guo, S; Li, S; Ma, K; Wang, J; Wei, S; Xu, Y; Zhang, F, 2022) |
| "Finally, REG1 knockdown in human squamous cell carcinomas lines enhanced PTGS2 mRNA levels after 12-O-tetradecanoylphorbol-13-acetate treatment." | ( Akira, S; Morisaka, H; Sano, S; Takaishi, M, 2023) |
| "Finally, REG1 knockdown in human squamous cell carcinomas lines enhanced PTGS2 mRNA levels after 12-O-tetradecanoylphorbol-13-acetate treatment." | ( Akira, S; Morisaka, H; Sano, S; Takaishi, M, 2023) |
| "For patients with esophageal squamous cell carcinoma (ESCC), standard therapeutic methods (cisplatin and radiotherapy) have been found to be ineffective and severely toxic." | ( Alu, A; Bai, Z; Bi, Z; Cheng, D; Cheng, Y; Lan, T; Liu, Y; Song, Y; Wei, X; Wei, Y, 2023) |
| "For patients with esophageal squamous cell carcinoma (ESCC), standard therapeutic methods (cisplatin and radiotherapy) have been found to be ineffective and severely toxic." | ( Alu, A; Bai, Z; Bi, Z; Cheng, D; Cheng, Y; Lan, T; Liu, Y; Song, Y; Wei, X; Wei, Y, 2023) |
| "Treating patients with esophageal squamous cell carcinoma (ESCC) is challenging due to the high chemoresistance." | ( Du, Y; Feng, F; Fu, Y; Li, M; Li, Y; Ma, Y; Wang, X; Yuan, P; Zhang, Y; Zhu, Q, 2023) |
| "Treating patients with esophageal squamous cell carcinoma (ESCC) is challenging due to the high chemoresistance." | ( Du, Y; Feng, F; Fu, Y; Li, M; Li, Y; Ma, Y; Wang, X; Yuan, P; Zhang, Y; Zhu, Q, 2023) |
| "B3 thymoma and especially squamous carcinoma patients may be treated using a similar therapy scheme as that utilized for thymic carcinoma." | ( Hao, Y; Jin, J; Si, J; Song, Z; Wei, J; Xiang, J; Xu, C, 2022) |
| "Treatment regimens for head and neck squamous cell carcinoma (HNSCC) typically include cisplatin and radiotherapy and are limited by toxicities." | ( Cohen, MS; Kovatch, KJ; Pearce, R; Prince, ME; Spielbauer, KK; Subramanian, C; Timmermann, BN, 2022) |
| "Anal squamous cell carcinoma (ASqCC) is a rare malignancy, traditionally treated with combined chemoradiation, with a continuous infusion of 5-fluorouracil (5-FU) and mitomycin C (MMC)." | ( Ben David, MA; Grinberg, V; Hod, K; Kalmus, Y; Levin, D; Lipski, Y; Pfeffer, RM; Schlosser, S; Zalmanov, S, 2023) |
| "Human tongue squamous cell carcinoma cell lines (SCC-15 cells) were treated with melatonin, erastin, or their combination." | ( Choi, WS; Li, X; Su, Y; Tao, Z; Wang, C; Wang, L; Zhu, W, 2023) |
| "Esophageal squamous cell carcinoma (ESCC) is a deadly disease with few prevention or treatment options." | ( Brydges, CR; Croce, CM; Farber, JL; Fiehn, O; Fong, LY; Huebner, K; Jing, R; Smalley, KJ, 2023) |
| "Head and neck squamous cell carcinoma (HNSCC) is a significant public health problem, with a need for novel approaches to chemoprevention and treatment." | ( Iwenofu, OH; Jordanides, PP; Lamenza, FF; Oghumu, S; Pracha, H; Roth, P; Ryan, NM; Siddiqui, A; Springer, A; Upadhaya, P, 2023) |
| "Feline oral squamous cell carcinoma (FOSCC) is an aggressive cancer in domestic cats that has no effective treatment option when advanced." | ( Bryan, JN; Burton, JH; Cermak, J; Chu, S; Lee, S; Marquardt, TM; Noall, L; Rogic, AM; Thombs, LA, 2023) |
| "Advanced cutaneous squamous cell carcinoma (cSCC) is treated with chemotherapy and/or radiotherapy, but these typically fail to achieve satisfactory clinical outcomes." | ( Hsu, CY; Kitamura, S; Maeda, T; Miyamoto, K; Nishihara, H; Tokuchi, K; Ujiie, H; Yanagi, T, 2023) |
| "Patients with early glottic squamous cell carcinoma treated via radiation therapy from January 2007 to November 2019 were reviewed." | ( Ishihara, S; Itoh, Y; Kawamura, M; Nagai, N; Naganawa, S; Oie, Y; Okumura, M; Ono, T; Oyoshi, H; Takase, Y, 2023) |
| "The treatment of oral squamous cell carcinoma (OSCC) includes systemic chemotherapy and is associated with aggressive side effects on patients." | ( Aboushelib, MN; Al-Wakeel, E; Badawi, MF; Elsaady, SA, 2023) |
| "Cervical squamous cell carcinoma line SiHa was treated with different concentrations of substance P." | ( Huang, L; Liu, H; Ma, J; Wang, Y; Yuan, S; Zhang, F, 2023) |
| "Oral squamous cell carcinoma (OSCC) has limited treatment options." | ( Chang, PL; Chen, YT; Hsiao, HC; Hsieh, LL; Hsu, FT; Hsu, LC; Lin, CN; Lin, KH; Tu, HF; Wang, HY, 2023) |
| "For the treatment of patients with oral squamous cell carcinoma (OSCC), the imaging of cervical lymph nodes and the evaluation of metastastic progression are of great significance." | ( Butch, CJ; Li, Y; Shi, J; Wang, Y; Wang, Z; Xie, D; Zhu, YP, 2023) |
| "Cutaneous squamous cell carcinomas (cSCCs) of the lip have been reported to be at higher risk for poorer post-treatment outcomes." | ( Le, K; Nadir, U; Nijhawan, RI; Shi, K; Srivastava, D, 2023) |